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Abstract 
 
Damage to cartilage, caused either by disease or injury, affects a large number of 
people worldwide, severely reducing the patients quality of life and generating a 
huge burden on healthcare systems.  The limited success of treatment options such as 
tissue grafts has been the driving force behind much research into tissue engineering 
strategies for cartilage repair.  One of the challenges associated with tissue 
engineering cartilage is that of generating constructs of clinically relevant sizes since 
the formation of a crust of tissue at the scaffold periphery restricts the supply of 
nutrients to the growing tissue.  The hypothesis of this thesis was that a tissue 
engineering system incorporating scaffolds containing both random and anisotropic 
porosity and a novel flow perfusion bioreactor system would facilitate in vitro tissue 
formation by enhancing the supply of nutrients to the growing construct.  This 
hypothesis was examined using cartilage as a model tissue.  It was shown that 
scaffolds combining both random and anisotropic porosity (sparse knit scaffolds) had 
improved flow properties compared to scaffolds containing random porosity alone 
(needled felt scaffolds).  Following studies to characterise the scaffolds and to 
determine the appropriate conditions for seeding cells into the scaffolds, cartilage 
formation within the different scaffolds was assessed over a four week culture 
period.  It was found that the flow perfusion system was not as favourable for in vitro 
cartilage formation as either the commercially available Rotary Cell Culture 
System (RCCS) or static culture.  One of the sparse knit scaffolds (sparse knit 4) 
and the needled felt were further compared for cartilage formation over an eight 
week culture period, using static and RCCS culture.  With respect to collagen and 
glycosaminoglycan (GAG) production, cartilage constructs generated from the two 
scaffold systems were similar.  Following static culture it was found that more viable 
cells were present at the centre of sparse knit 4 scaffolds than needled felt scaffolds.  
It was therefore concluded that scaffolds combining random and anisotropic porosity 
were advantageous for culturing tissues in environments where nutrient supply was 
reliant on diffusion alone. 
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Chapter 1 
Introduction 
 
1.1 General introduction 
Musculoskeletal conditions, such as arthritis, affect 15% of people in the United 
Kingdom; severely reducing the patients quality of life and costing in excess of £5 
billion per year (Arthritis Research Campaign 2002).  In 1999 it was estimated that 
the worldwide market for cartilage repair was $1 billion (LGC Biomaterials State of 
the Art Report 2002).  With an increasingly ageing population it is anticipated that 
the number of people affected and the resulting burden on healthcare systems will 
increase dramatically over the years to come (Buckwalter and Mankin 1998a, 
Bentley and Minas 2000 and Peretti et al 2000).  Treatment options currently 
available include the use of tissue grafts and prosthetic joints; however these 
methods are limited by the poor availability of suitable donor tissue and the risk of 
infection and implant failure associated with total joint replacements (Langer and 
Vacanti 1993).  These limitations are the driving force behind much research into 
cell-based methods for effectively treating diseased or damaged cartilage (Cima and 
Langer 1993).  Tissue engineering has been defined as an interdisciplinary field that 
applies the principles of engineering and the life sciences toward the development of 
biological substitutes that restore, maintain, or improve tissue function (Langer and 
Vacanti 1993).  Tissue engineering strategies generally involve the following stages:  
(1) identification and isolation of a suitable source of cells; (2) manufacture of a 
device to either carry or encapsulate the cells; (3) uniform seeding of cells onto or 
into the device and appropriate culture; and (4) in vivo implantation of the 
engineered construct (Figure 1.1; Langer 2000).  Cartilage tissue engineering studies 
to date have addressed the use of different cell types, scaffolds and culture systems.   
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Figure 1.1   Schematic representation of a tissue engineering strategy: (A) isolation 
of an appropriate cell population; (B) fabrication of a scaffold; (C) seeding of cells 
into scaffold and in vitro culture of cell-scaffold construct; and (D) implantation of 
tissue engineered device. 
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 One of the major challenges of tissue engineering is the formation of a shell of 
tissue at the periphery of the device, which limits the supply of nutrients to the centre 
of the growing tissue causing cell and tissue death.  This thesis investigates the use of 
scaffolds with novel architectures and a new flow-through bioreactor to facilitate the 
formation of tissues in vitro.   Cartilage was selected as an example tissue on which 
to perform the studies since the phenomenon of capsule formation at the periphery of 
scaffolds has been reported in previous cartilage tissue engineering studies (Freed et 
al 1999).  The aim of this chapter is to describe cartilage - its composition, structure 
and function; cartilage damage and repair; and tissue engineering as a potential 
method for repairing cartilage defects.  A detailed explanation of the aims of this 
thesis is given at the end of this chapter. 
 
1.2 Cartilage 
Cartilage has three key functions within the body.  Firstly, it acts as a template for 
the growth and development of long bones.  Cartilage forms a large part of the foetal 
skeleton and has an important role in endochondral ossification.  In addition, 
cartilage is present at the articulating surfaces of bones, where it provides a low-
friction surface.  It also acts as a supporting framework in some organs within the 
body, for example in the trachea where it prevents airway collapse.  There are three 
types of cartilage:  elastic cartilage, fibrocartilage and hyaline cartilage.  Cartilage 
differs with respect to biochemical composition, structure and location within the 
body (Serafini-Fracassini and Smith 1974).  Elastic cartilage, which is found within 
the external ear and larynx, contains elastin, which comprises approximately 20% of 
the dry tissue weight (Serafini-Fracassini and Smith 1974 and Temenoff and Mikos 
2000a).  Fibrocartilage contains lower glycosaminoglycan (GAG) levels than other 
types of cartilage, possesses highly organised collagen fibres and is found at the ends 
of ligaments and tendons (Serafini-Fracassini and Smith 1974 and Temenoff and 
Mikos 2000a).   
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 Menisci, which are present within the knee joint, are formed from fibrocartilage.  
Hyaline cartilage contains increased quantities of GAGs compared to the other 
cartilage types (Serafini-Fracassini and Smith 1974).  Articular cartilage, which is 
present at the articulating surfaces of bones within synovial joints, is formed from 
hyaline cartilage (Mankin 1974).   
 
1.3 Articular cartilage and meniscal fibrocartilage 
The location of articular cartilage and the menisci within the knee joint are shown in 
Figure 1.2.  Articular cartilage forms a durable layer 0.5 to 7.0 mm thick at the 
surface reducing friction between the bones and distributing loads across the entire 
joint surface (Carver and Heath 1999).  The meniscus is a fibrocartilaginous tissue 
which consists of two semilunar wedge-shaped sections.  The two sections lie 
between the tibia and fibia in the knee joint (Sweigart and Athanasiou 2001).  
Menisci within the knee are responsible for shock absorption, lubrication and 
stability (Mow et al 1990 and Sweigart et al 2003). 
 
1.3.1 Composition of articular cartilage and meniscal fibrocartilage 
The exact biochemical composition of both articular cartilage and meniscal 
fibrocartilage varies with species, age and location within the tissue (Serafini-
Fracassini and Smith 1974 and McDevitt and Webber 1990).  In general terms, both 
tissues are composed of cells within an extracellular matrix (ECM) composed of 
fibrillar components, for example collagen, proteoglycans, non-collagenous proteins 
and water (Figures 1.3 and 1.4, Alberts et al 2002).  Articular cartilage is considered 
to be one of the simplest tissues within the body since it possesses a single cell type, 
the chondrocyte; it is aneural and has no vascular or lymphatic supply (Buckwalter 
and Mankin 1997a).   
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Figure 1.2  The location of articular cartilage within a knee joint (adapted from Drury 
and Shipley 1998). 
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Figure 1.3   The organisation of chondrocytes and ECM within articular cartilage.  The 
ECM is composed of collagen, proteoglycan, water and other proteins. 
 
 
 35
  
 
 
Chondrocyte
      
ECM 
Figure 1.4   The organisation of cells and ECM within meniscal  fibrocartilage.  The 
ECM is composed of collagen, proteoglycan, water and other proteins. 
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 Meniscal fibrocartilage, in contrast, contains a region of vascularisation (the red zone 
at the periphery) and an avascular region (the inner white zone) (Sweigart et al 
2003).  The proportion of meniscal tissue that is vascularised decreases with age 
(Sweigart and Athanasiou 2001). 
 
1.3.1.a  Cells 
Chondrocytes form a very small proportion of articular cartilage, typically around 
1% of the dry tissue weight (Buckwalter and Mankin 1997a).  The cells within 
meniscal fibrocartilage are called fibrochondrocytes as they are generally considered 
to be a cross between chondrocytes and fibroblasts (Sweigart et al 2003).  Both 
chondrocytes and fibrochondrocytes are responsible for synthesis of the cartilage 
ECM macromolecules, the assembly and organisation of these macromolecules into 
an ordered framework and the continual replacement of degraded matrix components 
(Buckwalter and Mankin 1997a).  In both tissues, the cells are rounded and contained 
within lacunae (Sweigart et al 2003).  One of the key differences between 
chondrocytes and fibrochondrocytes is that the predominant collagen secreted by 
fibrochondrocytes is type I, whereas that of chondrocytes is type II (Benjamin and 
Ralphs 2004). 
 
1.3.1.b  Proteoglycans 
Proteoglycans consist of a core protein to which one or more GAG chains are 
attached (Buckwalter and Mankin. 1997a).  GAGs are unbranched polysaccharide 
chains which contain repeating disaccharide units where one of the sugars within the 
repeating unit is an amino sugar, for example N-acetylglucosamine, and the second is 
usually a uronic acid, for example glucuronic acid (Alberts et al 2002).  Since each 
of the disaccharides contains at least one negatively charged carboxylate or sulphate 
group, GAGs contain long chains of negative charge which attract cations and repel 
anions (Buckwalter and Mankin 1997a).  
 
 
 
 
 37
 There are four groups of GAGs:  i) hyaluronan, ii) chondroitin sulphate and dermatan 
sulphate, iii) keratan sulphate and iv) heparan sulphate, the first three groups of 
which are present in articular cartilage (Buckwalter and Mankin 1997a).  The two 
most abundant GAGs within meniscal cartilage are chondroitin sulphate and 
dermatan sulphate, which between them account for approximately 80% of the total 
GAG content (Almarza and Athanasiou 2004).  Proteoglycans comprise between 15 
and 30% of the dry weight of articular cartilage (Freed et al 1998).  Within both 
cartilage types, two classes of proteoglycan are present:  large aggregating 
proteoglycan monomers, for example aggrecan, and small proteoglycans, such as 
decorin, biglycan and fibromodulin (Buckwalter and Mankin 1997a and Nakano et al 
1997).  Aggrecan consists of chains of chondroitin and keratan sulphate bound to 
core proteins.  Individual aggrecan monomers interact with hyaluronan, as shown in 
Figure 1.5, to form high molecular weight aggregates.  These interactions are 
stabilised by link protein, which binds to both the hyaluronan and a specific binding 
site at the N-terminus of the aggrecan (Hardingham 1979).   The GAG/proteoglycan 
aggregates form gels which occupy a large volume relative to their mass.  These 
hydrophilic gels draw in considerable quantities of water that confer high 
compressive strength properties to the tissue (Bryant and Anseth 2001).  The smaller 
non-aggregating proteoglycans are involved in binding macromolecules, for example 
decorin and fibromodulin bind with type II collagen and therefore it is postulated that 
they may play a role in organising and stabilising the collagen meshwork (Hedbom 
and Heinegard 1993 and Hasler et al 1999).  The smaller proteoglycans are also able 
to bind transforming growth factor-E (TGF-E), a cytokine known to stimulate 
cartilage matrix synthesis (Buckwalter and Mankin 1997a). 
 
1.3.1.c  Fibrillar components 
In articular cartilage, GAGs and proteoglycans are contained within and associated 
with a fibrous network of collagen, which accounts for 50-60% of the dry tissue 
weight (LeBaron and Athanasiou 2000).  The predominant collagen of articular 
cartilage is type II (Heath and Magari 1996).  Type II collagen forms rope-like fibrils 
which aggregate into larger cable-like bundles or fibres (Alberts et al 2002). 
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Figure 1.5   The association of aggrecan molecules with hyaluronan. 
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 Articular cartilage also contains other members of the collagen family such as type 
XI, a fibrillar collagen involved in the establishment of a fibre network; type IX 
collagen, a fibril-associated collagen thought to aid linkage of the collagen fibrils to 
the rest of the ECM, type VI, which is found in the matrix immediately surrounding 
chondrocytes and is believed to help attachment of the cells to the ECM; and type X, 
which is involved in chondrocyte hypertrophy  (Loeser 1993).  The collagen network 
provides articular cartilage with tensile strength (Alberts et al 2002).  In contrast to 
articular cartilage, meniscal fibrocartilage contains small quantities of elastin (0.6% 
dry weight). The majority of the fibrillar component of meniscal tissue is collagen 
(Sweigart and Athanasiou 2001).  The predominant collagen of meniscal 
fibrocartilage is type I, with types II, III, V and VI also present.  These collagens 
account for between 60 and 70% of the dry tissue weight.  Within the menisci, the 
orientation of collagen fibres varies with location, for example collagen fibres within 
the deep zone are circumferentially orientated (Petersen and Tillmann 1998).   
 
1.3.1.d  Non-collagenous proteins and glycoproteins 
In addition to proteoglycans and collagens, both articular cartilage and meniscal 
fibrocartilage contain non-collagenous proteins and glycoproteins.  Some of these 
molecules are thought to be involved in the organisation and maintenance of the 
ECM structure (Buckwalter and Mankin 1997a).  Anchorin CII, for example, is a 
collagen binding protein found at the surface of chondrocytes that is believed to help 
anchor chondrocytes to collagen fibrils (Von der Mark et al 1986).  Another example 
is fibronectin, a protein that has been idenitifed in many other tissues.  It has been 
shown that chondrocytes attach to fibronectin and that the binding is mediated by 
integrins (Sommarin et al 1989 and Loeser 1993).  Whilst the exact role of 
fibronectin in cartilage is not fully understood, it is postulated that it may be involved 
in matrix organisation or cell-matrix interactions (Hayashi et al 1996).  Three 
adhesion glycoproteins have been identified within meniscal fibrocartilage all of 
which have been found to contain the arginine-glycine-aspartine (RGD) peptide 
sequence:  type VI collagen, fibronectin and thrombospondin (McDevitt and Webber 
1990). 
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 1.3.1.e  Tissue fluid 
Tissue fluid contains gases, small proteins, metabolites and a large number of cations 
(Buckwalter and Mankin 1997a).  Interactions between the negative charge of the 
large aggregating proteoglycans and the cations within the tissue fluid help retain 
water within the tissue and contribute to the mechanical properties of both cartilage 
types (Buckwalter and Mankin 1997a).    
 
1.3.2 Structure of articular cartilage and meniscal fibrocartilage 
Both articular cartilage and meniscal fibrocartilage are highly organised structures.  
Throughout the tissues differences in cell morphology, metabolic activity and matrix 
composition have been observed (Buckwalter and Mankin 1997a).  Articular 
cartilage can be divided into regions according to the distance of matrix from the 
cells:  the pericellular, territorial and interterritorial compartments (Newman 1998).  
In general, the pericellular and territorial regions are thought to facilitate attachment 
of chondrocytes to the ECM and to protect them during loading of the tissue 
(Buckwalter and Mankin 1997a).  The mechanical properties of articular cartilage are 
due to the interterritorial matrix which may be divided into four zones according to 
distance from the articular surface: the superficial, transitional, middle and calcified 
zones (Figure 1.3, Buckwalter and Mankin 1997a).  The knee meniscus can be 
divided into three zones, in which cell morphology and collagen fibre orientation 
differs: the superficial, middle and deep zones (Figure 1.6).  In addition, the tissue 
can be divided according to vascularisation into the inner third (avascular white 
zone), middle third (partially vascularised red-white zone) and the outer third 
(vascularised red zone) (Figure 1.6). 
   
1.3.2.a  Regions of the articular cartilage matrix  
The pericellular region occurs where the membranes of cells appear to be attached to 
the ECM (Temenoff and Mikos 2000a).  The matrix in this region contains a high 
concentration of proteoglycans.  Anchorin CII and type VI collagen are present in 
this region of articular cartilage, supporting the hypothesis that this matrix region is 
involved in attachment of chondrocytes to the ECM (Buckwalter and Mankin 
1997a). 
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Figure 1.6   A schematic representation of the structural organisation of the knee 
meniscus. 
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 The pericellular matrix of each chondrocyte is contained within envelopes of 
territorial matrix known as lacunae (Temenoff and Mikos 2000a).  It is believed that 
these collagenous envelopes protect the cells from mechanical forces experienced 
within the tissue (Buckwalter and Mankin 1997a).    The interterritorial region 
comprises the majority of the ECM and is considered to be responsible for the 
mechanical properties of articular cartilage (Temenoff and Mikos 2000a).  Within 
each of the different zones of articular cartilage, the collagen fibres of the 
interterritorial matrix regions are orientated differently.  For example, whilst the 
collagen fibres within the superficial zone are arranged parallel to the articular 
surface, those within the middle zone lie perpendicular to the articular surface 
(Buckwalter and Mankin 1997a). 
 
1.3.2.b  Zones of articular cartilage 
The superficial zone is organised into two layers, a layer of elongated chondrocytes 
and a sheet of collagen fibres arranged parallel to the articulating surface of the joint 
(Temenoff and Mikos 2000a).  The dense arrangement of collagen fibres in this 
region of the tissue provides it with its low friction surface and high tensile strength 
(Guilak and Mow 2000).  It has been shown that the surface of articular cartilage 
plays an important role in the development of the diarthrodial joint (Ward et al 1999) 
and that many growth factors and their receptors are expressed at the articular surface 
(Archer et al 1994 and Hayes et al 2001).  It has been reported that a population of 
progenitor cells, which are probably involved in cartilage development via 
appositional growth, reside within the superficial zone of cartilage (Douthwaite et al 
2004).  The transitional zone of articular cartilage is so-called because the 
composition of the matrix is transitional between that of the superficial and middle 
zones (Buckwalter and Mankin 1997a).  Chondrocytes within the transitional zone 
are rounded and contained within a matrix containing a higher proportion of 
proteoglycans and lower concentration of collagens than the superficial zone 
(Temenoff and Mikos 2000a).  Within the middle zone, spheroidal chondrocytes are 
found within lacunae and organised in columns perpendicular to the articulating 
surface (LeBaron and Athanasiou 2000).   
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 The matrix within the middle zone contains the highest concentration of 
proteoglycans and the largest diameter collagen fibrils (Buckwalter and Mankin 
1997a).    The calcified zone forms a thin transitional layer between the cartilage and 
the subchondral bone (Buckwalter and Mankin 1997a).  The chondrocytes within the 
calcified ECM occupy a smaller volume than cells within the middle region and in 
some cases are completely embedded in a calcified matrix (Temenoff and Mikos 
2000a). 
 
1.3.2.c  Zones of meniscal fibrocartilage 
The superficial zone faces the femur and is the thinnest of the zones. In situ, cells 
within the superficial zone are oval and fusiform and collagen fibres are arranged in 
a random mesh. The middle zone is embedded between the superficial and deep 
zones.  The majority of collagen fibres within the middle zone are randomly 
orientated, although at the anterior and posterior sections, the fibres are orientated 
into a radial configuration.  The deep zone accounts for the largest portion of the 
meniscus and contains a population of cells with a rounded morphology.  The 
collagen fibres in this region of the tissue are arranged circumferentially (Almarza 
and Athanasiou 2004).   
 
1.4 Articular cartilage formation in vivo 
Cartilage is initially formed by undifferentiated mesenchymal stem cells (MSCs) 
(Buckwalter and Mankin 1997a).  Clustering of these cells by cell condensation is 
necessary for chondrogenic differentiation (Tavella et al 1997).  It has been proposed 
that cell condensation is a two-stage process.  In the first step, cells aggregate via 
integrin-fibronectin interactions.  Cell adhesion molecules, such as neuronal cell 
adhesion molecule (N-CAM) and N-cadherin, strengthen cell-cell interactions in the 
second stage (Tavella et al 1997).  Once cells are differentiated, secretion of ECM 
proteins occurs (Buckwalter and Mankin 1997a).  During phases of cartilage 
formation and growth, a high density of metabolically active cells are present within 
the tissue (Buckwalter and Mankin 1997a).   
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 Cartilage development may occur in one of two different ways: interstitial growth, 
where chondrocytes grow and divide and lay down additional matrix within the 
existing tissue; or appositional growth, where new surface layers of matrix are added 
to pre-existing matrix by cells in the perichondrium (Alberts et al 2002).  Studies 
have shown that the superficial zone of articular cartilage is responsible for 
appositional tissue growth and that this region of the tissue contains a population of 
progenitor cells (Hayes et al 2001 and Douthwaite et al 2004).   
  
1.5 Articular cartilage damage 
Although articular cartilage is able to withstand high levels of mechanical stress and 
continually renew its ECM, during normal aging processes the ability of 
chondrocytes to synthesise some proteoglycans and respond to stimuli that aid its 
continual remodelling decrease (Buckwalter and Mankin 1997a).  The limited ability 
of mature chondrocytes to maintain the integrity of the tissue increases its 
vulnerability to injury and disease, and can lead to the natural degeneration of 
cartilage (Buckwalter and Mankin 1997a).  Disease may cause degeneration of 
articular cartilage either directly or indirectly.  Primary osteoarthritis (Kreklau et al 
1999), osteochondrosis dissecans (Hunziker 1999a) and tumours (Schaefer et al 
2000) can all directly impair articular cartilage.  There are, in addition, a large group 
of conditions that can cause changes in cartilage that stimulate the onset of secondary 
osteoarthritis and consequently degeneration of the cartilage (Buckwalter and 
Mankin 1997b).   
 
Two types of defect can be seen in articular cartilage: intrinsic injuries, which are 
confined to the cartilage (Wakitani et al 1994), and extrinsic injuries, in which the 
subchondral bone is penetrated (Mankin 1974).  Degeneration of articular cartilage 
leads to chronic pain and, in severe cases, loss of the joints function and 
consequently total joint replacement is necessary (Brittberg et al 1994, Shortkroff et 
al 1996 and Gugala and Gogolewski 2000).   
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The poor quality of life for patients and the substantial cost to health services has 
stimulated a great deal of research into methods of repairing articular cartilage 
injuries (Buckwalter and Mankin 1998a, Bentley and Minas 2000 and Peretti et al 
2000). 
 
1.6 Cartilage repair in vivo 
The classical response of most tissues to injury requires two components:  specific 
cells types which are involved removing necrotic material and synthesis of new 
tissue and a vascular supply by which cells and bioactive molecules, such as growth 
factors, may reach the site of damage (Newman 1998).  Several factors influence the 
healing response of articular cartilage including the size of the defect and the age of 
the organism.  It has been shown in animal models that there is a proportional 
relationship between increasing defect size and decreasing ability to heal, with 
defects less than 3 mm in diameter able to heal completely without intervention 
(Convery et al 1972).  It is widely accepted that chondrocytes from skeletally 
immature animals have a greater capacity for proliferation and proteoglycan 
synthesis (Kreder et al 1994)  which correlates with the observation that improved 
healing is observed in younger patients (Newman 1998).  In addition, whether the 
defect is confined to cartilaginous tissue (intrinsic defect) or whether it penetrates the 
subchondral bone (extrinsic defect) influences its ability to heal.         
 
1.6.1 Healing of intrinsic defects 
Since articular cartilage is avascular, classical tissue repair processes are rarely 
observed in intrinsic defects (Newman 1998).   Initial increases in mitotic activity 
and matrix synthesis have been detected in chondrocytes close to defect sites, 
although no significant healing was observed (Campbell 1969).  The containment of 
chondrocytes within a meshwork of collagens and proteoglycans is thought to 
prevent their migration from regions of healthy tissue to the injury site (Newman 
1998).  It has been proposed that the articular cartilage matrix contains natural 
inhibitors of vascular and macrophage invasion (Mankin 1982).   
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Whilst intrinsic defects rarely heal, they are relatively stable and progression to 
osteoarthritis is uncommon (Mankin 1982).     
 
1.6.2 Healing of extrinsic defects 
The penetration of the subchondral bone in extrinsic defects allows access to 
vascular tissue and so a more classical healing response may be observed (Convery 
et al 1972).  It has been reported that fibrin clot formation is seen within extrinsic 
defects (Shapiro et al 1993).  Such clots allow entrapment of cells from blood and 
MSCs from within the bone marrow (Shapiro et al 1993).  Metaplasia of the repair 
tissue allows formation of a hyaline-like chondroid tissue (Shapiro et al 1993).   
 
Although initial repair tissue is hyaline-like with rounded chondrocytes and 
substantial amounts of type II collagen, the amount of type I collagen within the 
tissue may increase with time and in less than 3 months degenerative changes in the 
cartilage composition may be evident (Furukawa et al 1980 and Shapiro et al 1993).  
Between 6 and 12 months post-injury it is not uncommon for the tissue to resemble 
fibrocartilage rather than hyaline cartilage (Shapiro et al 1993).   
 
1.7 Clinical attempts to repair cartilage 
A summary of different strategies for treating articular cartilage defects is presented 
in Table 1.1.  In general, these methods involve one or more of the following:  (i) 
surgical intervention; (ii) a space-filling device e.g. a tissue graft; or (iii) a treatment 
or component to stimulate a healing response and chondrogenesis e.g. penetration of 
the subchondral bone to allow infiltration of inflammatory and progenitor cells into 
the defect site (ODriscoll 1998).  Something that all current treatment options have 
in common is the variability in their success  functional repair can be achieved in 
some joints in some patients, but no one treatment allows complete healing of all 
defects in all patients (Lohmander 2003).   
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Strategy  Method
 
Reference(s) 
 
 
Surgery/Arthroscopy 
 
 
Chondral shaving 
 
Buckwalter and Lohmander 
1994 
 
Abrasion arthroplasty 
 
Johnson 1986 & Altman et al 
1992 
 
Subchondral drilling 
 
Pridie 1959 
 
Osteotomy 
 
Byers 1974 
Physical stimulation of chondrogenesis Continuous passive motion 
 
Salter et al 1980 
Tissue grafts Perichondral graft(autograft/allograft) 
 
Skoog et al 1972 
 
Periosteal graft (autograft/allograft) 
 
Rubak et al 1982 
 
Cartilage graft (autograft/allograft) 
 
Schatten et al 1958 
 
Mosaicplasty 
 
Hangody et al 1998 
 
Osteochondral graft (autograft/allograft) 
 
Herndon and Chase 1952 
Cellular transplantation Autologous chondrocyte transplantation 
 
Chesterman  and Smith 1968,  
Bentley and Greer 1971 & 
Brittberg et al 1994 
 
 
Mesenchymal stem cells 
 
Wakitani et al 1994 
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Strategy  Method
 
Reference 
 
 
  
 
  
  
Pharmacologic modulation Corticosteroids 
 
Olah and Kostenszky 1976 
 
Hyaluronan 
 
Smith and Ghosh 1987 
 
Bioactives Bone morphogenetic protein-2 (BMP-2) 
 
                  TGF- E 
 
                  Basic fibroblast growth factor (bFGF)
  
 
Sato and Urist 1984 
 
van Beuningen et al 1993-
1994 
 
Cuevas et al 1988 
 
Biomaterials Space filling device Wyre and Downes 2000 
 
 
Matrix for delivery of cells/bioactives/both Martin et al 2001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1  Methods used in articular cartilage repair. 
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1.7.1 Surgical intervention 
A variety of surgical procedures have been used in the treatment of articular cartilage 
defects.  These include chondral shaving, abrasion arthroplasty, subchondral drilling 
and osteotomy.  It has been reported that chondral shaving of degenerated and partial 
thickness defects has provided symptomatic relief as a consequence of removing the 
source of irritation from within the joint (Buckwalter and Lohmander 1994).  This 
procedure does not, however, stimulate chondrogenesis or repair of the injury site 
since there is no penetration of the subchondral bone (Chen et al 1999).  Abrasion 
arthroplasty involves scraping a few millimetres of the subchondral cortex and so 
allows penetration of cells from the vasculature and bone into the defect site 
(Friedman et al 1984).  The repair tissue resulting from the procedure has been 
reported to be highly variable, ranging from fibrous to hyaline-like cartilage 
(Buckwalter and Lohmander 1994).  It has been proposed that subchondral drilling, 
where multiple holes are drilled through the cartilage into the subchondral bone, 
produces more favourable results than both chondral shaving and abrasion 
arthoplasty (Chen et al 1999).   In animal studies, however, similar variability in 
repair tissue has been observed following use of this technique as for abrasion 
arthroscopy (Mitchell and Shepard 1976).   
 
Osteotomies involve mechanical realignment of the joint in order to redistribute 
loads within the joint away from the diseased or damaged articular cartilage 
(Buckwalter and Lohmander 1994).  This method is generally reserved for patients 
who are considered too young for total joint replacement (Newman 1998).  In 
addition there is some evidence to suggest that changes in loading result in 
stimulation of repair in the diseased tissue (Buckwalter and Mankin 1997b).  Total 
joint replacements are often used in patients with arthritis when other treatment 
options have been unsuccessful and severe degeneration of the joint has occurred 
(Moran and Tourret 2001).  Prosthetic joints have a limited lifetime since they often 
loosen within the joint, creating bone loss and pain (Moran and Tourret 2001).  For 
this reason the use of total joint replacements is often restricted to the elderly (Moran 
and Tourret 2001).   
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1.7.2 Physical stimulation of chondrogenesis 
Several studies have reported the detrimental effect of immobilisation and the 
benefits of intermittent motion on synovial joints (Mooney and Ferguson 1966, Woo 
et al 1975 and Salter et al 1984).  It was reported by van Kampen and van de Stadt 
that in in vivo models, immobilisation of joints led to degenerative changes, for 
example loss of proteoglycan (van Kampen and van de Stadt 1987).  Continuous 
passive motion (CPM) is a method used whereby the joint is continuously moved 
within a mechanical splint.  It is often used after surgery in order to prevent stiffness 
and increase the range of movement within the joint.  Whilst repair tissue resembling 
hyaline cartilage has been observed within defects treated with CPM, complete 
healing was not seen within joints where the defect was either greater than 3 mm in 
diameter or confined to the articular cartilage surface (Salter et al 1984).  These 
observations imply that CPM does not initiate or stimulate cartilage healing, 
although it does have beneficial effects once repair has been initiated (Chen et al 
1999). 
 
1.7.3 Pharmacologic modulation 
A variety of pharmacologic agents have been used in the treatment of cartilage 
defects including growth factors, hyaluronan and corticosteroids.  These treatments 
have been applied as a means to increase the number of chondrocytes within the 
defect and their secretion of matrix components (Temenoff and Mikos 2000a).  The 
agents may be administered either systemically or locally (ODriscoll 1998).  There 
is conflicting evidence as to whether corticosteroids enhance cartilage-healing or if 
they induce arthropathy (Behrens et al 1976, Salter et al 1967).  Hyaluronan is used 
as a viscosupplement since it is has been shown in arthritis models that it binds to 
and penetrates into damaged articular cartilage, giving the cartilage a coating which 
is potentially both a lubricant and protectant (Iwata 1993).  Growth factors such as 
TGF-E and bone morphogenetic proteins (BMPs) have been shown to have 
chondrogenic effects in vitro (Elford et al 1992).   
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Whilst intra-articular injections of TGF-E have been shown to increase proteoglycan 
synthesis, the formation of osteophytes, consistent with osteoarthritis, have also been 
observed (van Beuningen et al 1993-1994).  More recent attempts to utilise the 
therapeutic effects of growth factors has concentrated on the use of carrier devices 
which can release the active factors into the defect site in a controlled manner 
(Elisseeff et al 2001).   
 
1.7.4 Tissue grafts 
Tissue grafting involves removal of suitable tissue from a donor site and 
transplanting it into the defect site.  The graft tissue may be obtained from the patient 
(autograft) or from a donor (allograft).  Each of these types of graft has advantages 
and disadvantages (ODriscoll 1998).  Whilst autografts do not carry the risk of an 
immune response associated with use of tissue from a donor, the amount of 
autologous cartilage available for transplantation is limited.  In addition the removal 
of healthy tissue introduces a second defect within the joint (Temenoff and Mikos 
2000a).  Perichondral, periosteal, chondral and osteochondral grafts have all been 
used in the treatment or articular cartilage defects (Buckwalter and Mankin1997b).        
 
1.7.4.a  Perichondral grafts 
Skoog and colleagues first reported the use of perichondral grafts for joint 
resurfacing (Skoog et al 1972).  The perichondrium is a membrane of fibrous 
connective tissue that surrounds cartilage, except at the articulating surface.  It has 
been reported to contain MSCs which are capable of proliferation and chondrogenic 
differentiation.  Perichondral grafts have been used to repair articular cartilage 
defects in human and animal models.  The repair tissue observed within these studies 
has varied from fibrocartilage to hyaline-like neocartilage (Chen et al 1999).  The 
use of rib perichondrium in full thickness defects has led to hyaline-like cartilage 
formation within 8 weeks, although following 8-12 months of normal joint function 
degeneration of the repair tissue has been reported (Amiel et al 1985, Homminga et 
al 1989 and Homminga et al 1990). 
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1.7.4.b  Periosteal grafts 
The perisoteum is present at the outermost surface of bones and is also a fibrous 
connective tissue believed to contain a population of MSCs (Chen et al 1999).  As a 
cartilage graft material, perisoteal tissue has generally shown more promise than 
perichondral tissue (Chen et al 1999).  The use of periosteal grafts offers the 
advantage that it is present in larger quantities.  It has been shown that perisoteum 
can be securely fitted into defects of a range of sizes and shapes (ODriscoll 1998).  
Differentiation of periosteal grafts into hyaline-like cartilage has been observed in 
both lapine and equine models (Rubak et al 1982 and Vachon et al 1989).  Adhesives 
such as fibrin and cyanoacrylate have been used to secure periosteal grafts within 
defect sites with variable success (Sullins et al 1985, Vachon et al 1989 and Tsai et 
al 1992).  Clinical data for the use of periosteal grafts in combination with adhesives 
and postoperative physical stimulation, such as continuous passive motion in 
younger patients, shows promise for this therapy (Buckwalter et al 1993 and 
Buckwalter and Lohmander 1994).   
 
1.7.4.c  Cartilage grafts 
Small plugs of cartilage from low-weight-bearing regions of joints may be used for 
transplantation.  Articular cartilage autografts have been harvested from the patella, 
femoral condyle and proximal fibula (ODriscoll 1998).  The use of articular 
cartilage grafts has shown mixed results in patients.  In one study, 70% of patients 
reported improved symptoms, while in others immune responses were observed 
following implantation of fresh allografts (Wirth and Rudert 1996 and Goldberg and 
Caplan 1999).  Other concerns associated with the use of cartilage grafts include the 
effect of harvesting on tissue morbidity in the donor site and the ability of cartilage 
from a less weight-bearing region to withstand the forces experienced at the joint 
surface (Temenoff and Mikos 2000a and Hunziker 1999b).  It has recently been 
reported that cartilage resected with blunt instruments contained a band of dead cells 
at the edge of the injury site, whilst cartilage resected using sharp scalpels contained 
a limited number of dead cells and matrix regeneration was observed.   
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This has implications in the use of cartilage grafts since the authors propose that the 
use of sharp, precise instruments is necessary to facilitate integration of tissue at the 
defect site (Redman et al 2004).  
 
1.7.4.d  Osteochondral grafts 
Osteochondral grafts offer the advantage that in addition to providing a fully formed 
articular cartilage matrix they can restore the subchondral bone in extrinsic defects 
(Czitrom et al 1990).  A study carried out by Outerbridge and colleagues reported 
successful treatment of patients using osteochondral grafts up to six years after the 
procedure was performed (Outerbridge et al 1995).  Mosaicplasty is a technique 
which involves the removal of plugs of osteochondral tissue from a relatively non-
weight-bearing region of the knee and transplanting them into an articular defect 
(ODriscoll 1998).  The success of osteochondral grafts depends on the cause of the 
cartilage damage, for example studies have shown that osteochondral allografts 
provide effective treatment of localised post-traumatic defects but they perform 
unpredictably in patients with osteoarthritis (Buckwalter and Mankin 1998a). 
 
1.7.5 Cellular transplantation 
An alternative to filling the defect site with tissue is to use cells with the ability to 
form a new cartilage matrix (Temenoff and Mikos 2000a).  The aim of cellular 
transplantation methods is to take a small biopsy of cells with chondrogenic 
potential, expand the number of cells in vitro and then return them to the defect site 
to restore the tissue mass (Temenoff and Mikos 2000a).  The cells may be mature 
differentiated chondrocytes or osteochondral progenitor cells, such as MSCs 
(Buckwalter and Mankin 1997b, Caplan et al 1997).  MSCs may prove advantageous 
for the treatment of full-thickness defects where both bone and cartilage healing are 
required (ODriscoll 1998).  In a study comparing MSCs and articular chondrocytes 
for the treatment of defects in rabbit knees, similar healing was observed in both 
treatment groups (Wakitani et al 1994).  Whilst the repair tissue exhibited good 
mechanical properties, the repair tissue failed to integrate with the host tissue 
(Wakitani et al 1994).   
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The implantation of chondrocytes into cartilage defects has been studied for many 
years (Chesterman and Smith 1968).  One of the challenges associated with filling a 
defect site with cells in suspension is how to retain the cells within the site for long 
enough to allow the formation of a cartilaginous matrix (Aston and Bentley 1986).  
In the case of autologous chondrocyte implantation (ACI) this problem has been 
overcome by suturing a flap of periosteal tissue over the defect site (Temenoff and 
Mikos 2000a).  Clinical studies have shown promising results, with good repair 
tissue maintained in a large number of patients up to ten years after the treatment 
(Gillogly et al 1998).  Whilst ACI is a well-established method for treating joint 
surface defects, it may not be appropriate for the treatment of all cartilage defects.  
Although excellent repair has been observed in defects within the femoral condyle, 
only limited healing was observed in patellar defects (Brittberg et al 1994 and 
Brittberg 1999).  A further disadvantage of ACI is the requirement for a periosteal 
flap and the morbidity that occurs at the donor site.  An alternative method for 
retaining cells within the defect site is to use a porous scaffold (Temenoff and Mikos 
2000a).  Tissue engineering has evolved as a method for regenerating tissues both in 
vitro and in vivo based on the idea of seeding cells into a highly porous scaffold that 
facilitates cell attachment and tissue formation (Langer and Vacanti 1993).     
 
1.8 Tissue engineering cartilage 
The ultimate aim of cartilage tissue engineering is the in vitro generation of 
cartilaginous constructs for implantation.  These constructs should be able to develop 
further upon implantation into the patient so that functional cartilage with the 
required anisotropic biochemical composition and mechanical properties is able to 
fully integrate with the host cartilage and bone (Vunjak-Novakovic 2003).  Figure 
1.1 shows a schematic representation of an approach commonly employed in 
cartilage tissue engineering.  In this strategy, a biopsy of cells would be obtained 
from the patient and expanded by in vitro culture.  The cells would then be seeded 
into a scaffold structure which would support cell attachment, extracellular matrix 
secretion and tissue formation.   
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It has been proposed that the tissue may either be grown entirely in vitro and 
implanted into the defect as hyaline cartilage or that the developing tissue within the 
scaffold structure may be implanted and allowed to form cartilage in vivo 
(Hutmacher 2000).  Tissue engineering methods offer solutions to problems 
encountered with transplantation of tissue grafts, namely the shortage of suitable 
tissue to provide an autograft and the risk of immune responses to the foreign tissue 
used in an allograft (Freed and Vunjak-Novakovic 1998, Sittinger et al 1996).  The 
type of cells, the scaffold material and design and the culture conditions employed 
can all be varied in order to optimise the properties of the cartilage formed.  Table 
1.2 presents a summary of some cartilage tissue engineering studies from the last 
twelve years.  It is clear from this table that a variety of cell sources, scaffold types 
and culture systems have been used in cartilage engineering studies.  The cells used 
in these studies have varied not only with respect to the animal from which the tissue 
was obtained, but also with respect to the type of cartilage or tissue that the cells 
were isolated from.  For example articular, meniscal and nasal cartilage have all been 
used as a source of chondrocytes for articular cartilage engineering studies (Kafienah 
et al 2002 and Huckle et al 2003).  The scaffolds used in tissue engineering studies 
have been fabricated from both synthetic (for example PGA) and natural (for 
example collagen and hyaluronan) materials (Freed et al 1993 and Nehrer et al 
1998).  In addition the scaffolds used have been hydrogels, fibrous meshes and 
porous matrices (Buschmann et al 1992 and Freed et al 1993).     Both in vivo and in 
vitro environments have been employed to allow cartilage regeneration.  Examples 
of in vivo systems include the subcutaneous implantation of cell-scaffold constructs 
into immuno-compromised mice and implantation of constructs directly into 
cartilage defects (Puelacher et al 1994 and Vacanti et al 1994).     In vitro culture 
systems used have varied from static tissue culture plates to more complex bioreactor 
systems (Buschmann et al 1992 and Dunkelman et al 1995).    The length of time for 
which the cell-scaffold constructs were cultured in these studies varied from 1 week 
to 7 months (Freed and Vunjak-Novakovic 1995 and Freed et al 1997).   
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Cell source Scaffold type(s) Culture system(s) Culture time Reference 
Buschmann et al 1992 Bovine articular
cartilage 
 Agarose gel Static culture 10 weeks 
Bovine articular
cartilage 
 Non-woven PGA mesh 
 
Porous PLA matrix 
Static culture 6 weeks Freed et al 1993 
Bovine articular
cartilage 
 Non-woven PGA mesh Mixed dish 
 
Static culture 
8 weeks Freed et al 1994a 
Bovine articular
cartilage 
 Non-woven PGA mesh Spinner flask 
 
Static culture (75 cm2 
tissue culture flask) 
6 weeks Freed et al 1994c 
Bovine articular
cartilage 
 Non-woven  PGA mesh In vivo (subcutaneously 
implanted into nude mice) 
12 weeks Puelacher et al 1994 
Lapine articular
cartilage 
 Non-woven PGA mesh In vivo (within cartilage  
defects in rabbits) 
7 weeks Vacanti et al 1994 
Lapine articular
cartilage 
 Non-woven PGA mesh Perfused cartridge 4 weeks Dunkelman et al 1995 
Bovine articular
cartilage 
 Non-woven PGA mesh Rotating wall bioreactor  
 
Spinner flask 
1 week Freed and Vunjak-
Novakovic 1995 
Bovine articular
cartilage 
 Non-woven PGA mesh Rotating wall bioreactor 7 months Freed et al 1997 
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 Bovine articular
cartilage 
 Non-woven PGA mesh  
 
Porous collagen matrix 
Closed-loop recirculation 
system 
 
Static culture (Petri dishes) 
35 days 
 
 
 
Grande et al 1997 
Embryonic chick
bone marrow  
 Non-woven PGA mesh  
 
Mixed dish 4 weeks Martin et al 1998 
Canine articular
cartilage 
 Type I collagen  GAG 
sponge 
 
Type II collagen  GAG 
sponge 
In vivo (Superficial 
cartilage defects in adult 
dogs) 
15 weeks Nehrer et al 1998 
Bovine articular
cartilage 
 Non-woven PGA mesh  
 
Mixed agarose-coated petri 
dish 
6 weeks Martin et al 1999  
Bovine meniscal
cartilage 
 Type I collagen  GAG 
sponge 
 
Type II collagen  GAG 
sponge 
Not stated by author 3 weeks Mueller et al 1999 
Bovine articular
cartilage 
 Non-woven PGA mesh  
 
Static culture (static
spinner flask) 
 6 weeks 
 
Spinner flask 
 
Rotating wall bioreactor 
Vunjak-Novakovic et al 
1999 
Bovine articular
cartilage 
 Cell - fibrinogen
suspension in PLGA fleece  
 Flow perfusion followed 
by in vivo (subcutaneous 
implantation in athymic 
nude mice) 
In vitro 8 days 
followed by 
In vivo 12 
weeks 
Duda et al 2000 
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 Canine articular
cartilage 
 Type I collagen  GAG 
copolymer matrix 
 
Type II collagen  GAG 
copolymer matrix 
Static culture (24-well 
plates) 
14 days Lee et al 2000  
Bovine articular
cartilage 
 Cells encapsulated in 
alginate within
demineralised trabecular
bovine bone matrix 
 
 
In vivo (subcutaneously 
implanted into athymic 
mice) 
 
Cells encapsulated in 
alginate within non-woven 
PLGA matrix 
8 weeks Marijnissen et al 2000 
Lapine articular
cartilage 
 Ethisorb 210
(polydioxanone/polyglactin) 
fleece 
 Static (96-well plate) 
 
PLLA fleece 
4 weeks Rudert et al 2000 
Human bone marrow PLA cube 
 
PLA-alginate cube 
Static (12 mm culture 
plate) 
21 days Caterson et al 2001 
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 Bovine articular
cartilage 
 Non-woven PGA mesh  
 
Static culture (Petri dish) 
 
Mixed Petri dish 
 
Static spinner flask 
 
Mixed spinner flask 
 
Rotating wall bioreactor 
4 weeks Gooch et al 2001  
Human articular
cartilage 
 non (pellet cultures) Mixed conical tubes 2 weeks Jakob et al 2001 
Bovine articular
cartilage 
 Non-woven PGA mesh Mixed 6-well plates 7 weeks Kellner et al 2001 
Rat articular
cartilage 
 Alginate sponge 
 
Alginate-hyaluronan sponge 
 
Cells encapusalated in 
alginate 
Static (24-well plate) 40 days Miralles et al 2001 
Foetal bovine
epiphysis 
 Diphenylphosphorylazide 
cross-linked collagen
sponge 
 
Static culture (24-well 
plate) 
1 month Roche et al 2001 
Bovine articular
cartilage 
 PLGA sponge 
 
Collagen sponge 
 
PLGA-collagen sponge 
In vivo (subcutaneous 
implantation in athymic 
mice) 
8 weeks Sato et al 2001 
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 Bovine articular
cartilage 
 Cross-linked type I
collagen-chondroitin 
sulphate matrix 
 Static culture (96-well 
plates)  
14 days van Susante et al 2001 
 
Human articular
cartilage  
 Hyaluronan benzyl ester 
non-woven mesh 
Static culture 60 days Grigolo et al 2002 
Bovine articular
cartilage 
 Non-woven PGA mesh 
 
Bovine nasal 
cartilage 
 
Human articular 
cartilage 
 
Human nasal 
cartilage 
Orbital shaker (75 rpm) 
 
 
Orbital shaker (75 rpm) 
followed by in vivo 
(subcutaneous 
implantation in athymic 
mice) 
40 days 
 
 
in vitro 40 days 
followed by 
in vivo 6 weeks  
Kafienah et al 2002 
Human auricular
cartilage 
 Alginate beads Static culture (24 well 
plates, 10 beads per well) 
21 days Mandl et al 2002 
Porcine articular
cartilage 
 Gelatin-chondroitin-
hyaluronan tri-copolymer 
porous matrix 
Static culture (Petri dishes) 
 
Spinner flasks 
5 weeks Chang et al 2003 
Bovine articular
cartilage 
 Polyurethane porous matrix 
 
PLA porous matrix 
Static culture (12-well 
plates) 
42 days Grad et al 2003 
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 Ovine mensical
cartilage 
 Non-woven PGA mesh 
 
Human articular 
cartilage 
 
PCL porous foam 
 
PLGA porous foam 
 
Polyethylene glycol 
dimethacrylate hydrogel 
Static culture (Petri dishes) 4 weeks Huckle et al 2003 
Bovine articular
cartilage 
 Alginate beads Static culture (24-well 
plates) 
14 days Masuda et al 2003 
Bovine articular
cartilage (full
thickness) 
 
 
Porous calcium
polyphosphate  
 
Bovine articular 
cartilage (mid and 
deep zone) 
 
Bovine articular 
cartilage (deep zone) 
 Static culture 8 weeks Waldman et al 2003 
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 Bovine articular
cartilage 
 Poly(L-lactic acid-H 
caprolactone) porous
scaffold 
 
Static culture (10cm 
dishes) followed by in vivo 
(subcutaneous 
implantation in athymic 
mice)  
In vitro 1 week 
followed by in 
vivo 40 weeks 
Isogai et al 2004 
Human ear cartilage 
 
Human nasal 
cartilage 
 
Human rib cartilage 
non (pellet culture) Pellet culture (on orbital 
shaker at 30rpm) 
2 weeks Tay et al 2004 
Bovine articular
cartilage 
 Macroporous alginate
hydrogel 
 In vivo (subcutaneous 
implantation in
immunocomprimised 
mice) 
 
24 weeks Thornton et al 2004 
Bovine articular
cartilage 
 Poly (ethylene glycol)  
terephthalate / poly
(butylene terephthalate) co-
polymer  (PEGT/PBT) 
compression moulded 
sponge 
 
Spinner flask followed by 
in vivo (subcutaneous 
implantation in nude mice) 
 
PEGT/PBT fibrous scaffold 
In vitro 14 days 
followed by 
In vivo 28 days 
Malda et al 2005 
Table 1.2   Summary of cartilage tissue engineering studies. 
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1.8.1 Cells 
Cells used in tissue engineering must be biosynthetically active and have nutrients, 
metabolites and other regulatory molecules readily available (Jackson and Simon 
1999).  The donor age and differentiation state have all varied in the cells used in 
cartilage tissue engineering studies to date (Buckwalter and Mankin 1997b, Huckle 
et al 2003 and Vunjak-Novakovic 2003).  Mature, differentiated chondrocytes are 
advantageous for cartilage regeneration as they are the native cell population within 
cartilage and synthesise the appropriate ECM components (Grande et al 1999 and 
Freed et al 1999).  Different chondrocyte populations are present in the different 
types of cartilage, for example articular chondrocytes are found in articular cartilage 
and fibrochondrocytes in meniscal cartilage.  Articular chondrocytes are therefore the 
most obvious choice of cell for articular cartilage tissue engineering.  Whilst articular 
chondrocytes can easily be isolated, obtaining an appropriate number of cells with 
the capacity to regenerate cartilage is one of the challenges facing tissue engineers 
(Huckle et al 2003).  It is possible to expand cell populations using in vitro cell 
culture techniques; although it has been observed that in monolayer culture articular 
chondrocytes dedifferentiate, become fibroblastic in appearance and secrete a fibrous 
matrix.  It has been documented that culturing the cells within a 3-dimensional 
environment such as a porous scaffold can help them retain their chondrocytic 
phenotype (Freed and Vunjak-Novakovic 1998).  A population of progenitor cells 
have recently been isolated from the superficial zone of articular cartilage 
(Douthwaite et al 2004).  These cells have been shown to form cartilage in pellet 
cultures, when implanted into wounded explant cultures and when injected in ovo 
(Thomson et al 2004).  In addition it has been shown that these cells retain their 
ability to produce articular cartilage following several population doublings (Bishop 
2003).  The use of chondrocytes from other cartilage types for engineering articular 
cartilage has also been studied (Huckle et al 2003).  Huckle and colleagues reported 
that fibrochondrocytes isolated from whole ovine menisci produced a cartilaginous 
matrix following 2 week dynamic culture and that the cells contained within the 
matrix were rounded, although there was some controversy as to whether the 
cartilage formed was more like articular or meniscal cartilage (Huckle et al 2003).   
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Kafienah and co-workers have published data showing that chondrocytes from nasal 
cartilage can be used to engineer articular cartilage following in vitro expansion 
(Kafienah et al 2002).  The regenerative capacity of cells also varies with respect to 
animal age (Webber et al 1986).  Other cell types that have been used in cartilage 
tissue engineering studies include stem cells isolated from a variety of tissues, such 
as muscle (Deasy et al 2002) and adipose (Erikson et al 2001); MSCs (Caplan et al 
1997 and Pittenger et al 1999); and even adult dermal fibroblasts (Nicoll et al 1998).  
Despite these cells having greater proliferative capacities than adult articular 
chondrocytes they do not have the intrinsic ability to differentiate into chondrocytes 
unless given specific stimuli (Huckle et al 2003).   
 
1.8.2 Scaffolds 
A wide range of scaffolds have been used in cartilage tissue engineering studies.  
These scaffolds may be categorised with respect to the types of material used (natural 
or synthetic, degradable or non-degradable), the geometry of the scaffold (gels, 
fibrous meshes or porous sponges) and their structure (total porosity, pore size, 
connectivity and distribution; Vunjak-Novakovic 2003).   It is crucial that a tissue 
engineering scaffold is fabricated from a material that is biocompatible, allowing 
attachment of cells, ECM secretion and tissue formation without the induction of an 
inflammatory or toxic response (Freed et al 1994a, Sawtell et al 1995, Chapekar 
2000, Middleton and Tipton 2000, Temenoff and Mikos 2000b and Agrawal and Ray 
2001).  In order for cells to be able to infiltrate the structure uniformly, it should 
contain a large number of interconnected pores (Chapekar 2000, Freed et al 1994a 
and Kuo and Ma 2001).  The size of the pores is important to the infiltration and 
attachment of the cells, for chondrocytes an optimum pore size of between 100 and 
200 Pm has been suggested (Agrawal and Ray 2001 and Freyman et al 2001).  The 
scaffold must also be permeable, to allow diffusion of nutrients into the matrix and 
the removal of metabolic and degradation by-products from it (LeBaron and 
Athanasiou 2000).  Finally, it is important that the scaffold has mechanical properties 
that allow it to withstand implantation and the loads experienced in vivo (Chapekar 
2000, Agrawal and Ray 2001, Kuo and Ma 2001 and Freyman et al 2001).   
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The material used should be easily processed into the required structure and shape 
and be able to withstand sterilisation processes (Freed and Vunjak-Novakovic 1998, 
Middleton and Tipton 2000, Freed et al 1994a, Temenoff and Mikos 2000a and 
Ishaug-Riley et al 1999).  
 
1.8.2.a  Scaffold material 
1.8.2.a.i Natural materials 
Many natural materials have been used because of their similarity with cartilage 
ECM components, for example hyaluronan (Brun et al 1999, Lindenhayen et al 1999 
and Allemann et al 2001) and collagen (Fujisato et al 1996, Uchio et al 2000 and 
Allemann et al 2001).  Other natural materials used in cartilage tissue engineering 
studies include agarose (Saris et al 2000), alginate (Fragonas et al 2000) and chitosan 
(Suh and Matthew 2000).  Natural polymers are advantageous in tissue engineering 
applications as they can undergo cell-specific interactions (Grande et al 1997 and 
Chen et al 2002).  The use of natural materials, however, is limited by the large 
variation between batches, the lack of large supplies for commercial use and as they 
are often derived from non-human tissue they carry the risk of transferring pathogens 
(Marler et al 1998 and Temenoff and Mikos 2000b).   
 
1.8.2.a.ii Synthetic materials 
Synthetic polymers are often used in preference to natural materials as it is possible 
to mass-produce polymers with custom-designed properties.  Poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA) and co-polymers of PLA and PGA (PLGA) are commonly 
used in tissue engineering studies as they have Food and Drug Administration (FDA) 
approval for use within the human body.  Other synthetic polymers that have been 
used in tissue engineering applications include poly(ethyleneterephalate) (PET) 
(Ishaug-Riley et al 1999 and Li et al 2001), poly(caprolactone) (PCL) (Middleton 
and Tipton 2000) and poly(tetrafluoroethylene) (PTFE) (Neher et al 1998, Freed et al 
1999 and Wyre and Downes 2000).  Ideally a scaffold that is to be implanted into the 
human body should be biodegradable (Freed and Vunjak-Novakovic 1998, Hunziker 
1999a and Ishaug-Riley et al 1999) and the degradation products should be non-toxic 
(Freed et al 1994a and Agrawal and Ray 2001).    
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The degradation profiles of synthetic polymers can be controlled to match the rate at 
which the tissue develops, hence ensuring the structural integrity of the construct is 
maintained throughout tissue regeneration (Woodfield et al 2002).  In addition, it is 
possible to incorporate biologically active species such as growth factors into 
synthetic scaffolds in order to encourage specific cell responses, for example 
differentiation (Whitaker et al 2001).   
 
1.8.2.b  Scaffold design 
Both injectable and preformed scaffolds have been used in tissue engineering studies 
(Lu et al 2001).  Injectable scaffold materials can be combined with cells in vitro, 
injected into the defect and polymerised in situ (Lu et al 2001 and Hou et al 2004).  
From a clinical perspective, injectable scaffolds are an attractive option since they 
minimise patient discomfort, scar formation and risk of infection (Hou et al 2004).  
Injectable scaffolds also offer the advantage that they may be implanted using 
minimally invasive surgery techniques into defects of various shapes and sizes, 
although on implantation they may lack the mechanical stability of porous and 
fibrous scaffolds (Lu et al 2001).    Preformed scaffolds, for example porous foams, 
may be implanted into defects either alone as a space filling device; in combination 
with cells and/or growth factors; or with tissue that has formed within the scaffold 
during a period of in vitro culture (Temenoff and Mikos 2000a and Lu et al 2001).    
Pores can be introduced into polymer scaffolds using particulate leaching, emulsion 
freeze drying or supercritical fluid technology (Hutmacher 2000).  Since the use of 
high temperatures and organic solvents are not necessary in supercritical fluid 
scaffold processing, it is possible to incorporate biological factors into the scaffold 
during processing that encourage favourable cell responses (Watson et al 2002 and 
Yang et al 2003).  Non-woven fibrous scaffolds can be fabricated from a variety of 
polymers, both natural, for example hyaluronan and synthetic, for example PLA.  
Manufacture of fibrous scaffolds involves extrusion of the polymer into fibres, the 
fibres are then crimped and cut and then needle punched into a non woven mesh 
from which scaffolds may be cut (Vunjak-Novakovic et al 1999).  Sittinger and 
colleagues have proposed that non woven fibrous scaffolds may be preferable to 
porous scaffolds for in vitro tissue formation (Sittinger et al 1996).   
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Non woven fibrous scaffolds have previously been shown to support in vitro 
cartilage regeneration (Freed and Vunjak-Novakovic 1993, Puelacher et al 1994 and 
Aigner et al 1998).               
 
1.8.3 Culture environment 
Different methods of culturing cells within scaffolds in vitro have been used 
including static petri-dishes, dynamic spinner flasks, flow perfusion systems and 
rotating wall bioreactors (Figure 1.7; Temenoff and Mikos 2000a and Vunjak-
Novakovic et al 1999).   
 
1.8.3.a  Static culture 
Constructs grown in static culture tend to remain small, with the majority of ECM 
formation at the edges of the scaffold. Any tissue formed tends to be fibrous and 
poorly organised (LeBaron and Athanasiou 2000, Marler et al 1998, Vunjak-
Novakovic et al 1999 and Freed and Vunjak-Novakovic 1997).   
 
1.8.3.b  Dynamic culture 
Dynamic systems allow improved mixing and therefore enhanced mass transfer rates 
for gases, nutrients, metabolites and growth factors (Temenoff and Mikos 2000a and 
Freed and Vunjak-Novakovic 1998).  Using dynamic culture systems, such as the 
spinner flask, flow perfusion systems or the rotating wall bioreactor, cells have been 
uniformly seeded throughout scaffolds (Marler et al 1998) which is thought to 
encourage ECM formation throughout the entire structure (Temenoff and Mikos 
2000a).  In addition to improving cell seeding, dynamic culture systems have been 
shown to improve cartilage regeneration (Vunjak-Novakovic et al 1999 and 
Temenoff and Mikos 2000a).  Customised culture systems have also been developed 
by various researchers, which allow investigation of specific mechanical stimuli (for 
example dynamic compression) on in vitro cartilage formation (Chowdhury et al 
2003).   
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Figure 1.7    Dynamic culture systems: (A) spinner flask, (B) rotating wall bioreactor 
and (C) flow perfusion system. 
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1.8.3.b.i Spinner flask culture systems 
Spinner flasks are a relatively simple culture system.  A diagrammatic representation 
of a spinner flask is given in Figure 1.7 A.  A needle, to which scaffolds may be 
attached, is suspended from the flasks stopper and the medium may be mixed within 
the flask by a magnetic stirrer.  Spinner flasks may be used for seeding cells into 
scaffolds as well as for culture of cell-scaffold constructs.  Freed and colleagues have 
reported that cartilage constructs cultured within spinner flasks were larger than 
those grown statically (Freed and Vunjak-Novakovic 1997).   
 
1.8.3.b.ii Stimulated microgravity bioreactor systems 
Rotating wall bioreactors, for example the Rotary Cell Culture System (RCCS) 
originally designed by the National Aeronautics Space Administration (NASA), 
simulate the effects of microgravity and thereby limit the mechanical mixing that 
occurs within the culture system (Temenoff and Mikos 2000a).  A schematic 
representation of a rotating wall bioreactor is shown in Figure 1.7 B.    Scaffolds may 
be maintained within a constant state of free-fall by adjusting the speed at which the 
bioreactor rotates to that at which the centrifugal force within the system balances the 
forces of gravity and fluid drag (Freed and Vunjak-Novakovic 1997).  Gaseous 
exchange occurs within the bioreactor through a semi-permeable membrane.  Small 
movements of the scaffolds relative to the culture medium generate gentle mixing 
within the system (Freed and Vunjak-Novakovic 1997).  Freed and co-workers have 
reported that cartilage with a composition similar to that of hyaline cartilage has been 
generated using rotating wall bioreactors (Freed and Vunjak-Novakovic 1997 and 
Freed et al 1998).   
 
1.8.3.b.iii Flow perfusion culture systems 
Flow perfusion systems typically consist of a chamber, within which the scaffolds 
are maintained, which is connected to a peristaltic pump used to control the exchange 
of fresh and waste medium between a reservoir and the cell culture chamber (Figure 
1.7 C, Temenoff and Mikos 2000a).   
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Two groups have reported good matrix formation by chondrocytes cultured in 
perfusion systems (Sittinger et al 1996 and Vunjak-Novakovic et al 1999), although 
a more recent study by Mizuno and colleagues showed little cartilage formation by 
articular chondrocytes in a flow perfusion system (Mizuno et al 2001) indicating that 
there is some controversy as to the benefit of using flow perfusion systems in 
cartilage tissue engineering studies.      
 
1.9 Thesis aims 
Tissue engineering methods are being developed to allow the repair or replacement 
of diseased or damaged tissues.  A strategy often employed in tissue engineering is to 
take a biopsy of the required tissue, isolate the cells and seed them into scaffolds.  
The cell-seeded scaffolds are cultured within an appropriate culture system to allow 
tissue regeneration.  One of the limitations of current cartilage tissue engineering 
methods is the formation of a capsule of tissue around the periphery of the scaffold.  
This capsule impedes the flow of nutrients from the culture medium to the centre of 
the tissue, resulting in necrosis of the construct centre.  The work within this thesis 
aims to address this limitation by incorporating innovative scaffold architectures and 
a novel flow-through bioreactor system into the tissue engineering strategy outlined 
above.    
 
1.9.1  General aims 
The principal aim of this thesis was to investigate a novel system for tissue 
engineering based on new scaffold and bioreactor designs.  In order to assess this 
system two hypotheses were addressed.  The first hypothesis was that scaffolds with 
both random and anisotropic porosity would be beneficial for engineering tissue of a 
clinically relevant size.   The scientific basis for this hypothesis was that the presence 
of wider aligned pores within the random porous network would improve the supply 
of nutrients to the centre of the construct and prevent the formation of a necrotic 
core.  Within this thesis, four scaffold types were assessed for cartilage tissue 
engineering (Figure 1.8).   
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Figure 1.8   The different scaffolds used in this thesis and schematic representations of 
the fibre arrangements within the scaffolds: (A) needled felt, (B) sparse knit 3, (C) 
sparse knit 4 and (D) sparse knit 5.  
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Scaffolds containing random and anisotropic porosity of three different designs 
(sparse knit (SK) scaffolds 3, 4 and 5) were compared to scaffolds with random 
porosity alone (needled felt, NF).  The second hypothesis was that a flow-through 
bioreactor system would be advantageous for tissue engineering.  It was proposed 
that the flow of medium within the novel bioreactor system would provide an 
enhanced supply of nutrients to the growing constructs.  The work presented in this 
thesis compares the flow-through system with static culture and a bioreactor that 
simulates microgravity (RCCS¥) for in vitro culture of cartilage. 
 
1.9.2  Experimental objectives 
The experimental objectives of this thesis and the chapters within which they will be 
considered are presented in Figure 1.9.  In Chapter 3, the different scaffolds are 
described with respect to fibre arrangement, density and resistance to flow.   In 
addition, the optimum conditions for obtaining a high-density of evenly distributed 
cells throughout the scaffolds were determined for three different cell types: a human 
osteosarcoma cell line (HOS TE85), bovine articular chondrocytes (BACs) and ovine 
meniscal fibrochondrocytes (OMCs).  SK and NF scaffolds were assessed for in vitro 
engineering cartilage using OMCs in Chapter 3.  In the work presented in Chapter 4, 
each of the different scaffold types were cultured in static 6-well plates, the RCCS 
and a novel flow perfusion bioreactor for four weeks.  The two best performing 
scaffolds and culture systems from Chapter 4 were further assessed for in vitro 
cartilage regeneration in the work presented in Chapter 5.  OMCs were cultured in 
both scaffold types and culture environments for 8 weeks.  The biochemical 
composition and histological appearance of native ovine articular and meniscal 
cartilage were determined and used as a comparison for the engineered tissue. 
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Chapter 3 
Experimental Objective 1 
Characterisation of different 
scaffolds and assessment of 
optimum seeding conditions for 
different cell and scaffold types. 
Chapter 5 
Experimental Objective 4 
Further assessment of tissue 
formation in the different 
scaffolds and culture systems 
(8-week culture). 
Chapter 4 
Experimental Objective 2
Assessment of tissue 
formation in NF and SK 
scaffolds (4-week culture).
Experimental Objective 3
Assessment of tissue 
formation in different 
bioreactor systems (4-
week culture). 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9   The organisation of the experimental aims within chapters of this thesis. 
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 Chapter 2 
5 General Materials and Methods  
 
2.1 Materials  
A list of materials and suppliers is given in Appendix 1. 
  
2.2  Methods 
2.2.1 Scaffold manufacture  
Scaffolds used in this work were fabricated from polyethylene terephthalate (PET).  
The structure of PET is shown in Figure 2.1.   
 
2.2.1.a  Manufacture of needled felt scaffolds 
Smith & Nephew (York, UK) supplied needled felt scaffolds.  The needled felt (NF) 
material was woven from PET fibres 15 Pm in diameter using the methods shown in 
Figure 2.2.  Sheets of the PET NF material were cut into discs 9 mm in diameter and 
4 mm thick.  Figure 2.3 A shows a digital image of an NF scaffold.  A schematic 
representation of the fibre arrangement within NF scaffolds is shown in Figure 2.4 A.   
 
2.2.1.b  Manufacture of sparse knit scaffolds 
Sparse knit scaffolds were manufactured using the Raschel Warp Knitting process at 
Culzean Fabrics (Kilmarnock, Scotland) on behalf of Smith & Nephew.  Sparse knit 
scaffolds contained PET fibres of two diameters, 15 and 100 Pm.  Three different 
sparse knit (SK) scaffold materials were produced (SK 3, 4 and 5).  Sheets of the SK 
materials were cut into discs 9 mm in diameter and 4 mm thick.  Figures 2.3 B, C & 
D show digital images of the SK scaffolds.  A schematic representation of the fibre 
arrangement within SK scaffolds is shown in Figure 2.4 B.   
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Figure 2.1       The structure of polyethylene terephthalate (PET). 
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Figure 2.2       The stages in needled felt material manufacture. 
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Figure 2.3    Digital image of (A) a needled felt scaffold, (B) a sparse knit 3 scaffold, 
(C) a sparse knit 4 scaffold and (D) a sparse knit 5 scaffold. 
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Figure 2.4     Schematic representations of the fibre arrangement in (A) a needled   
felt scaffold and (B) a sparse knit scaffold. 
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2.2.2 Isolation of cartilage  
2.2.2.a  Isolation of bovine articular cartilage  
Bovine lower limbs were supplied by G. Wood and Sons Abattoir (Clipstone, 
Nottinghamshire, UK).  Bovine articular cartilage was isolated from the 
metacarpalphalangeal joint of 30 month old cows using a method originally 
described by Archer and colleagues (Archer et al 1990).   Figure 2.5 shows the stages 
involved in the isolation procedure.  The joint was opened under aseptic conditions 
and washed with Gentamicin phosphate buffered saline (PBS) solution (Appendix 
2.1.2).  The cartilage was removed from the upper articulating surface of the joint 
using a scalpel blade and washed in Gentamicin PBS solution. 
 
2.2.2.b  Isolation of ovine meniscal cartilage  
Ovine meniscal cartilage was isolated from the stifle joint of 4 month old sheep 
(obtained from Broomhall Butchers Ltd, Dursley, Gloucestershire) using a method 
previously described by Collier and Ghosh (Collier and Ghosh 1995).  Figure 2.6 
shows the stages involved in the isolation procedure.  The joint was opened under 
aseptic conditions and washed with Gentamicin PBS solution.  The menisci were 
removed from the joint using a scalpel blade and washed in Gentamicin PBS 
solution. 
 
2.2.2.c  Isolation of ovine articular cartilage  
Ovine articular cartilage was isolated from the stifle joint of 4-month old sheep using 
a method similar to that described in Section 2.2.2.a (Archer et al 1990).   The joint 
was opened under aseptic conditions and washed with Gentamicin PBS solution.  
The cartilage was removed from the upper articulating surface of the joint and 
washed in Gentamicin PBS solution. 
 
2.2.3 Isolation of chondrocytes 
2.2.3.a  Isolation of bovine articular chondrocytes (BACs)  
Bovine articular cartilage was isolated as described in Section 2.2.2.a.  Cartilage 
pieces were washed in Gentamicin PBS solution and diced finely. 
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 Stage 1 
 
Incisions were made across the surface of 
the metacarpalphalangeal joint. 
 
 
 
 
 
Stage 2 
 
The skin was cut away from the joint. 
 
 
 
 
 
 
Stage 3 
 
The ligaments at the centre of the joint 
were cut in order to fully expose the 
joint. 
 
 
 
 
Stage 4 
 
Cartilage was removed from the upper 
articulating surface of the joint. 
 
 
 
 
 
 
Figure 2.5     The stages involved in the isolation of bovine articular cartilage. 
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 Stage 1 
 
An incision was made across the upper 
surface of the stifle joint. 
 
 
 
 
 
Stage 2 
 
The skin was cut away from the joint. 
 
 
 
 
 
 
Stage 3 
 
The ligaments at the centre of the joint 
were cut in order to fully expose the 
joint. 
 
 
 
 
Stage 4 
 
The menisci were removed from the 
joint. 
 
 
 
 
 
 
Figure 2.6      The stages involved in the isolation of ovine meniscal cartilage. 
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 Chondrocytes were obtained by enzymatic digestion, with agitation in pronase 
digestion medium (Appendix 2.2.2) for 1 hour and collagenase digestion medium 
(Appendix 2.2.3) for 3 hours in a humidified incubator (37ºC, 5% CO2).  The 
resulting cell suspension was passed through a 70 Pm cell strainer (BD Falcon, 
Fahrenheit Laboratory Supplies, Rotherham, South Yorkshire, UK) to remove any 
debris and washed by centrifugation (1200 rpm, 259 x g; Sigma SciQuip 3K15, 
Scientific Laboratory Supplies, Nottingham, UK) in chondrocyte medium (Appendix 
2.3.1).  Cell viability and number were determined using a haemocytometer and 
trypan blue exclusion.  
 
2.2.3.b  Isolation of ovine meniscal fibrochondrocytes (OMCs) 
Ovine meniscal cartilage was isolated as described in Section 2.2.2.b.  Meniscal 
tissue was washed in Gentamicin PBS solution and diced finely.  Fibrochondrocytes 
were obtained by enzymatic digestion, with agitation in pronase digestion medium 
for 2 hours and collagenase digestion medium for 20 hours in a humidified incubator 
(37ºC, 5% CO2).   Debris was removed from the cell suspension by filtration through 
a 70 Pm cell strainer.  The cells were washed by centrifugation (1200 rpm, 259 x g) 
in chondrocyte medium and their number and viability determined using a 
haemocytometer and trypan blue exclusion.  
 
2.2.3.c  Isolation of ovine articular chondrocytes (OACs) 
Ovine articular cartilage was isolated as described in Section 2.2.2.c.  Cartilage 
pieces were washed in PBS and diced finely.  Chondrocytes were obtained by 
enzymatic digestion, with agitation in pronase digestion medium for 1 hour and 
collagenase digestion medium for 3 hours in a humidified incubator (37ºC, 5% CO2).  
The resulting cell suspension was passed through a 70 Pm cell strainer to remove any 
debris and washed by centrifugation (1200 rpm, 259 x g) in chondrocyte medium.  
Cell viability and number were determined using a haemocytometer and trypan blue 
exclusion.  
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 2.2.4 Cell culture 
2.2.4.a  Culture of BACs 
BACs were isolated as described in Section 2.2.3.a.  Primary BACs with viability 
greater than 95% were used in each experiment (i.e. cells were not expanded in 
vitro).  
 
2.2.4.b  Culture of OMCs 
OMCs were isolated as described in Section 2.2.3.b.  Cells with viability greater than 
95% were cultured in Nunc tissue culture flasks with a surface area of 175 cm2.  
When cells were 80-90% confluent, a cell suspension was obtained by enzymatic 
digestion with trypsin ethylenediaminetetraceitic acid (EDTA) in PBS (Appendix 
2.3.2).  Cells were split 1 in 2 and cultured to a maximum of passage 4 for tissue 
formation studies and to a maximum of passage 10 for seeding studies.     
 
2.2.4.c  Cryopreservation of OMCs 
Long term storage of OMCs was achieved by cryopreservation.  Cells were 
suspended in freezing medium (Appendix 2.3.3) and stored at -80qC overnight 
before being transferred to liquid nitrogen. 
 
2.2.4.d  Culture of OACs 
OACs were isolated as described in Section 2.2.3.c.  Primary OACs with viability 
greater than 95% were used in each experiment (i.e. cells were not expanded in 
vitro). 
 
2.2.4.e   Culture of Human Osteosarcoma (HOS) TE85 cells 
HOS TE85 cells obtained from the European Collection of Cell Cultures (ECACC; 
Wiltshire, UK) were cultured in Nunc tissue culture flasks with a surface area of 
75 cm2 in HOS TE85 medium (Appendix 2.3.4) until 80-90% confluent.  When 
confluent, a cell suspension was obtained by enzymatic digestion with trypsin/EDTA 
in PBS.  Cells were used between passage 81 and 95.   
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2.2.4.f   Cryopreservation of HOS TE85 cells 
Long term storage of HOS TE85 cells was achieved by cryopreservation as described 
in Section 2.2.4.c. 
 
2.2.5 Culture of cell seeded scaffolds 
2.2.5.a  Preparation of scaffolds 
Scaffolds were autoclaved at 120qC for 20 minutes, transferred to the appropriate cell 
culture medium and allowed to soak for at least 12 hours.   
 
2.2.5.b  Seeding cells into scaffolds  
A cell suspension was obtained by enzymatic digestion with trypsin EDTA in PBS.  
The cells were washed by centrifugation (1200 rpm, 259 x g) and diluted to a 
concentration of 4 x 106 cells per mL in the appropriate culture medium.  Scaffolds 
were arranged in separate wells of 24-well non-tissue culture treated plates (BD 
Falcon, Fahrenheit Laboratory Supplies, Rotherham, South Yorkshire, UK).  The cell 
suspension was pipetted through each scaffold ten times (1 mL per scaffold) in order 
to encourage cell attachment and the plate transferred immediately to an orbital 
shaker (IKA Schüttler MTS4, Sigma-Aldrich, Poole, Dorset, UK) in a humidified 
incubator (37ºC, 5% CO2) and agitated for 18 hours.  
 
2.2.5.c  Static culture  
Seeded scaffolds were transferred to 6-well non-tissue culture treated plates (BD 
Falcon).  One scaffold was placed in each well containing 10 mL medium.  Three 
times per week, 5 mL of medium was removed and replaced with fresh culture 
medium.  Cell seeded scaffolds were cultured for 4 or 8 weeks in a humidified 
incubator (37ºC, 5% CO2). 
 
2.2.5.d  Rotary cell culture system™ (RCCS™) culture  
Seeded scaffolds were placed in RCCS vessels (Cellon SA, Luxembourg).  Each 
vessel contained 5 scaffolds and 50 mL culture medium.  Culture medium was 
replenished at a rate of 50% (25 mL) every three days.   
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Vessels were cultured for 4 or 8 weeks in a humidified incubator (37ºC, 5% CO2).  
The speed at which the vessels rotated was increased throughout the culture period to 
maintain cell-seeded scaffolds within a "microgravity-like" environment. 
 
2.2.5.e  Flow perfusion culture  
This bioreactor system was designed and custom-built at Smith & Nephew Research 
Centre (York, UK).  Figure 2.7 shows the arrangement of the Smith & Nephew flow 
perfusion bioreactor.  Seeded scaffolds were transferred to 12 individual ports within 
the bioreactor, which contained 600 mL culture medium that was replenished at a 
rate of 0.15 mL per minute.  Flow through the scaffolds was achieved by a separate 
peristaltic pump, which transferred liquid from one side of the bioreactor to the other 
at a rate of 342 mL per minute (equivalent to approximately 1 mL per minute 
through each scaffold).  Bioreactor culture experiments were carried out for 4 weeks 
in a humidified incubator (37ºC, 5% CO2). 
 
2.2.6 Biochemical analyses 
2.2.6.a  Preparation of samples  
2.2.6.a.i Preparation of ovine meniscal cartilage samples 
Ovine meniscal cartilage was isolated as described in Section 2.2.2.b, weighed (wet 
weight) and lyophilised.  Lyophilised cartilage samples were re-weighed (dry 
weight) and stored at -20qC until required for analysis. 
 
2.2.6.a.ii Preparation of ovine articular cartilage samples 
Ovine articular cartilage was isolated as described in Section 2.2.2.c.  Cartilage 
samples were prepared as described in Section 2.2.6.a.i. 
 
2.2.6.a.iii Preparation of cell-seeded scaffolds 
Scaffolds were seeded with cells and cultured as described in Sections 2.2.6.b-
2.2.6.e.    Scaffolds were removed from culture, washed three times in PBS, 
lyophilised, weighed and stored at -20qC until required for analysis. 
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Figure 2.7  The Smith & Nephew flow perfusion bioreactor.   
Peristaltic pump (A) controls the flow of medium through the system.  Peristaltic 
pump (B) controls the removal of waste medium (C) and supply of fresh medium 
(D).  The culture system is contained within a tank (E).  Tubing (F) and perspex 
sheets (G) direct medium flow through the scaffolds, which are held within 
individual ports (H).  The bioreactor lid (I) contains two sets of ports, one for 
attachment to pump B (J) and the other for attachment to the pump A (K).     
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 2.2.6.a.iv  Preparation of standard cell pellets 
Cells were cultured as described in Section 2.2.4 and washed by centrifugation (1200 
rpm, 259 x g).  The cell suspension was diluted to a concentration of 8 x 106 cells per 
mL in the appropriate culture medium.  Pellets of 8 x 106 cells were obtained by 
centrifugation of a 1 mL aliquot and removal of the supernatant.  Cell pellets were 
lyophilised and stored at -20°C until required for analysis.  
 
2.2.6.b  Papain digestion 
Papain, a proteolytic enzyme, was used to solubilise tissue samples.  This allowed 
dissociation of deoxyribonucleic acids (DNA) from nucleoproteins (Kim et al 1988) 
and sulphated glycosaminoglycans (GAGs) from other glycoproteins (Farndale et al 
1986).  Samples were prepared for papain digestion as described in Section 2.2.6.a.  
Samples were incubated with 1 mL papain solution (Appendix 2.4.1) overnight in a 
water bath at 60qC.  Papain solution without tissue or cells was also incubated at 
60qC overnight to be used as a diluent in biochemical assays (heat-treated papain 
solution).  Papain digests were allowed to cool to room temperature prior to use in 
biochemical assays.   
 
2.2.6.c Hoechst 33258 assay for quantification of DNA 
Hoechst 33258 is a bisbenzimidazole dye (2-[2-(-4-hydroxyphenyl)-6-
benzimidazole]-6-(-1-methyl-4-piperazyl)-benzimidazole trihydrochloride), which 
intercalates in adenosine-thymidine (A-T) regions of DNA producing fluorescence 
(Cesarone et al 1979).  Measurements of fluorescence intensity were used to assess 
cell number within cartilage samples and cell seeded scaffolds. 
 
2.2.6.c.i Preparation of standard solutions for assay calibration 
To produce a calibration curve of cell number versus fluorescence, cell pellets 
(Section 2.2.6.a.iv) were papain digested as described in Section 2.2.6.b and serially 
diluted with heat-treated papain to give standard solutions with the following cell 
concentrations: 0, 3.13 x 104, 6.25 x 104, 1.25 x 105, 2.5 x 105, 5 x 105, 1 x 106, 2 x 
106, 4 x 106 and 8 x 106 cells/mL.  For each assay a calibration curve was generated 
for the appropriate cell type.  
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 2.2.6.c.ii Assessment of cell number in cartilage samples 
Papain digested cartilage samples were diluted 1:10 with heat-treated papain 
solution.  Aliquots of each cartilage sample, calibration standard and heat-treated 
papain solution (75 PL) were placed in triplicate in a 24-well assay plate.  Hoechst 
buffer (1 mL; Appendix 2.4.2) and Hoechst 33258 working solution (1.5 mL; 
Appendix 2.4.3) were added to each well.  Plates were incubated in darkness for 5 
minutes, gently agitated and the fluorescence at excitation wavelength 355 nm and 
emission wavelength 460 nm measured using a fluorescence plate reader (MFX 
Microtiter Plate Fluorimeter, Dynex Technologies (UK) Ltd, West Sussex, UK).  The 
cell number was expressed as the number of cells per gram of dry tissue, which was 
determined by normalising the number of cells within the sample with respect to the 
lyophilised cartilage weight. 
  
2.2.6.c.iii Assessment of cell number in cell-seeded scaffolds 
Analysis of the number of cells within cell-seeded scaffolds was carried out as 
described in Section 2.2.6.c.ii, with the exception that cell-seeded scaffold digests 
were not diluted 1:10 with heat-treated papain solution.  As a control, scaffolds 
without cells were analysed as described above. 
 
2.2.6.d Alamar blue¥ assay for assessment of cell viability  
The Alamar blue assay is based on the detection of metabolic activity of cells 
(Fields and Lancester 1993).  The assay reagent, Alamar blue, contains a 
reduction-oxidation (REDOX) indicator (resazurin).  The metabolic activity of cells 
causes a chemical reduction in their medium, which leads to the production of a pink 
fluorescent product, resorufin (OBrien et al 2000).  Decreased fluorescence levels 
are indicative of a decrease in the synthetic rates of cells and therefore suggestive 
that cells have been cultured in a less favourable environment and have a lower 
relative viability compared to cells which yield higher fluorescence levels when 
incubated with Alamar blue.   
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 2.2.6.d.i Analysis of viability of cells within cell-seeded scaffolds 
Cell-seeded scaffolds were transferred to a 24-well plate, washed with PBS and 
incubated with 1 mL Alamar blue working solution (Appendix 2.4.4) for 90 
minutes in darkness within a humidified incubator (37qC, 5% CO2).  Following 
gentle agitation for 15 minutes, 200 PL aliquots were removed from each well and 
placed in a 96-well assay plate.   
 
The fluorescence at excitation wavelength 530 nm and emission wavelength 590 nm 
was measured using a fluorescence plate reader (MFX Microtiter Plate Fluorimeter).  
As a control, scaffolds without cells were incubated for 90 minutes in 1 mL Alamar 
blue working solution and analysed as described above. 
 
2.2.6.e 1, 9-dimethylmethylene blue (DMMB) assay for quantification of 
sulphated glycosaminoglycans (GAGs) 
DMMB is a cationic dye, which binds to sulphate and carboxylate groups within 
GAGs producing a concentration dependent metachromatic change (Enobakhare et al 
1996).  The magnitude of this change can be quantified by the measurement of 
optical density.   
 
2.2.6.e.i Preparation of standard solutions for assay calibration 
To generate a calibration curve of GAG concentration versus optical density, a 100 
Pg/mL solution of chondroitin-4-sulphate was prepared (Appendix 2.4.5) and diluted 
with heat-treated papain solution to give standard solutions of the following 
concentrations: 0, 5, 10, 15, 20, 25, 30, 40, 50 and 75 Pg/mL.   
 
2.2.6.e.ii Analysis of GAGs in cartilage 
Samples of papain-digested cartilage were diluted 1:100 with heat-treated papain 
solution.  Aliquots of the diluted cartilage samples, calibration standards and heat-
treated papain (20 PL) were placed in triplicate in a 96-well assay plate.  DMMB 
solution (200 PL, Appendix 2.4.6) was added to each well and optical density 
measured at 540 nm using a colourimetric plate reader (MRX Microplate Reader,  
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Dynex Technologies (UK) Ltd).  The GAG content per gram of each sample was 
calculated using the equation given in Appendix 3.1. 
 
2.2.6.e.iii Analysis of GAGs in cell-seeded scaffolds 
Analysis of GAG content within cell-seeded scaffolds was carried out as described in 
Section 2.2.6.e.ii, with the exception that cell-seeded scaffold digests were not 
diluted 1:100 with heat-treated papain solution. 
 
 
2.2.6.f Hydroxyproline assay for quantification of total collagen content 
Hydroxyproline, a major component of collagen, can be extracted from cartilage by 
acid hydrolysis and quantified by oxidation with N-chloro-p-toluenesulfonamide 
sodium salt (chloramine T).  Reaction of the resulting oxidation product with p-
dimethylaminobenzaldehyde (p-DAB) at 60qC leads to the generation of a coloured 
product, which can be measured using a colourimeter (Woessner 1961).  
 
2.2.6.f.i  Acid hydrolysis of samples 
Papain-digested cartilage and cell-seeded scaffolds (250 PL) were hydrolysed by 
overnight incubation with equal volumes of concentrated hydrochloric acid (HCl) at 
120qC.  The residues were dried at 90qC, allowed to cool to room temperature and 
re-dissolved in 1 mL 0.25 M sodium phosphate buffer (Appendix 2.4.7).  Heat-
treated papain solution (1 mL) was hydrolysed with an equal volume of HCl, dried at 
90qC, cooled and re-dissolved in 4 mL 0.25 M sodium phosphate buffer for use as a 
diluent in the assay (hydrolysed papain solution).  
 
2.2.6.f.ii Preparation of standard solutions for assay calibration 
To generate a calibration curve of hydroxyproline concentration versus optical 
density, a 100 Pg/mL solution of hydroxyproline was prepared (Appendix 2.4.8).  
This solution was diluted with hydrolysed papain solution to give the following 
concentrations of hydroxyproline: 0, 1, 2, 4, 5, 6, 8, 10, 15, 20 and 30 Pg/mL.   
 
 
2.2.6.f.iii Quantification of total collagen content in cartilage 
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Hydrolysed cartilage samples were diluted 1:10 with hydrolysed papain solution.   
Aliquots of the diluted hydrolysed cartilage samples, calibration standards and 
hydrolysed papain solution (50 PL) were placed in triplicate in a 96-well assay plate.  
Chloramine T solution (50 PL; Appendix 2.4.9) was added to each well and the plate 
incubated at room temperature for 20 minutes.  Following this incubation period 50 
PL p-DAB solution (Appendix 2.4.10) was added to each well and the plate 
incubated at 60qC in a water bath for 30 minutes.  The plate was allowed to cool to 
room temperature and the optical density measured at 540 nm on a colourimetric 
plate reader (MRX Microplate Reader).  The collagen content per gram of each 
sample was calculated using the equation given in Appendix 3.2. 
 
2.2.6.f.iv Quantification of total collagen content in cell-seeded scaffolds 
Analysis of total collagen content within cell-seeded scaffolds was carried out as 
described in Section 2.2.6.f.iii, with the exception that cell-seeded scaffold digests 
were not diluted 1:10 in hydrolysed papain solution. 
 
2.2.7 Histology  
Histological methods allowed examination of the structural organisation of tissue. 
Mayers haematoxylin was used to stain cell nuclei blue/black.  Mayers 
haematoxylin contains alum, a cation that binds to the anionic nuclear chromatin 
(Stevens and Wilson 1999).  Eosin was used to stain connective tissues shades of 
pink/red (Stevens and Wilson 1999).  Safranin O is a cationic dye that binds to 
negatively charged sulphate and carboxylate groups within GAG chains (Cook 
1999).   
 
2.2.7.a  Processing, paraffin embedding and sectioning cartilage 
Cartilage samples were fixed in 10% buffered formal saline and dehydrated by 
passing through an increasing series of industrial methylated spirits (IMS; 50% [v/v], 
70% [v/v], 90% [v/v], and 100%[v/v]) and xylene (Histopathology Department, 
Queens Medical Centre, Nottingham; (Anderson and Gordon 1999).   
 
Processed tissue was orientated and embedded in paraffin wax.  A microtome (Leica 
RM2165, Leica Microsystems, Milton Keynes, UK) with a stainless steel blade was 
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used to cut 5 Pm sections.  The sections were stretched out on a water bath at 
50qC, mounted on Superfrost microscope slides (Scientific Laboratory Supplies, 
Nottingham, UK) and heated to 56qC on a hot plate. 
 
2.2.7.b  Histological analysis of cartilage 
2.2.7.b.i Haematoxylin and eosin staining of cartilage 
Cartilage sections were deparaffinised by heating to 56qC and rehydrated by passing 
through xylene, a decreasing series of IMS (100% [v/v], 90% [v/v], 70% [v/v] and 
50%[v/v]) and tap water.  Slides were incubated in Mayers haematoxylin for 10 
minutes at room temperature and washed in tap water for 1 minute.  Sections were 
blued using Scotts tap water substitute for 2 minutes and washed in tap water for a 
further minute.  Sections were then partially dehydrated through an increasing series 
of IMS (50% [v/v], 70% [v/v], 90% [v/v]) for 1 minute each and dipped in 1% 
alcoholic eosin (Appendix 2.5.1).  Tissue sections were fully dehydrated by passing 
through IMS (100% [v/v]) and xylene prior to mounting with a distyrene plasticiser 
xylene mixture (DPX).  Slides were viewed in bright field using an inverted 
microscope (Leica DM IRBE, Leica Microsystems). 
 
2.2.7.b.ii Safranin O staining 
Cartilage sections were deparaffinised by heating to 56qC and rehydrated by passing 
through xylene, a decreasing series of IMS (100% [v/v], 90% [v/v], 70% [v/v] and 
50% [v/v]) and tap water.  Sections were incubated in Mayers haematoxylin for 10 
minutes at room temperature, washed in tap water for 1 minute, dipped in 0.02% 
(w/v) aqueous fast green (Appendix 2.5.2) for 4 minutes, dipped in 1% (v/v) acetic 
acid (Appendix 2.5.3) and placed in 0.1% (v/v) aqueous safranin O for 10 minutes.  
Tissue sections were then dehydrated through an increasing series of IMS (50% [v/v], 
70% [v/v], 90% [v/v], and 100%[v/v]) and xylene before mounting and viewing as 
described in Section 2.2.7.b.i.  
 
 
2.2.7.c  Processing, resin embedding and sectioning cartilage constructs 
Cartilage constructs were fixed in 4% paraformaldehyde (Appendix 2.5.4) prior to 
embedding in Technovit 8100, a hydroxyethylmethacrylate resin.  Fixed cell-seeded 
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scaffolds were then washed overnight in PBS, dehydrated in 100% acetone for 1 
hour and infiltrated with Technovit 8100 infiltration solution (Appendix 2.5.5) for 10 
hours at 4qC with agitation.  Samples were agitated in 5 mL Technovit 8100 
embedding solution (Appendix 2.5.6) for 5 minutes at 4qC and orientated within 
moulds containing 5 mL Technovit 8100 embedding solution such that sections 
could be taken through the transverse and sagittal planes (Figure 2.8).  The moulds 
were sealed hermetically and stored at 4qC to allow the resin to cure.  A microtome 
with a tungsten carbide blade was used to cut 5 Pm sections, which were stretched 
out on distilled water at room temperature, mounted on Superfrost microscope 
slides and allowed to dry at room temperature.  
 
2.2.7.d  Histological analysis of cell-seeded scaffolds 
2.2.7.d.i Haematoxylin and eosin staining 
Resin sections were washed for 5 minutes in distilled water.  Sections were incubated 
in Mayers haematoxylin for 10 minutes, washed in tap water for 1 minute and the 
haematoxylin blued in Scotts tap water substitute for 2 minutes.  Sections were then 
washed in tap water for 1 minute and dipped in 1% alcoholic eosin.  Excess staining 
was eliminated by washing with 25% (v/v) IMS.  Sections were mounted using DPX 
and viewed in bright field using an inverted microscope. 
 
2.2.7.d.ii Safranin O staining 
Resin sections were washed for 5 minutes in distilled water.  Sections were incubated 
in Mayers haematoxylin for 10 minutes at room temperature, washed in tap water 
for 1 minute, blued in Scotts tap water substitute for 2 minutes and tap water for 1 
minute.  Slides were placed in 0.02% (w/v) aqueous fast green for 4 minutes, dipped 
in 1% (v/v) acetic acid and placed in 0.1% (v/v) aqueous safranin O for 10 minutes.  
Excess staining was eliminated by washing with 25% (v/v) IMS.  Sections were 
mounted and viewed as described in Section 2.2.7.d.i. 
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Figure 2.8   The planes of section described within this thesis. 
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 2.2.8 Scanning electron microscopy (SEM) 
By scanning an electron beam across the surface of a sample, SEM allows high-
resolution images of the samples topography to be obtained.  
  
2.2.8.a  SEM of scaffolds 
Scaffolds were autoclaved at 120qC for 20 minutes, cut in half through the sagittal 
plane (Figure 2.8), orientated on carbon coated electron microscope stubs and sputter 
coated with gold for 4 minutes (Balzers Union SCD 030, Balzers, Fürstentum, 
Liechtenstein).  The outer surface and middle region of each sample were viewed 
using a scanning electron microscope (Philips 505, Philips, Eindhoven, The 
Netherlands).  Digital images were acquired using Semicaps 2000A software 
(version 8.2, Semicaps Pte Ltd, Singapore).   
 
2.2.8.b  SEM of cell-seeded scaffolds 
Cell-seeded scaffolds were prepared for SEM using a method described by Robinson 
and Gray (Robinson and Gray 1999).  Scaffolds were washed with PBS, fixed in 3% 
(v/v) glutaraldehyde solution (Appendix 2.6.1) at 4qC overnight, before washing in 
PBS and secondary fixing for 1 hour in 1% (v/v) osmium tetroxide solution 
(Appendix 2.6.2).  Samples were then dehydrated through an increasing series of 
ethanol (25% [v/v], 50% [v/v], 70% [v/v], 90% [v/v], 95% [v/v] and 100% [v/v]) and 
dried using hexamethyldisilaxane (HMDS).  Finally scaffolds were cut, mounted, 
sputter coated and viewed as described in Section 2.2.8.a. 
 
2.2.9 Statistical analysis 
For all data, the mean and standard error of the mean (SEM) were calculated.  The 
statistical significance of results was assessed using GraphPad InStat version 3.0 
(GraphPad Software Inc, San Diego, USA).  
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 Chapter 3 
Determination of the optimum 
conditions for seeding cells into needled 
felt and sparse knit scaffolds 
3.1 Introduction 
Scaffolds play a crucial role in tissue engineering applications, providing a matrix in 
which new tissue is regenerated.  For successful tissue formation it is essential that 
the scaffold structure faciliates efficient cell seeding, supports cell attachment and 
promotes cell proliferation and ECM secretion (Woodfield et al 2002).  For cartilage 
tissue engineering it is important that a high density of cells are distributed 
throughout the entire scaffold in order to promote chondrogenesis and prevent 
fibrous tissue formation (Freed and Vunjak-Novakovic 1998 and Li et al 2001).  
Table 3.1 summarises different seeding methods that have been used in cartilage 
tissue engineering studies.  These include the use of spinner flasks (Freed et al 
1994a); delivering cells into the scaffold within a vehicle, such as alginate 
(Marijnissen et al 2002) and agitating scaffolds within tissue culture plates on an 
orbital shaker (Brown et al 2000).  In this thesis the method described by Brown and 
colleagues was used to seed cells into scaffolds.  Whilst there are many reports in the 
literature on the need for optimising methods for seeding cells into tissue engineering 
scaffolds, there is little information comparing the effects of scaffold structure or cell 
type on the optimum seeding conditions.  
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Seeding method Scaffold type Cell type Reference 
 
Agitation 
 
PGA non woven mesh 
 
Porcine auricular chondrocytes  
 
Brown et al 2000 
 
 
Alginate 
Encapsulation 
 
Alginate beads 
 
Human articular chondrocytes 
 
Gagne et al 2000 
 
 
PLLA non woven matrix  Bovine articular chondrocytes Marijnisssen et al  2002 
 
 
Perfusion PEGT/PBT copolymer foam 
 
Bovine articular chondrocytes 
 
Wendt et al 2003 
 
 
Hyaluronan non woven mesh Bovine articular chondrocytes Wendt et al 2003 
 
 
Spinner flask 
 
PGA non woven mesh 
 
Bovine articular chondrocytes 
 
Freed et al 1994a 
 
 
PGA non woven mesh Bovine articular chondrocytes Vunjak-Novakovic et al 
1998 
 
Hyaluronan non woven mesh Bovine articular chondrocytes Wendt et al 2003 
 
 
Static 
 
PEGT:PBT copolymer foam 
 
Bovine articular chondrocytes 
 
Wendt et al 2003 
 
 
PGA non woven mesh Bovine articular chondrocytes Moran et al 2003 
Puelacher et al 1994 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 Methods used for seeding cells into scaffolds for cartilage tissue engineering. 
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3.2 Aims and hypotheses 
The first objective of this chapter was to describe the different scaffolds with respect 
to mass, density, the arrangement of fibres and the resistance of the scaffolds to fluid 
flow.  The second aim was to determine the optimum rate of agitation required to 
allow a high density of viable BACs and OMCs to be distributed homogeneously 
throughout NF, SK3, SK4 and SK5 scaffolds.  To establish if optimum conditions 
were cell type dependent, a comparison was made between BACs, OMCs and a 
human osteosarcoma cell line (HOS TE85).  The first hypothesis was that agitation 
speed would influence the number, distribution and viability of cells in scaffolds.  It 
has been reported that dynamic seeding conditions lead to higher cell densities in 
scaffolds than static methods (Li et al 2001), however it was postulated that 
excessive agitation may compromise cell viability.  Therefore for each scaffold type 
there would be an optimum rate of agitation at which an appropriate number of 
viable cells would be evenly distributed throughout the structure.  The second 
hypothesis was that the optimum rate of agitation would be dependent on scaffold 
architecture.  It was proposed that more dense scaffolds would require seeding at 
faster agitation speeds. 
 
3.3 Methods  
3.3.1 Characterisation of needled felt and sparse knit scaffolds 
3.3.1.a  Scaffold design and manufacture 
3.3.1.a.i  Needled felt scaffolds 
NF scaffolds were of the same design as PGA non-woven meshes used in various 
other cartilage tissue engineering studies (see Table 1.2 for details of studies using 
non-woven meshes).  Scaffolds were manufactured from PET as described in Section 
2.2.1.a.     
 
3.3.1.a.ii  Sparse knit scaffolds 
SK scaffolds were designed to overcome the gas exchange and nutrient transfer 
limitations of other tissue engineering scaffolds.   
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SK scaffolds contained bundles of randomly arranged fibres separated by aligned 
channels and held within upper and lower knitted crusts.  Three different SK 
scaffolds were designed (SK3, SK4 and SK5).  SK scaffolds were manufactured 
from PET using the method given in Section 2.2.1.b.  
 
3.3.1.b  Scanning electron microscopy of scaffolds 
Scaffolds were prepared for SEM and imaged as outlined in Section 2.2.8.a.  Images 
were taken of two samples for each scaffold type.  The upper surface and the middle 
region of each scaffold were imaged. 
 
3.3.1.c  Determination of average scaffold mass and density 
The average mass of each of the scaffold types was determined by individually 
weighing 20 scaffolds and dividing their combined weight by the total number of 
scaffolds (20).  Micro-callipers were used to accurately measure the diameter and 
thickness of each of the twenty scaffolds and the equation for the volume of a 
cylinder (Appendix 3.3) used to calculate the volume of each scaffold.  From the 
mass and volume of each scaffold, the density was calculated using the equation 
given in Appendix 3.4.  The statistical significance between the mass and density of 
each scaffold type was assessed using GraphPad InStat version 3.0.  Results were 
expressed as mean ± SEM.  A one way analysis of variance (ANOVA) with the 
Tukey-Kramer multiple comparisons post test were performed.   
 
3.3.1.d  Characterisation of scaffold resistances to fluid flow 
The apparatus shown in Figure 3.1 was used to characterise the flow-resistance 
properties of each of the scaffolds in conjunction with the formula given in Appendix 
3.5.  Scaffolds were fixed within lengths of silicon tubing 10 mm in diameter such 
that liquid flowing through the tube must pass through the scaffold.  Water was 
passed through the tubing at a flow rate controlled by a syringe pump and collected 
in a measuring cylinder.   Once the height of water above the scaffold had stabilised, 
the time taken for a given volume of water to collect in the measuring cylinder was 
recorded.    
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Figure 3.1  The apparatus used to characterise the resistance of each scaffold 
to flow where F represents the flow rate, h represents height of water above the 
scaffold and V represents the volume of water collected.  
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 For each scaffold type, two scaffolds were assessed.  The statistical significance of 
the flow resistance of each scaffold type was assessed using GraphPad InStat version 
3.0.  Results were expressed as mean ± SEM.  An ANOVA with the Tukey-Kramer 
multiple comparisons post test were performed.   
 
3.3.2 Cell culture 
BACs were isolated as described in Section 2.2.3.a.  Primary BACs were not 
expanded in vitro prior to use in seeding studies. OMCs were isolated and cultured as 
described in Sections 2.2.3.b and 2.2.4.b.  OMCs were used in seeding studies 
between passages 4 and 10.  HOS TE85 cells were obtained and cultured as 
described in Section 2.2.4.e and used in seeding studies between passages 81 and 95. 
 
3.3.3 Seeding cells into scaffolds 
Scaffolds were autoclaved and soaked in culture medium as described in Section 
2.2.5.a.  Scaffolds were seeded with BACs, OMCs or HOS TE85 cells as described 
in Section 2.2.5.b.  Briefly, cells were re-suspended in cell culture medium to a 
concentration of 4 x 106 cells per mL.  The cell suspension was pipetted through each 
scaffold (1 mL per scaffold) in a 24-well non-tissue culture treated plate and agitated 
at 0, 100, 200, 300 or 400 rpm for 18 hours. Scaffolds were seeded in triplicate for 
biochemical analysis and in duplicate for image analysis.   
 
3.3.4 Analysis of cell viability 
The Alamar blue assay was carried out as outlined in Section 2.2.6.d.i to assess the 
total relative viability of cells within each of the scaffolds following agitation for 18 
hours.  In brief, the cell-seeded scaffolds were transferred to a 24-well plate and 
washed three times with PBS. Samples were incubated with 1 mL Alamar blue 
working solution (Appendix 2.4.4) for 90 minutes in a humidified incubator (37qC, 
5% CO2).  Following gentle agitation for 15 minutes, 200 PL aliquots from each 
sample were transferred to a 96-well assay plate.  The fluorescence was measured at 
excitation and emission wavelengths of 530 nm and 590 nm respectively, using a 
fluorescence plate reader (MFX Microtiter Plate Fluorimeter).   
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 Control scaffolds (scaffolds without cells) were incubated with Alamar blue 
working solution and analysed in the same way.  The relative viability per cell for 
each sample was determined by dividing the total relative viability of cells within 
each sample by the number of cells within the scaffold (as determined using the 
method given in Section 3.3.5.c).  The statistical significance between the total 
relative viability and viability per cell of scaffolds agitated at 100, 200, 300 or 400 
rpm compared to those seeded statically was assessed using GraphPad InStat version 
3.0.  Results were expressed as mean ± SEM and a two-tailed unpaired t-test was 
performed in order to assess statistical significance.   
 
3.3.5 Analysis of cell number 
3.3.5.a Preparation of standard cell pellets, cell-seeded and control 
scaffolds 
Standard cell pellets for all cell types were prepared as outlined in Section 2.2.6.a.iv.  
Following the Alamar blue assay, cell-seeded and control scaffolds were washed 
three times in PBS, weighed, lyophilised, re-weighed and stored at -20qC until 
required for analysis.    
 
3.3.5.b Papain digestion of cell-seeded scaffolds, control scaffolds and 
standard cell pellets  
Samples were digested with papain in order to allow dissociation of DNA from 
nucleoproteins (Kim et al 1988).  The digestion was carried out as described in 
Section 2.2.6.b.  In brief, samples were incubated in 1 mL papain solution (Appendix 
2.4.1) overnight in a water bath at 60qC.  Papain digests were allowed to cool to 
room temperature prior to analysis using the Hoechst 33258 assay. 
 
3.3.5.c  Hoechst 33258 assay for DNA quantification 
The Hoechst 33258 assay was employed to quantify the number of cells within each 
scaffold following seeding.  Standard solutions of known cell number were produced 
for each cell type as summarised in Section 2.2.6.c.i.   The Hoechst 33258 assay was 
performed as described in Section 2.2.6.c.iii.   
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Briefly, 75 PL of each papain digested sample and standard were placed in triplicate 
in a 24-well assay plate.  Hoechst buffer (1 mL; Appendix 2.4.2) and Hoechst 33258 
working solution (1.5 mL; Appendix 2.4.3) were added to each well.  Plates were 
incubated in darkness for 5 minutes, gently agitated and the fluorescence measured at 
excitation and emission wavelengths of 355 nm and 460 nm respectively, using a 
fluorescence plate reader.  From a calibration curve of cell number versus 
fluorescence for each cell type, the number of cells within each scaffold was 
determined.  Results were expressed as mean ± SEM and a two-tailed unpaired t-test 
was performed in order to assess statistical significance.   
 
3.3.6 Analysis of cell distribution 
Scanning electron microscopy was used to visualise the position of cells within the 
scaffolds.  Section 2.2.8.b describes how scaffolds were prepared and imaged.  In 
brief, cell-seeded scaffolds were washed in PBS, fixed in 3% (v/v) glutaraldehyde 
solution (Appendix 2.6.1), washed in PBS and further fixed in 1% (v/v) osmium 
tetroxide solution (Appendix 2.6.2).  Samples were dehydrated by passing through 
increasing concentrations of ethanol and dried using hexamethyldisilaxane (HMDS).  
Scaffolds were cut in half through the sagittal plane and orientated on carbon coated 
electron microscope stubs such that the scaffold surface and centre could be seen 
(Figure 3.2).  Samples were sputter coated with gold for 4 minutes and viewed using 
a Philips 505 scanning electron microscope.  Digital images were obtained using 
Semicaps 2000A software.    
 
3.4 Results  
3.4.1 Characterisation of needled felt and sparse knit scaffolds 
3.4.1.a  Scaffold design 
Representative scanning electron micrographs of each of the scaffolds are shown in 
Figure 3.3.  Needled felt scaffolds contained a random entanglement of fibres with 
no regions of alignment (Figure 3.3 A & B).  Each of the sparse knit scaffolds 
contained a knitted upper and lower crust (Figure 3.3 C, E & G). 
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 Figure 3.2 Visualisation of the distribution of cells within scaffolds using 
SEM following overnight seeding.  Scaffolds were (A) cut through the sagittal 
plane and mounted on stubs such that images could be taken of (B) the upper 
surface and (C) centre of the scaffolds.  Red arrows indicate the field of view. 
Blue arrows indicate the scaffold fibres and yellow arrow heads denote the 
presence of cells within SEM images taken of (D) the upper surface and (E) the 
centre of a representative scaffold.  
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Figure 3.3 Representative scanning electron micrographs of each of the scaffold 
types:   (A and B) needled felt, (C and D) sparse knit 3, (E and F) sparse knit 4 and 
(G and H) sparse knit 5.  Images show the (A, C, E & G) surface and (B, D, F & H) 
centre of the scaffolds.  Arrows (         ) in images D, F & H indicate the orientation 
of aligned fibres.  Thicker fibres in sparse knit scaffolds are highlighted with 
triangles (       ). 
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This knitted crust held together bundles of randomly orientated fibres which were 
separated by aligned channels (Figure 3.3 D, F & H).  The sparse knit scaffolds also 
differed from the needled felt scaffold in that they contained fibres of two diameters.  
The larger diameter fibres within the sparse knit scaffolds played a structural role, 
helping keep the bundles of fibres within the knitted crusts.  Sparse knit 5 scaffolds 
differed from sparse knits 3 and 4 since its knitted crust was of a more open structure 
(Figure 3.3 G).  Sparse knit 3 scaffolds appeared more dense than sparse knit 4 
scaffolds (Figure 3.3 D & F). 
 
3.4.1.b  Scaffold mass and density 
The average mass and density of each of the scaffold types are presented in Figure 
3.4 A and B.  No significant difference was detected between the mass or density of 
NF or SK4 scaffolds.   
 
3.4.1.c  The resistance of scaffolds to fluid  flow 
The resistance of each of the scaffold types to the flow of liquid through them is 
shown in Figure 3.5.  All scaffolds showed a decrease in resistance to flow with 
increasing flow rate.    At all flow rates, NF scaffolds showed increased resistance to 
flow compared to the sparse knit scaffolds.  At a flow rate of 50 ml per minute, the 
resistance of NF scaffolds to flow was significantly greater than that of the SK 
scaffolds.  At the slower flow rates it was not possible to measure the resistance of 
SK4 and SK5 scaffolds to flow since a height of water could not be retained above 
the scaffold in the tube.   
  
3.4.2 Assessment of optimum seeding conditions 
In order to determine the optimum seeding conditions for each of the scaffold types 
using BACs, OMCs and HOS TE85 cells, three parameters were investigated: cell 
viability (Alamar Blue assay), seeding efficiency (Hoechst 33258 assay) and the 
arrangement of cells within scaffolds (SEM). 
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Figure 3.4  Graphs representing (A) the average mass and (B) the average 
density of each of the scaffold types.  Results expressed as mean (n=20) r SEM.  
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Figure 3.5 The resistance of each of the scaffolds to flow of liquid at 
different flow rates.  Results expressed as mean (n=2) r SEM, ** indicates P < 
0.01.  
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3.4.2.a  Analysis of seeding cells into NF scaffolds  
3.4.2.a.i Analysis of seeding BACs into NF scaffolds 
The effect of agitation speed on the number, total relative viability and relative 
viability per cell of BACs in NF scaffolds is presented in Figure 3.6.  Seeding BACs 
into NF scaffolds with agitation at 200 or 300 led to significantly more cells within 
scaffolds, compared to scaffolds seeded statically (P<0.001 and P<0.05  respectively, 
Figure 3.6 A).  Agitating BACs with NF scaffolds at either 100 or 400 rpm did not 
increase the number of cells within the scaffolds significantly compared to static 
seeding (Figure 3.6 A).  The total relative viability of BACs in NF scaffolds was 
increased in scaffolds seeded with agitation at 100 rpm (P<0.05), 200 rpm (P<0.001), 
300 rpm (P<0.001) and 400 rpm (P<0.001) compared to scaffolds seeded statically 
(Figure 3.6 B).  The relative viability per cell of BACs in NF scaffolds following 
seeding at each of the speeds was determined by normalising the total relative 
viability of cells with respect to cell number (Figure 3.6 C).    The normalised 
relative viability of BACs in NF scaffolds was significantly greater in scaffolds 
agitated at 400 rpm compared to scaffolds seeded under static conditions (P<0.05, 
Figure 3.6 C).  No significant difference was determined between the normalised 
relative viabilities of BACs in NF scaffolds seeded at 100 rpm, 200 rpm or 300 rpm 
compared to those seeded at 0 rpm (Figure 3.6 C).  Scanning electron microscopy 
allowed visualisation of the distribution of cells at the surface and centre of scaffolds 
as shown in Figure 3.2.     Representative images of NF scaffolds seeded with BACs 
at each of the speeds are shown in Figure 3.7.  NF scaffolds seeded either statically 
or at 100 rpm contained a small number of BACs at both the surface and in the centre 
(Figure 3.7 A, B, C & D).  Agitation at 200 rpm led to an increased number of cells 
within the scaffolds, which were distributed evenly throughout the constructs (Figure 
3.7 E & F).  Increasing the seeding speed to 300 and 400 rpm led to a less even 
distribution of cells within the scaffolds, with more cells present at the centre than at 
the surface (Figure 3.7 G, H, I & J).    The optimum speed for seeding BACs into NF 
scaffolds was therefore 200 rpm, since a large number of cells were evenly 
distributed throughout the scaffolds and the viability of cells was not significantly 
compromised compared to scaffolds seeded statically.    
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Figure 3.6  The effect of agitation speed on (A) the number, (B) the total 
relative viability and (C) the relative viability per cell of  BAC 
OMC         HOS cells in NF scaffolds.      
Results expressed as mean (n=3) r SEM (* indicates P<0.05, ** indicates 
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R
el
at
iv
e 
v
ia
b
il
it
y
 p
er
 c
el
l 
Agitation speed (rpm) 
C 
*
*
).
ncnj
 111
             
                 
                 
                 
                 
                 
0 rpm 
100 rpm 
200 rpm 
300 rpm 
400 rpm 
A B
C D
E F
G H
I J
 
 
Figure 3.7  The effect of agitation speed on the arrangement of BACs at (A, C, E, 
G & I) surface and (B, D, F, H & J) centre of NF scaffolds.
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3.4.2.a.ii  Analysis of seeding OMCs into NF scaffolds      
The number, total relative viability and relative viability per cell of OMCs in NF 
scaffolds following overnight seeding at 0, 100, 200, 300 or 400 rpm are shown in 
Figure 3.6.  Seeding the scaffolds with agitation at 200, 300 and 400 rpm led to 
significant increases in the number of cells contained within the scaffolds compared 
to scaffolds seeded statically (Figure 3.6 A).  The total relative viability was greatest 
for OMCs in NF scaffolds seeded at 200 and 300 rpm (Figure 3.6 B).  Normalising 
the total relative viability with respect to cell number indicated that the viability of 
OMCs in NF scaffolds agitated at 100, 200, 300 and 400 rpm was compromised 
compared to that of OMCs which were seeded into NF scaffolds without agitation 
(Figure 3.6 C).  Scanning electron microscopy demonstrated that the distribution of 
cells within the scaffolds was affected by agitation speed.  Few cells were visible 
within scaffolds seeded either at 0 or 100 rpm (Figure 3.8 A, B, C & D).  Increasing 
the agitation speed to 200 rpm led to more OMCs at both the surface and centre of 
NF scaffolds (Figure 3.8 E & F).  A further increase in the number of OMCs at both 
the surface and centre of NF scaffolds was observed following agitation at 300 rpm 
(Figure 3.8 G & H).  Increasing the agitation speed to 400 rpm led to an uneven 
distribution of cells within the scaffolds, with an increased number of cells within the 
central region of the scaffolds (Figure 3.8 I & J).    Based on this information, 
agitation speeds of 200 rpm or greater were advantageous for obtaining a high 
density of evenly distributed OMCs within NF scaffolds, although the viability of the 
cells within these scaffolds was reduced compared to that of cells seeded into 
scaffolds without agitation. 
 
3.4.2.a.iii Analysis of seeding HOS TE85 cells  into NF scaffolds 
Figure 3.6 shows the effect of agitation speed on the number, total relative viability 
and viability per cell of HOS TE85 cells in NF scaffolds.  Agitating NF scaffolds at 
200, 300 or 400 rpm led to increased numbers of cells within the scaffolds (P<0.01, 
P<0.001 and P<0.001 respectively, Figure 3.6 A).  Agitating NF scaffolds with HOS 
TE85 cells at these speeds led to the detection of greater total relative viabilities 
compared to that of HOS TE85 cells in NF scaffolds seeded without agitation 
(P<0.01, Figure 3.6 B). 
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 The relative viability per HOS TE85 cell for NF scaffolds agitated at 400 rpm was 
significantly lower than that of cells seeded into scaffolds without agitation (P<0.05, 
Figure 3.6 C).  No significant difference was detected between the relative viability 
per cell of HOS TE85 cells in NF scaffolds seeded at 100, 200 or 300 rpm compared 
to those seeded without agitation.  Representative scanning electron micrographs of 
NF scaffolds seeded with HOS TE85 cells at each of the speeds are shown in Figure 
3.9.  Few HOS TE85 cells were detected in NF scaffolds seeded at either 0 or 100 
rpm (Figure 3.9 A, B, C & D).  Scaffolds agitated at 200 and 300 rpm contained a 
greater number of cells at both the surface and centre (Figure 3.9 E, F, G & H).  In 
NF scaffolds agitated at 400 rpm, a pellet of HOS TE85 cells was visible at the 
centre (Figure 3.9 J).  It was therefore shown that agitating NF scaffolds with HOS 
TE85 cells at speeds greater than 200 rpm led to a greater number of cells within the 
scaffolds and that the viability of these cells was compromised when agitated at 400 
rpm. 
 
3.4.2.b  Analysis of seeding cells into sparse knit 3 (SK3) scaffolds 
3.4.2.b.i Analysis of seeding BACs into SK3 scaffolds 
The effect of agitation speed on the number, total relative viability and viability per 
cell for BACs in SK3 scaffolds is presented in Figure 3.10.  The number of BACs in 
SK3 scaffolds increased with increasing agitation speed.  Significantly more cells 
were detected in scaffolds following overnight seeding at 200 rpm (P<0.01), 300 rpm 
(P<0.001) and 400 rpm (P<0.001) compared to scaffolds seeded without agitation 
(Figure 3.10 A).  The total relative viability of cells within the scaffolds was 
increased in constructs following agitation at 100, 200, 300 and 400 rpm (Figure 3.10 
B) although when these values were normalised with respect to cell number, it was 
clear that the viability of BACs was compromised by agitation at each of these 
speeds (Figure 3.10 C).    Representative images of SK3 scaffolds seeded with BACs 
at each of the speeds are shown in Figure 3.11.  Following static seeding, more cells 
were present at the surface of SK3 scaffolds than in the middle (Figure 3.11 A & B). 
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Figure 3.8  The effect of agitation speed on the arrangement of OMCs at (A, C, 
E, G & I) surface and (B, D, F, H & J) centre of NF scaffolds.
0 rpm 
100 rpm 
200 rpm 
300 rpm 
400 rpm 
A B
C D
E F
G H
I J
 115
             
                 
                 
                 
                 
                 
 Figure 3.9  The effect of agitation speed on the arrangement of HOS TE85 cells
at (A, C, E, G & I) surface and (B, D, F, H & J) centre of NF scaffolds. 
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Overnight agitation at 100 rpm led to more cells in the centre of SK3 scaffolds 
compared to at the surface (Figure 3.11 C & D).  SK3 scaffolds agitated with BACs 
overnight at 200, 300 or 400 rpm contained a more even distribution of cells 
although more cells were visible in the scaffolds seeded at 300 or 400 rpm compared 
to those seeded at 200 rpm (Figure 3.11 E, F, G & H).  This data shows that agitating 
SK3 scaffolds with BACs at speeds greater than 200 rpm leads to more cells evenly 
distributed throughout the scaffold, although the viability of the cells is 
compromised. 
 
3.4.2.b.ii Analysis of seeding OMCs into SK3 scaffolds 
Figure 3.10 shows the effect of agitation speed on the number and viability of OMCs 
in SK3 scaffolds.  Seeding SK3 scaffolds with OMCs at speeds of 200 rpm (P<0.05), 
300 rpm (P<0.001) or 400 rpm (P<0.001) led to a significant increase in the number 
of cells, compared to seeding them statically (Figure 3.10 A).  The total relative 
viability of OMCs in SK3 scaffolds seeded at 200 rpm and 300 rpm was significantly 
greater than that of OMCs in these scaffolds seeded statically (P<0.01 and P<0.05 
respectively, Figure 3.10 B).  Normalising the relative viability with respect to cell 
number indicated that agitation of  SK3 scaffolds with OMCs at 200 and 300 rpm led 
to a reduction in cell viability, compared to that of OMCs in SK3 scaffolds seeded 
without agitation (P<0.05, Figure 3.10 C).    SEM revealed few OMCs either at the 
surface or in the centre of SK3 scaffolds seeded in static plates (Figure 3.12 A & B).  
Agitation of SK3 scaffolds with OMCs at 100, 200, 300 or 400 rpm led to more 
evenly distributed cells (Figure 3.12 C, D, E, F, G, H, I & J).   It was also observed 
that OMCs at the surface of SK3 scaffolds agitated at 400 rpm were flattened, whilst 
those in the centre were rounded (Figure 3.12 I & J).  This information shows that 
agitation speeds greater than 200 rpm are required to increase the number of OMCs 
within SK3 scaffolds and to ensure that the cells are distributed throughout the 
constructs, although agitation at 200 and 300 rpm was detrimental to cell viability 
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Figure 3.11  The effect of agitation speed on the arrangement of BACs at (A, C, 
E, G & I) surface and (B, D, F, H & J) centre of SK3 scaffolds.
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 Figure 3.12  The effect of agitation speed on the arrangement of OMCs at (A, C, 
E, G & I) surface and (B, D, F, H & J) centre of SK3 scaffolds.
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3.4.2.b.iii Analysis of seeding HOS TE85 cells  into SK3 scaffolds 
The number and relative viability of HOS TE85 cells seeded into SK3 scaffolds at 
different agitation speeds are presented in Figure 3.10.  Agitating SK3 scaffolds with 
HOS TE85 cells at 200, 300 or 400 rpm led to a significant increase in the number of 
cells retained within the scaffolds compared to those seeded without agitation 
(P<0.001, P<0.01 and P<0.05 respectively, Figure 3.10 A).  The total relative 
viability of HOS TE85 cells in these scaffolds was also significantly greater than that 
of scaffolds seeded at 0 rpm (P<0.001, Figure 3.10 B).  The viability per HOS TE85 
cell in SK3 scaffolds was determined by normalising the total relative viability with 
respect to cell number.  It was shown that the viability of HOS TE85 cells in SK3 
scaffolds was only compromised following agitation at 400 rpm (Figure 3.10 C).  
Representative scanning electron micrographs of HOS TE85 cells in SK3 scaffolds 
are shown in Figure 3.13.  Few HOS TE85 cells were visible in SK3 scaffolds which 
were seeded either without agitation or at 100 rpm (Figure 3.13 A, B, C & D).  In 
SK3 scaffolds agitated at 200, 300 or 400 rpm more cells were visible (Figure 3.13 
E, F, G, H, I & J).  HOS TE85 cells were distributed more evenly throughout SK3 
scaffolds agitated at 300 rpm (Figure 3.13 G & H).  In summary, seeding SK3 
scaffolds with HOS TE85 cells at agitation speeds of 200 and 300 rpm led to 
increased numbers of cells retained within the scaffolds without causing a significant 
reduction in cell viability.  
 
3.4.2.c  Analysis of seeding cells in sparse knit 4 (SK4) scaffolds 
3.4.2.c.i Analysis of seeding BACs into SK4 scaffolds 
The effect of agitation speed on the number and relative viability of BACs within 
SK4 scaffolds is shown in Figure 3.14.  SK4 scaffolds seeded with BACs at agitation 
at each of the speeds contained more cells than scaffolds seeded without agitation 
(Figure 3.14 A).    Greater total relative cell viability was detected for BACs cells in 
these scaffolds (Figure 3.14 B).  Normalising the total relative viability with respect 
to cell number indicated that agitation at each of these speeds led to compromised 
cell viability (Figure 3.14 C). 
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Figure 3.13  The effect of agitation speed on the arrangement of HOS TE85cells
at (A, C, E, G & I) surface and (B, D, F, H & J) centre of SK3 scaffolds. 
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Figure 3.14  The effect of agitation speed on (A) the number, (B) the total 
relative viability and (C) the relative viability per cell of     BAC,   OMC and 
HOS cells in SK4 scaffolds. 
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  More BACs were visible at the surface of SK4 scaffolds than in the centre following 
static seeding (Figure 3.15 A & B).  Few cells were visible in scaffolds agitated at 
100 or 200 rpm (Figure 3.15 C, D, E & F).  A greater number of BACs were detected 
in SK4 scaffolds agitated at 300 and 400 rpm and it was observed that these cells 
were present both at the surface and in the centre of scaffolds (Figure 3.15 G, H, I & 
J).  This data shows that whilst the number and distribution of BACs within SK4 
scaffolds can be improved by seeding them at agitation speeds of 300 or 400 rpm, the 
viability of these cells may be compromised.     
  
3.4.2.c.ii Analysis of seeding OMCs into SK4 scaffolds 
Figure 3.14 shows graphs presenting the effect of seeding speed on the number and 
relative viability of OMCs within SK4 scaffolds.  Agitating SK4 scaffolds with 
OMCs at 200 rpm (P<0.001), 300 rpm (P<0.01) or 400 rpm (P<0.01) led to 
significant increases in the number of cells retained within the scaffolds, compared to 
scaffolds seeded statically (Figure 3.14 A).  The total relative viability of OMCs in 
these scaffolds was significantly increased at 300 and 400 rpm (P<0.01, Figure 3.14 
B).  Assessment of the relative viability of each OMC within the scaffolds showed 
that whilst the viability of the cells was not compromised by agitation at 100 or 200 
rpm, it was reduced in cells agitated at 300 and 400 rpm (Figure 3.14 C).  SK4 
scaffolds seeded with OMCs at 0 or 100 rpm contained more cells at the surface than 
in the centre (Figure 3.16 A, B, C & D).  Scaffolds agitated at 200, 300 and 400 rpm 
contained a higher density of evenly distributed cells than scaffolds seeded at 0 and 
100 rpm (Figure 3.16 E, F, G, H, I & J).   It was therefore shown that agitation at 
speeds greater than 200 rpm led to more OMCs within SK4 scaffolds although at 300 
and 400 rpm the viability of these cells was compromised.   
 
3.4.2.c.iii Analysis of seeding HOS TE85 cells  into SK4 scaffolds 
The effect of agitation speed on the number and viability of HOS TE85 cells seeded 
into SK4 scaffolds is presented in Figure 3.14.  Seeding the scaffolds with agitation 
at 200, 300 and 400 rpm led to an increase in the number of cells retained within the 
scaffolds compared to SK4 scaffolds seeded statically or at 100 rpm (Figure 3.14 A).   
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 Figure 3.15  The effect of agitation speed on the arrangement of BACs at (A, C, 
E, G & I) surface and (B, D, F, H & J) centre of SK4 scaffolds.
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Figure 3.16  The effect of agitation speed on the arrangement of OMCs at (A, C, 
E, G & I) surface and (B, D, F, H & J) centre of SK4 scaffolds.
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 The increased number of HOS TE85 cells within SK4 scaffolds was significant 
following agitation at 200 and 300 rpm (P<0.001 and P<0.01 respectively).  The total 
relative viability of HOS TE85 cells in SK4 scaffolds was also greater for cells in 
scaffolds seeded at 200, 300 and 400 rpm compared to those seeded either without 
agitation or with agitation at 100 rpm (Figure 3.14 B).  The relative viability per cell, 
as determined by normalising the total relative viability with respect to cell number, 
for HOS TE85 cells seeded into SK4 scaffolds is shown in Figure 3.14 C.  No 
significant difference was detected between the relative viabilities of HOS TE85 
cells seeded into SK4 scaffolds at each of the speeds.  Using SEM, few cells were 
visible either at the surface or in the centre of scaffolds seeded at 0 or 100 rpm 
(Figure 3.17 A, B, C & D).  In scaffolds seeded at 200 rpm, more HOS TE85 cells 
were visible at the centre of scaffolds than at the surface (Figure 3.17 E & F).  
Agitating SK4 scaffolds with HOS TE85 cells overnight at 300 and 400 rpm led to a 
more even distribution of cells within the scaffolds (Figure 3.17 G, H, I & J).  The 
data presented shows that agitating SK4 scaffolds with HOS TE85 cells at 200, 300 
and 400 rpm led to an increase in the number of cells retained within the scaffolds, 
without compromising the viability of the cells.   The distribution of HOS TE85 cells 
within these scaffolds was more even at 300 and 400 rpm compared to the other 
speeds. 
 
3.4.2.d  Analysis of seeding cells into sparse knit 5 (SK5) scaffolds 
SK5 scaffolds were introduced to the project in the final year, when it had been 
decided to use OMCs in preference to BACs for cartilage formation studies to ensure 
consistency in the cell type being used by all partners in this project.  For this reason, 
seeding optimisation studies on SK5 scaffolds were only performed using OMCs and 
HOS TE85 cells. 
 
3.4.2.d.i Analysis of seeding OMCs into SK5 scaffolds 
Figure 3.18 shows the effect of agitation speed on the number, total relative viability 
and viability per cell of OMCs seeded into SK5 scaffolds.  Increased cell numbers 
were detected in scaffolds seeded at 200 and 300 rpm compared to those scaffolds 
seeded at 0, 100 or 400 rpm (Figure 3.18 A). 
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Figure 3.17  The effect of agitation speed on the arrangement of HOS TE85 cells
at (A, C, E, G & I) surface and (B, D, F, H & J) centre of SK4 scaffolds. 
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Figure 3.18  The effect of agitation speed on (A) the number, (B) the total 
relative viability and (C) the relative viability per cell of   OMC and       HOS 
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The total relative viability of OMCs in SK5 scaffolds agitated at each of the speeds 
was greater than that of those cells seeded into SK5 scaffolds without agitation 
(Figure 3.18 B).  The relative viability of each cell was compromised in those 
scaffolds agitated at 100, 200 and 300 rpm whilst that of cells in scaffolds seeded at 
400 rpm was greater compared to the cells in scaffolds seeded without agitation 
(Figure 3.18 C).  Representative scanning electron micrographs of SK5 scaffolds 
seeded with OMCs are presented in Figure 3.19.  Few cells were visible in scaffolds 
seeded without agitation (Figure 3.19 A & B).  Following agitation at 100, 200 and 
300 rpm, more OMCs were visible within SK5 scaffolds (Figure 3.19 C, D, E, F, G 
& H).  SK5 scaffolds agitated with OMCs at 400 rpm were similar in appearance to 
those seeded without agitation with few cells visible within the scaffolds (Figure 3.19 
I & J).  Therefore, seeding OMCs into SK5 scaffolds at either 200 or 300 rpm led to 
increased numbers of cells within the scaffolds, although the viability was reduced 
compared to that of cells in scaffolds seeded statically. 
 
3.4.2.d.ii Analysis of seeding HOS TE85 cells  into SK5 scaffolds 
The effect of agitation speed on the number and relative viability of HOS TE85 cells 
in SK5 scaffolds is shown in Figure 3.18.  Agitating SK5 scaffolds with HOS TE85 
cells at 200, 300 and 400 rpm led to greater numbers of cells within the scaffolds 
compared to seeding without agitation or seeding at 100 rpm (Figure 3.18 A).  This 
was also reflected in the increase in total relative viability of HOS TE85 cells seeded 
into these scaffolds (Figure 3.18 B).  The relative viability of each HOS TE85 cell 
did not appear to be affected by agitation as shown by no significant differences 
between the relative viabilities of cells seeded into SK5 scaffolds at each of the 
speeds (Figure 3.18 C).  SK5 scaffolds seeded with HOS TE85 cells either without 
agitation or with agitation at 100 rpm did not appear to contain many cells (Figure 
3.20 A, B, C & D).  SEM revealed more HOS TE85 cells within SK5 scaffolds 
seeded with agitation at 200 and 300 rpm and that these cells were distributed evenly 
throughout the scaffold (Figure 3.20 E, F, G & H).  SK5 scaffolds seeded with HOS 
TE85 cells at 400 rpm contained evenly distributed cells (Figure 3.20 I & J).   
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Figure 3.19 The effect of agitation speed on the arrangement of OMCs at (A, C, 
E, G & I) surface and (B, D, F, H & J) centre of SK5 scaffolds.
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Figure 3.20 The effect of agitation speed on the arrangement of HOS TE85 cells
at (A, C, E, G & I) surface and (B, D, F, H & J) centre of SK5 scaffolds. 
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Agitating SK5 scaffolds with HOS TE85 cells at 200, 300 and 400 rpm therefore 
allowed a greater number of cells to be seeded evenly into the scaffolds, without 
compromising cell viability.   
  
3.5 Discussion 
Scaffolds are used in tissue engineering systems to provide cells with a three 
dimensional support upon which they may attach, proliferate and secrete ECM 
components (Sharma and Elisseeff 2004).  One of the essential features of a tissue 
engineering scaffold is that it must contain pores so that nutrients can be supplied to 
the growing tissue (Vunjak-Novakovic 2003).  It is evident from Table 1.2 that 
various scaffolds have been used in cartilage engineering studies and that these 
scaffolds have differed in terms of the material from which they have been 
manufactured and their structure.  Many previous cartilage tissue engineering studies 
have used scaffolds containing a random distribution of fibres.  Promising results 
have been observed in studies using these scaffolds with different cell sources and 
culture systems (Martin et al 1998 and Vunjak-Novakovic et al 1999).  One 
limitation of these scaffolds is that the ultimate size of the cartilage construct is 
limited by the availability of nutrients during culture.  It is well accepted that in 
larger constructs the formation of tissue at the scaffold periphery impedes the flow of 
nutrients from the culture environment into the centre of the scaffold and so cell 
viability is lost and the centre of the growing tissue become necrotic (Freed et al 
1999).  One of the hypotheses of this thesis was that scaffolds containing both 
random and anisotropic porosity would be beneficial for viable tissue regeneration in 
vitro since the presence of wider aligned channels within the scaffold would facilitate 
the flow of nutrient-containing medium into the construct throughout the culture 
period.   
 
The first section of this chapter was concerned with characterising these novel 
scaffolds with respect to mass, density, the arrangement of fibres and the resistance 
of the scaffolds to fluid flow.  Three different SK scaffolds were designed and 
manufactured by Smith & Nephew.   
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These scaffolds all contained bundles of randomly arranged fibres separated by 
aligned channels to facilitate nutrient transfer.  NF scaffolds, containing randomly 
arranged fibres, were used in the studies presented in this thesis as a control scaffold.  
The resistance of each of the scaffolds to the flow of liquid was assessed and at each 
of the flow rates it was determined that the resistance of the SK scaffolds was lower 
than that of the NF scaffolds, indicating that the presence of aligned channels within 
the sparse knit scaffolds did improve their flow properties.  It was also found that 
SK4 scaffolds were similar to NF scaffolds with respect to mass and density.  In 
comparison, SK3 and SK5 scaffolds were more dense than NF scaffolds. In addition, 
the crusts on SK3 and SK4 scaffolds were more densely knitted than that of SK5 
scaffolds. 
 
The density with which cells are initially seeded into scaffolds and their arrangement 
within the scaffolds are important parameters in tissue engineering.  These factors 
affect cell proliferation, differentiation and migration, and ultimately the quality of 
the engineered tissue (Li et al 2001).  The aim of the second section of this chapter 
was therefore to determine the optimum agitation speed for seeding BACs, OMCs 
and HOS TE85 cells into NF, SK3, SK4 and SK5 scaffolds.  The effect of agitation 
speed on the number, relative viability and distribution of cells within the scaffolds 
was determined.  Since it is important that a high density of evenly distributed cells 
are initially seeded into scaffolds for in vitro cartilage regeneration, the optimum 
agitation speed for each cell and scaffold type was selected based on the number and 
distribution of cells (Vunjak-Novakovic et al 1998).  For all scaffold and cell types, 
seeding with agitation increased the number of cells within the scaffolds.  This is in 
agreement with previous studies that have reported improved seeding using dynamic 
seeding methods (Li et al 2001).  In the studies presented in this chapter it was found 
that agitation speed influenced the number, distribution and viability of the cells 
seeded into the scaffolds.  Following overnight agitation at 200 rpm, a large number 
of BACs and OMCs were distributed evenly throughout NF scaffolds.  In contrast, 
for HOS TE85 cells it was necessary to agitate NF scaffolds at 300 rpm in order to 
ensure a high number of cells were retained within the scaffold.   
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It was determined that for seeding each of the three cell types into SK3 scaffolds, 
overnight agitation at 300 rpm led to both an increase in cell number and a more 
homogeneous distribution of cells.  Whilst a reduction in relative viability was 
detected for BACs and OMCs seeded into SK3 scaffolds with agitation, this effect 
was not observed in HOS TE85 cells.  For all cell types, agitation at 300 rpm also led 
to an increase in the number of cells contained within SK4 scaffolds.  Following 
overnight agitation at this speed the cells were evenly distributed within the 
scaffolds.  As for SK3 scaffolds, a reduction in the relative viability of BACs and 
OMCs, but not HOS TE85 cells, was detected following agitation at 300 rpm.  
Overnight agitation at 200 rpm allowed an increased number of OMCs to be seeded 
into SK5 scaffolds compared to the other agitation speeds, although it was observed 
that the number of OMCs detected within these scaffolds was lower than the number 
detected within each of the other scaffold types.  As for NF scaffolds, it was found 
that overnight seeding at 300 rpm allowed a large number of HOS TE85 cells to be 
seeded homogeneously into SK5 scaffolds.  A reduction in the relative viability of 
OMCs was detected following agitation at 100, 200 and 300 rpm, compared to that 
of OMCs seeded into SK5 scaffolds without agitation.  As for the other sparse knit 
scaffolds, the viability of HOS TE85 cells seeded into SK5 scaffolds with agitation 
was not compromised.     
 
Following overnight seeding at 200, 300 and 400 rpm, the number of OMCs in NF, 
SK3 and SK4 scaffolds was found to be greater than the 4 x 106 cells initially seeded 
into the scaffolds.  This suggests that the proliferation rate of OMCs under these 
conditions was greater than that of the other two cell lines.  It is well documented 
that chondrocytes within articular cartilage have a low proliferative rate (Buckwalter 
and Mankin 1998b).  The cells within meniscal fibrocartilage display phenotypic 
traits of both chondrocytes and fibroblasts and are generally known as 
fibrochondrocytes (Huckle et al 2003).  It is probable, therefore, that OMCs have a 
greater capacity for proliferation than BACs and that the increased number of OMCs 
within scaffolds following overnight incubation is due to cell proliferation.   
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In addition, it was noted that the relative viability of HOS TE85 cells seeded into SK 
scaffolds was not compromised by agitation.  This indicates that this osteosarcoma 
cell line is more resilient to agitation than the two primary chondrocyte cell lines.      
 
The first hypothesis proposed was that agitation speed would influence the number, 
distribution and viability of cells in scaffolds.  For all scaffolds, seeding with 
agitation led to an increased number of cells contained within the scaffolds compared 
to static seeding.   This study therefore supports previous work that has shown 
improved seeding of cells into scaffolds using dynamic rather than static methods (Li 
et al 2001).  In dynamic seeding, cells are transported into scaffolds by convection as 
a result of an increase in the relative velocity between the cells and the scaffold 
(Vunjak-Novakovic et al 1996).  It has been postulated that high seeding densities 
could enhance in vitro formation of tissues by mimicking phases of cell condensation 
and differentiation that occur during embryonic development (Gurdon 1988 and 
Tachetti et al 1992).  Indeed, enhanced biochemical composition and structural 
stability have been observed in engineered cartilage that resulted from constructs 
with high initial cell loading (Vunjak-Novakovic et al 1998).   
 
In addition to high seeding densities, uniform spatial distributions of cells within 
scaffolds are necessary for functional tissue formation (Vunjak-Novakovic et al 
1998).  Galban and colleagues have proposed that non-uniform seeding may lead to 
spatial variations in cell and nutrient concentration within scaffolds and hence 
impede cartilage formation by limiting mass transport (Galban and Locke 1999).  
The speed with which the scaffolds were agitated was shown to affect the 
distribution of cells within each of the scaffolds.  For NF scaffolds, increasing the 
speed of agitation from 0 to 200 rpm led to a more even distribution of cells within 
the scaffolds, however further increasing the speed to 400 rpm led to an increased 
number of cells at the centre of scaffolds and few at the surface.  This is in agreement 
with reports from Li and colleagues that enhanced cell seeding does not necessarily 
coincide with improved uniformity (Li et al 2001).   
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It was found for BACs and OMCs that the relative viability per cell was affected by 
agitation, for example seeding OMCs into NF scaffolds with agitation at 100, 200, 
300 and 400 rpm led to a reduction in relative viability in comparison to that of 
OMCs seeded into NF scaffolds without agitation.  Although there are several reports 
in the literature on the effect of different seeding conditions on the number and 
distribution of cells in tissue engineering scaffolds, few authors mention the effect of 
the seeding conditions on cell viability.   
 
The second hypothesis was that the optimum rate of agitation would be dependent on 
scaffold architecture.  The scaffold is important for providing a structure to which 
cells can attach and for supporting tissue formation (Vunjak-Novakovic et al 1998).  
Scaffold structures used in cartilage tissue engineering studies include non-woven 
fibre meshes (Freed et al 1994a and Puelacher et al 1994) and porous foam scaffolds 
(Wendt et al 2003).  Wendt and colleagues have reported similar optimum seeding 
conditions for both non-woven and porous foam scaffolds with different pore 
structures (Wendt et al 2003).  The scaffolds used by Wendt and co-workers had 
open upper and lower scaffold surfaces and so differed from the SK3 and SK4 
scaffolds used in our study which had dense upper and lower crusts.  It was 
proposed that the presence of more dense upper and lower crusts may impede the 
penetration of cells into the scaffolds; hence these scaffolds would require seeding at 
faster agitation speeds than those scaffolds with more open structures (NF and SK5).  
In this study, the optimum agitation speed for seeding BACs and OMCs into SK3 
and SK4 scaffolds was determined to be 300 rpm, whilst the optimum agitation 
speed for NF and SK5 scaffolds was 200 rpm, thus confirming this hypothesis.  In 
contrast, for HOS TE85 cells, no difference in optimum agitation speed was 
determined for the scaffolds with more open structures compared to those with the 
more dense upper and lower crusts.  It is unknown why there are variations in 
optimum agitation speed for different cell types, however it is postulated that it may 
be due to differences in cell size and density.  In order to ascertain whether cell 
density influences cell seeding, the density of each cell type could be compared using 
centrifugation.  It is also possible that the different cell types interact differently with 
the scaffold materials and the fibres.      
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This study demonstrated that different seeding conditions were required to ensure a 
high density of homogeneously distributed cells were seeded into each of the 
scaffold types for BACS, OMCs and HOS TE85 cells, therefore highlighting the 
need for seeding optimisation studies prior to commencing tissue engineering studies 
as both scaffold architecture and cell type may influence the optimum seeding 
conditions.  
 
3.6 Conclusions 
The work presented within this chapter describes a novel scaffold structure which 
has enhanced flow properties compared to a more traditional fibrous tissue 
engineering scaffold.  The effect of agitation speed on the number, viability and 
distribution of BACs, OMCs and HOS TE85 cells within NF and SK scaffolds was 
determined.  The optimum agitation speed for seeding each of the cell types into the 
different scaffolds was determined and is summarised in Table 3.2.  The optimum 
seeding conditions varied with both scaffold architecture and cell type.  In terms of 
scaffold architecture, faster agitation speeds were required to ensure a high density of 
cells were able to penetrate the more densely knitted scaffolds.  With respect to cell 
type, for identical scaffolds, faster agitation speeds were required for HOS TE85 
cells than chondrocytes.  The work presented in this chapter highlights the 
importance of performing studies of this nature prior to commencing tissue 
engineering work in order to determine the optimum parameters for seeding 
particular cell lines into scaffold structures. 
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Scaffold Type 
 
 
Scaffold description 
Scaffold 
density 
 
Optimum seeding 
speed (BACs) 
Optimum seeding 
speed (OMCs) 
Optimum seeding 
speed (HOS) 
 
Needled felt  
 
 
Open scaffold structure 
with randomly orientated 
fibres. 
 
 
0.049 g cm-3
 
 
200 rpm 
 
 
200 rpm 
 
 
300 rpm 
Sparse knit 3  
 
 
Bundles of randomly 
arranged fibres separated 
by aligned channels and 
held together by densely 
knitted upper and lower 
crust. 
 
 
0.069 g cm-3
 
 
300 rpm 
 
 
300 rpm 
 
 
300 rpm 
Sparse knit 4  
 
 
As sparse knit 3. 
 
 
0.047 g cm-3
 
 
300 rpm 
 
 
300 rpm 
 
 
300 rpm 
Sparse knit 5 
 
 
As sparse knit 3, except 
upper and lower crust 
less dense. 
 
 
 
0.083 g cm-3
 
 
N/A 
 
 
200 rpm 
 
 
300 rpm 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2 Summary of scaffold properties and optimum seeding conditions. 
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Chapter 4 
Comparison of the roles of scaffold 
architecture and bioreactor systems on 
initial cartilage formation in vitro 
 
4.1 Introduction and aims 
As previously described, there have been numerous attempts to engineer cartilage in 
vitro over the past decade.  One of the key challenges in cartilage tissue engineering 
is that of producing tissue constructs of clinically useful sizes.  Freed and co-workers 
have reported that to overcome this challenge there is a need to ensure that an 
appropriate supply of nutrients is available to the entire construct throughout the in 
vitro culture period (Freed et al 1998 and Obradovic et al 2000).  Pei and colleagues 
have proposed that optimisation of parameters such as scaffold material, scaffold 
structure and culture system is necessary in order to enhance in vitro cartilage 
regeneration and allow formation of larger constructs with an appropriate structure 
and composition (Pei et al 2002).  This is in agreement with Freed and Vunjak-
Novakovic, who suggested that two environmental factors play an important role in 
in vitro tissue regeneration: (1) scaffold structure and (2) the culture system (Freed 
and Vunjak-Novakovic 1998).  There have been several attempts to improve the 
supply of nutrients to growing tissues in vitro based on modifications to both the 
culture systems used and the scaffold architecture (Malda et al 2005).  These include 
studies by Bhardwaj and colleagues and Woodfield and co-workers who investigated 
the use of scaffolds with different structures for tissue engineering cartilage 
(Bhardwaj et al 2001 and Woodfield et al 2002).     
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The aim of this chapter was to compare different scaffold architectures and culture 
systems for their suitability for tissue engineering cartilage.  The hypotheses 
proposed within this thesis were that scaffolds combining random and anisotropic 
porosity and a novel flow-perfusion bioreactor would be advantageous for in vitro 
cartilage formation.  In this chapter, needled felt and each of the sparse knit scaffolds 
were compared for in vitro cartilage tissue formation over a four week period.  In 
addition, the novel flow-perfusion bioreactor was compared with a commercially 
available culture system, the RCCS, and static 6-well tissue culture plates.         
 
4.2 Methods 
4.2.1 Preparation of scaffolds 
Scaffolds were manufactured and prepared for cell-seeding as described in Sections 
2.2.1 and 2.2.5.a.   
 
4.2.2  Cell culture 
OMCs were isolated from ovine meniscal cartilage and cultured as outlined in 
Sections 2.2.3.b and 2.2.4.b.   
 
4.2.3 Culture of cell-seeded scaffolds 
Scaffolds were seeded with OMCs as described in Section 2.2.5.b under the 
conditions optimised in Chapter 3.  For NF and SK5 scaffolds an agitation speed of 
200 rpm was used and for SK3 and SK4 scaffolds the agitation speed was 300 rpm 
(Table 3.2).  Following overnight seeding, scaffolds were transferred to either static 
6-well plates (Section 2.2.5.c), RCCS vessels (Section 2.2.5.d), or the flow-
perfusion bioreactor (Section 2.2.5.e).  All cultures were maintained for four weeks.  
For both static and RCCS cultures, medium was replenished at a rate of 50% three 
times per week.  Medium was supplied to the flow-through bioreactor at a rate of 
0.15 mL per minute.  For each culture condition, five scaffolds of each type were 
cultured, three of which were used for biochemical analysis and two for histology.  
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The experiments were repeated twice such that for each scaffold type and culture 
environment, six samples were analysed for their biochemical content and four for 
their histological appearance. 
   
4.2.4 Analysis of constructs 
Following the four-week culture period, scaffolds were removed from their 
respective culture environments and washed three times in sterile PBS.    
 
4.2.4.a  Biochemical analyses and assessment of increase in construct 
weight 
Scaffolds for biochemical analysis were transferred to pre-weighed Eppendorf tubes 
and re-weighed in order to calculate the wet weight of the constructs.  Scaffolds were 
lyophilised and re-weighed so that a dry weight for each construct could be 
obtained.  The percentage increase in construct weight was determined using the 
equation given in Appendix 3.6.  Samples were digested using papain, as outlined in 
Section 2.2.6.b.  Following overnight incubation, samples were allowed to cool and 
aliquots taken for DNA, GAG and collagen assays.   
 
4.2.4.a.i Assessment of cell number 
The total cell number for each construct was determined using the Hoechst 33258 
assay.  The assay was performed as in Section 2.2.6.c.  The number of cells within 
each construct was determined and normalised with respect to the mass of the 
constructs (Appendix 3.7).   
 
4.2.4.a.ii Assessment of GAG content 
The DMMB assay was used to quantify the GAG content of each construct according 
to the procedure outlined in Section 2.2.6.e.  The GAG content for each sample was 
calculated using the equation given in Appendix 3.1. 
   
4.2.4.a.iii Assessment of total collagen content 
The total collagen content of each sample was assessed using the hydroxyproline 
assay (Section 2.2.6.f) and calculated using the equation given in Appendix 3.2. 
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4.2.4.b  Histological analysis 
Prior to histological examination, samples were fixed in 4% paraformaldehyde at 
4qC (Appendix 2.5.4).   
 
4.2.4.b.i Resin embedding constructs 
Constructs were processed, embedded in Technovit 8100 resin and sectioned as 
described in Section 2.2.7.c.   
 
4.2.4.b.ii Safranin O staining 
Sections were stained with safranin O as outlined in Section 2.2.7.d.ii.  Following 
staining, sections were mounted and imaged using an inverted microscope (Leica 
DM IRBE, Leica Microsystems). 
  
4.2.5 Statistical analysis 
The statistical significance of results was assessed using GraphPad InStat version 3.0 
(GraphPad Software Inc, San Diego, USA).  Results were expressed as mean ± SEM.  
An ANOVA and the Tukey-Kramer Multiple Comparisons post-test were performed.  
Results were considered significant when P<0.05 (*), very significant when P<0.01 
(**) and extremely significant when P<0.001 (***). 
 
4.3 Results 
4.3.1 Increase in construct weight 
The increase in construct weights with culture time was determined as outlined in 
Section 4.2.4.a.  Figures 4.1 and 4.2 show the increase in construct weight for each of 
the scaffold types following 4-week static, RCCS or flow perfusion culture.  The 
two graphs show the same data expressed using different parameters for the x axis in 
order to clearly show the statistical significance of the results.  All scaffolds cultured 
in either static 6-well plates or the RCCS showed greater increases in dry weight 
than those cultured in the flow perfusion system (Figure 4.1).  For NF and SK4 
scaffolds, the increase in weight of constructs cultured within the RCCS was 
greater than that of constructs cultured statically (Figure 4.1).   
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Figure 4.1 Comparison of the % increase in construct weight for each of the 
scaffold types following 4-week      static,      RCCS or     flow perfusion 
culture.  Results expressed as mean (n=3) r SEM (* indicates P<0.05, ** 
indicates P<0.01). 
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Following 4 week static and flow perfusion culture, no significant differences 
between the increases in construct weight for each of the scaffold types was detected 
(Figure 4.2).  SK4 scaffolds cultured within the RCCS, however, showed a greater 
increase in weight than either SK3 or SK5 scaffolds (P<0.05, Figure 4.2). 
 
4.3.2 Cell content 
The number of cells per gram of dry construct following 4-week culture was 
measured as described in Section 4.2.4.a.i.  Figures 4.3 and 4.4 show a comparison of 
the cell content in NF, SK3, SK4 and SK5 scaffolds following culture in each of the 
systems.  Over the four week culture period the number of cells within all scaffolds 
increased.  For NF, SK3 and SK4 scaffolds, no statistically significant difference in 
the cell content of the scaffolds was detected for each of the culture systems.  For 
SK5 scaffolds, the number of cells in scaffolds cultured statically was significantly 
greater than the number in constructs cultured in either RCCS or flow perfusion 
systems (P<0.05 and P<0.001 respectively, Figure 4.3).  In addition, more cells were 
detected in SK5 scaffolds following RCCS culture than following culture in the 
flow perfusion system (P<0.001, Figure 4.3).  Following 4-week static culture, NF 
scaffolds contained more cells per gram construct than SK5 scaffolds (P<0.001, 
Figure 4.4).  Comparing each of the scaffold types following RCCS culture, the 
cell content of NF scaffolds was greater than that of SK3 and SK5 scaffolds (P<0.05 
and P<0.001 respectively, Figure 4.4).  In addition SK4 scaffolds cultured within the 
RCCS contained more cells per gram than SK5 scaffolds (P<0.05, Figure 4.4).  NF 
scaffolds cultured within the flow perfusion bioreactor contained a greater number of 
cells per gram than each of the other scaffold types (P<0.001, Figure 4.4).  Of the 
sparse knit scaffolds cultured within the flow perfusion system, SK4 scaffolds 
contained a greater concentration of cells than either SK3 or SK5 scaffolds (P<0.001, 
Figure 4.4) and SK3 scaffolds contained an increased number of cells compared to 
SK5 scaffolds (P<0.001, Figure 4.4).      
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Figure 4.2  Comparison of the % increase in construct weight of   NF, 
SK3,      SK4 and      SK5 constructs following 4-week culture in each of 
the culture systems.  Results expressed as mean (n=6) r SEM (* indicates 
P<0.05). 
  
Flow perfusion 
asas
 146
  
0.0E+00
3.0E+08
6.0E+08
9.0E+08
1.2E+09
NF SK3 SK4 SK5
 
***
***
C
el
l 
n
u
m
b
er
 (
p
er
 g
 d
ry
 t
is
su
e)
 
Scaffold type 
Figure 4.3 Comparison of the cell number (per gram dry construct weight) 
in each of the scaffold types following 4-week     static,       RCCS or      flow 
perfusion culture.  Results expressed as mean (n=6) r SEM (* indicates P<0.05, 
*** indicates P<0.001). 
  
*
 147
  
0.0E+00
3.0E+08
6.0E+08
9.0E+08
1.2E+09
static RCCS S&N
  
 
 
******
***
*
C
el
l 
n
u
m
b
er
 (
p
er
 g
 d
ry
 t
is
su
e)
 
Culture system 
Figure 4.4 Comparison of the cell number (per g dry construct weight) of 
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4.3.3 GAG content 
The GAG content of each of the constructs was assessed using the DMMB assay as 
described in Section 4.2.4.a.ii.  Figures 4.5 and 4.6 show the GAG content of NF, 
SK3, SK4 and SK5 scaffolds as a percentage of the dry construct weight following 4-
week culture in each of the systems.  NF constructs contained a greater concentration 
of GAGs following culture in the RCCS, compared to either static or flow 
perfusion culture (P<0.001, Figure 4.5).  Similarly, following RCCS culture SK3 
constructs had a greater GAG content compared to static and flow perfusion culture 
(P<0.001, Figure 4.5).  In addition, the GAG content of SK3 scaffolds was 
significantly increased following static culture compared to  flow perfusion culture 
(P<0.01, Figure 4.5).  GAGs accounted for a greater proportion of SK4 scaffolds 
following RCCS and static culture compared to flow perfusion culture (P<0.001, 
Figure 4.5).  SK4 scaffolds cultured within the RCCS also contained a higher 
concentration of GAGs than those cultured statically (P<0.001, Figure 4.5).  Both 
static and RCCS culture led to higher concentrations of GAGs within SK5 
scaffolds, as compared to flow perfusion culture (P<0.05, Figure 4.5).  There was no 
statistically significant difference between the GAG content of each scaffold type 
following 4-week static or flow perfusion culture.  NF scaffolds contained a greater 
concentration of GAGs than SK3 and SK5 scaffolds following RCCS culture 
(P<0.05 and P<0.001 respectively, Figure 4.6).  RCCS culture led to a greater 
concentration of GAGs in SK3 and SK4 scaffolds, compared to SK5 scaffolds 
(P<0.01 and P<0.001 respectively, Figure 4.6).   
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Figure 4.5 Comparison of the GAG composition (% dry tissue weight) of 
each scaffold type following 4 week     static
culture.  Results expressed as mean (n=6) r SEM (* indicates P<0.05, ** 
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Figure 4.6  Comparison of the GAG composition (% dry tissue weight) of 
 NF, K3, K4 and K5 constructs following 4-week culture in 
each of the culture systems.  Results expressed as mean (n=6) r SEM (* 
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4.3.4 Total collagen content 
The hydroxyproline assay was used to determine the total collagen content of 
constructs as outlined in Section 4.2.4.a.iii.  Figures 4.7 and 4.8 show the collagen 
content as a percentage of the construct dry weight for NF, SK3, SK4 and SK5 
scaffolds following 4-week culture in each of the systems.  Following RCCS 
culture, the collagen content of NF constructs was greater compared to static and 
flow perfusion culture (P<0.01 and P<0.001 respectively, Figure 4.7).  There was no 
significant difference between the different culture systems with respect to the 
collagen content of SK3 scaffolds following 4 weeks culture.  The collagen content 
of SK4 scaffolds was greater following RCCS culture compared to both static and 
flow perfusion culture (P<0.05, Figure 4.7).  Static culture led to a higher collagen 
content in SK5 scaffolds than either RCCS or flow perfusion culture (P<0.01, 
Figure 4.7).  NF scaffolds contained a significantly greater amount of collagen than 
SK3 scaffolds following static culture (P<0.01, Figure 4.8).  There was no significant 
difference between the collagen content of the other scaffold types following static 
culture.  Although on average the collagen content of NF and SK4 scaffolds was 
greater than other scaffolds following 4-week RCCS culture, no significance was 
detected between these scaffolds and SK3 or SK5 scaffolds.  Following 4-week flow 
perfusion culture, NF scaffolds contained a higher concentration of collagen than 
SK5 scaffolds (P<0.05, Figure 4.8).  No significant difference was detected between 
the collagen contents of the other scaffolds following flow perfusion culture. 
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Figure 4.7 Comparison of the collagen composition (% dry tissue weight) of 
each scaffold type following 4 week     static,     RCCS or         flow perfusion 
culture.  Results expressed as mea  (n=6) SEM (* indicates P<0.005, ** 
indicates P<0.01). 
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Figure 4.8  Comparison of the collagen composition (% dry tissue weight) of 
asn NF,     SK3,      SK4 and      SK5 constructs following 4-week culture in
each of the culture systems.  Results expressed as mean (n=6) r SEM (* 
indicates P<0.05, ** indicates P<0.01). 
  
 154
  
4.3.5 Safranin O staining 
Following 4-week culture, scaffolds were fixed, embedded, sectioned and stained 
with safranin O as described in Section 4.2.4.b.  For all scaffolds and culture 
environments, cells within the scaffolds stained positively with safranin O.  Figure 
4.9 shows representative images of NF scaffolds following 4-week static, RCCS 
and flow perfusion culture.  NF scaffolds cultured under static conditions contained 
cells both at the surface and in the centre (Figure 4.9 A & B).  More intense safranin 
O staining was visible at the outer edge of the scaffolds.  NF scaffolds cultured 
within the RCCS were similar in appearance to those cultured in static plates 
(Figure 4.9 C & D).  Cells were present throughout the scaffolds with more intense 
staining visible at the outer edges.  Figure 4.9 E & F shows representative sections 
through NF scaffolds that were cultured in the flow perfusion bioreactor.  Fewer cells 
were present in these scaffolds compared to those cultured either in static plates or 
the RCCS.   
 
Figure 4.10 shows sections taken from SK3 scaffolds following static, RCCS or 
flow perfusion culture for 4 weeks.  Following static culture, cells were present 
throughout the knitted surface of SK3 scaffolds (Figure 4.10 A).  In the central 
region of scaffolds, cells were restricted to the bundles of fibres and the aligned 
channels could be seen between the fibres (Figure 4.10 B).  At the surface of 
constructs cultured in the RCCS more cells appeared to be present than in those 
cultured in static plates (Figure 4.10 C).  The central region of constructs cultured in 
the RCCS was similar to that of those cultured statically, with cells present within 
the bundles of fibres and aligned channels visible between the bundles (Figure 4.10 
D).  SK3 scaffolds cultured within the flow perfusion system contained few cells 
(Figure 4.10 E & F).  More cells were present within the knitted crusts than in the 
centre of constructs.   
 
 155
             
               
A B
*
*
               
C D
*
*
               
FE 
*
*
 
 
 
Figure 4.9 Representative images showing haematoxylin and safranin O staining 
of NF constructs following 4-week (A & B) static, (C & D) RCCS and (E & F) 
flow perfusion culture.  Images show (A, C & E) top surface and (B, D & F) centre 
of constructs.  Scale bars represent 50 Pm.  Asterisks (*) highlight the appearance of 
cells and arrow heads (Ż) highlight polymer fibres within images.    
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Figure 4.10 Representative images showing haematoxylin and safranin O staining 
of SK3 constructs following 4-week (A & B) static, (C & D) RCCS and (E & F) 
flow perfusion culture.  Images show (A, C & E) top surface and (B, D & F) centre 
of constructs.  Scale bars represent 50 Pm.  The orientation of aligned fibres within 
the constructs is highlighted with arrows (       ). 
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Representative images of SK4 scaffolds following 4-week static, RCCS or flow 
perfusion culture are shown in Figure 4.11.  Following static culture, constructs 
contained a homogeneous distribution of cells (Figure 4.11 A & B).  The presence of 
aligned channels between the bundles of fibres was difficult to detect within the 
centre of these samples (Figure 4.11 B) indicative that matrix formation may have 
occurred within the channels.  Sections taken from SK4 scaffolds cultured within the 
RCCS for 4 weeks were similar in appearance to those cultured statically (Figure 
4.11 C & D).  Cells within these constructs were evenly distributed throughout both 
the knitted crust and the scaffold centre, with the aligned channels not clearly visible.  
SK4 scaffolds cultured within the flow-perfusion bioreactor contained few cells 
which were present predominantly at the outer edge of the construct (Figure 4.11 E 
& F).   
 
Representative sections through SK5 scaffolds following 4-week static, RCCS or 
flow perfusion culture are shown in Figure 4.12.  Following culture in each of the 
three systems, SK5 scaffolds contained few cells and a thin layer of safranin O 
staining was visible at the outer edge of constructs.  SK5 scaffolds cultured within 
the RCCS appeared to contain more cells than those constructs cultured statically 
or in the flow perfusion system (Figure 4.12 C & D).  To allow comparison of the 
histological appearance of all samples Figure 4.13 shows representative sections 
from the centre of constructs from each scaffold type and culture system.  Constructs 
cultured within the flow perfusion bioreactor contained fewer cells than scaffolds 
cultured either in static 6-well plates or the RCCS, regardless of scaffold type 
(Figure 4.13 C, F, I & L).       
 
 158
  
               
               
               
A B
C D
E F
 
Figure 4.11 Representative images showing haematoxylin and safranin O staining 
of SK4 constructs following 4-week (A & B) static, (C & D) RCCS and (E & F) 
flow perfusion bioreactor culture.  Images show (A, C & E) top surface and (B, D & 
F) centre of constructs.  Scale bars represent 50 Pm for images A, B, C & D and 100 
Pm for images E & F.  The orientation of aligned fibres within the constructs is 
highlighted with arrows (       ). 
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Figure 4.12 Representative images showing haematoxylin and safranin O staining 
of SK5 constructs following 4-week (A & B) static, (C & D) RCCS and (E & F) 
flow perfusion bioreactor culture.  Images show (A, C & E) top surface and (B, D & 
F) centre of constructs.  Scale bars represent 100 Pm.  The orientation of aligned 
fibres within the constructs is highlighted with arrows (       ). 
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Figure 4.13 Representative images showing haematoxylin and safranin O staining 
of sections taken through the centre of each of the scaffold types following 4 week 
static, RCCS and flow perfusion culture.  Images show NF, SK3, SK4 scaffolds 
and SK5 scaffolds. In all images the scale bar represents 50 Pm except those marked 
with *, where the scale bar represents 100 Pm.  
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4.4 Discussion  
The aim of this chapter was to compare different scaffold architectures and culture 
systems for their suitability for engineering tissues in vitro.  It was postulated that 
scaffolds combining random and anisotropic porosity and a novel flow perfusion 
bioreactor system would be advantageous for regenerating tissues of a clinically 
relevant size.  To test these hypotheses, each of the different scaffolds were cultured 
in either static 6-well tissue culture plates, the RCCS or the flow perfusion system 
for 4 weeks with OMCs and the resulting cartilage compared between scaffold and 
culture systems.  
      
Following 4 week culture, NF scaffolds cultured within the RCCS and SK4 
scaffolds cultured either in static plates or the RCCS all showed an increase in 
weight of more than 30%.  For all culture systems, NF scaffolds contained a greater 
number of cells following 4 week culture than the other scaffolds.  SK4 scaffolds that 
were cultured in the RCCS contained more cells than SK5 scaffolds cultured in the 
same way.  For all scaffold types, constructs cultured within the RCCS had a 
higher GAG content compared to those cultured within static 6-well plates and those 
cultured within the flow perfusion system.  In the same way, the GAG content of 
constructs cultured statically was greater than that of those cultured within the flow 
perfusion system.  It is possible that GAGs were produced by cells in scaffolds 
cultured within the flow perfusion system but during the flow of medium through the 
scaffold the GAG was washed away before an extracellular matrix could form.  
GAGs formed a greater component of all samples compared to collagen at this stage 
of culture.  During embryonic limb development, the limb first forms from a 
proteoglycan matrix which is later strengthened by the formation of collagen fibrils 
and eventually remodelled into bone and cartilage.  It is therefore likely that the 4-
week old constructs were immature and further culture would allow the formation of 
a collagen meshwork and later maturation into cartilage.  NF and SK4 scaffolds 
contained more collagen following 4-week RCCS culture than following either 
static or flow-perfusion culture.   
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Histological examination of the constructs revealed that fewer cells were present in 
scaffolds cultured within the flow perfusion bioreactor compared to either those 
cultured in either static plates or the RCCS.  It was also observed that SK5 
scaffolds contained few cells regardless of the environment in which they were 
cultured.        
 
There have been many attempts to regenerate functional tissues in vitro using tissue 
engineering strategies based on using scaffolds and bioreactors (Vunjak-Novakovic 
2003).    Scaffolds play a vital role in tissue engineering strategies since they provide 
a three-dimensional matrix to which attached cells proliferate and excrete 
extracellular matrix components (Hutmacher 2000, Agrawal and Ray 2001 and 
Sharma and Elisseeff 2004).  Vunjak-Novakovic has reported that it vital that these 
scaffolds contain pores to allow the supply of nutrients to the tissue and that the 
structure of the scaffold controls the mass transfer of nutrients and metabolites to 
growing tissues (Vunjak-Novakovic 2003).  The first hypothesis proposed in this 
thesis was that scaffolds containing both random and anisotropic porosity would be 
advantageous for in vitro tissue regeneration since they would facilitate the supply of 
fresh nutrients to the growing tissue and the removal of excretion products.  It has 
previously been reported that fibrous scaffolds are more suitable for cartilage tissue 
engineering than either porous scaffolds (Sittinger et al 1996) or agarose gels 
(Vunjak-Novakovic et al 1999).  In this study it was found that of the three novel 
scaffolds which contained both random and anisotropic porosity, two of them (SK3 
and SK4) supported cartilage formation whilst the third (SK5) did not.  A potential 
explanation for the limited tissue formation with SK5 scaffolds may be that the 
scaffold was not sufficiently dense to retain proteins within the structure and allow 
tissue to form.  GAGs, for example, may have been produced by the cells and 
secreted into the culture medium.  The control scaffolds (NF scaffolds) also 
supported in vitro cartilage formation.  SK5 scaffolds contained fewer cells than the 
other scaffold types; however their respective GAG and collagen compositions were 
similar, except following RCCS culture.   
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As reported in Chapter 3, SK5 scaffolds showed less resistance to flow than the other 
scaffold types.  It is possible that the lower number of cells in SK5 scaffolds was the 
result of cells being washed out of the scaffolds during medium replenishment.  SK3 
scaffolds had a similar cell and GAG content to NF and SK4 scaffolds, although it 
was found that following RCCS culture, SK3 scaffolds contained less collagen.  It 
was shown in Chapter 3 that SK3 scaffolds were more dense than NF and SK4 
scaffolds (which were of a similar density).   This suggests that scaffold density may 
be important for supporting extracellular matrix protein secretion in certain culture 
environments.  Based on the GAG and total collagen composition of the different 
constructs, SK4 scaffolds appeared to be the most suitable, of the three novel 
scaffolds, for cartilage regeneration.            
 
It has been reported that in vitro culture conditions strongly influence cartilage 
formation (van der Kraan et al 2002).  Bioreactors offer several advantages over 
static culture systems including providing growing constructs with uniform mixing 
of nutrients and facilitating the maintenance of these nutrient levels (Temenoff and 
Mikos 2000a).  Examples of bioreactor systems used for in vitro cartilage 
engineering include the spinner flask, rotating wall bioreactors (for example the 
RCCS) and perfusion systems (Freed and Vunjak-Novakovic 1997, Freed et al 
1998 and Sittinger et al 1994).  It is believed that the composition and morphology of 
tissue engineered constructs is enhanced following dynamic culture (Vunjak-
Novakovic 2003).  Studies by Sittinger and colleagues have reported good cartilage 
formation in constructs following 2 and 7 week culture in flow perfusion systems 
(Sittinger et al 1994 and Bujia et al 1995).  In contrast, a recent study by Mizuno and 
co-workers showed limited cartilage formation by articular chondrocytes following 
culture in a flow perfusion system (Mizuno et al 2001).  The second hypothesis 
proposed in this thesis was that a novel flow perfusion bioreactor would enhance the 
quality of engineered cartilage by facilitating mass transfer of nutrients and 
metabolites.  In the studies described in this chapter a novel flow perfusion 
bioreactor that was designed and built by Smith & Nephew was compared with 
RCCS and static culture for in vitro cartilage formation.   
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With respect to the GAG and collagen content of constructs it appeared in these 
studies that the flow perfusion system did not support in vitro cartilage formation.  
Cartilage-like tissue formation was observed in NF and SK4 scaffolds that were 
cultured in the RCCS, a system that has previously been shown to support 
cartilage formation (Freed et al 1998).  It has been observed that rotating wall 
bioreactors have led to the production of cartilage with composition and mechanical 
properties more similar to that of native cartilage compared to constructs generated 
using mixed or static flasks (Vunjak-Novakovic et al 1999 and Martin et al 2000).  
These observations have led to the proposition that hydrodynamic culture conditions 
facilitate the formation of functional cartilage (van der Kraan et al 2002).  It is 
generally accepted that cartilage generation in static cultures is restricted by the 
limited supply of nutrients since mass transport is reliant on simple diffusion 
(Vunjak-Novakovic 2003).   
 
4.5 Conclusions 
From the studies presented in this chapter it has been shown that of the different 
scaffolds, NF and SK4 scaffolds showed improved initial cartilage formation, with 
respect to GAG and collagen production following 4-week culture and the best 
performing bioreactor was the RCCS.   To further test the hypothesis that scaffolds 
with random and anisotropic porosity facilitate in vitro cartilage formation, NF and 
SK4 scaffolds were cultured for 8 weeks in either static plates or the RCCS.  The 
results of these studies are presented in Chapter 5 of this thesis. 
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Chapter 5 
Further assessment of the role of 
scaffold architecture on cartilage 
formation in vitro 
 
5.1 Introduction and aims 
As described in Chapter 4, scaffolds are an integral part of any tissue engineering 
strategy, acting as structural templates which modulate and coordinate tissue 
formation (Freed and Vunjak-Novakovic 1998).  One of the important features of a 
tissue engineering scaffold is its porous network.  This network must allow cell 
migration, proliferation and synthesis of ECM components (Woodfield et al 2002).  
In addition, the porosity must be sufficient to permit high seeding densities and 
minimise diffusional constraints during in vitro cultivation (Freed et al 1999).  It has 
previously been shown that it is necessary for the pores within the scaffolds to be 
interconnected to facilitate nutrient transfer to, and waste removal from, cells 
throughout scaffold (Lu et al 2001 and Woodfield et al 2002).  One of the current 
challenges of tissue engineering is that of satisfying the mass transfer requirements 
of the growing construct throughout its culture since it is known that cell 
proliferation increases mass transfer requirements whilst accumulation of ECM 
within the scaffold decreases its porosity (Freed and Vunjak-Novakovic 1998).  In 
addition to construct density and the nutrient requirements of cells within the 
scaffold, the mass transport requirements of a tissue engineering construct will 
depend on the dimensions of the construct.  Tissue engineering studies to date have 
concentrated on cylindrical scaffolds 3-10 mm in diameter and 1-5 mm thick, with 
volumes in the range 0.007-0.39 cm3 (Vunjak-Novakovic et al 1998).   
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It has been proposed that a cartilage defect may be so large as to be equivalent to a 
cylinder 2.5 cm in diameter and 2.5 cm thick, occupying a volume of 12.3 cm3 
(Kladny et al 1999, Anderson et al 2002 and Woodfield et al 2002).  Figure 5.1 
shows the discrepancy between the size of current tissue engineering scaffolds and 
the potential size of a cartilage defect.  There is therefore a need to used advanced 
scaffold designs which take into account the actual size of tissue defects and the 
nutrient requirements of a tissue engineered construct of those dimensions 
(Woodfield et al 2002).  One of the hypotheses of this thesis was that scaffolds 
combining random and anisotropic porosity would facilitate in vitro tissue 
regeneration by improving the supply of nutrients to the growing tissue.  Having 
shown in Chapters 3 and 4 that a high density of cells could be seeded into these 
scaffolds and that they supported in vitro cartilage formation, the aim of this chapter 
was to assess cartilage formation and cell viability in these scaffolds following 8-
week culture. 
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B
Figure 5.1     A schematic representation of the difference in size between (A) current 
tissue engineering scaffolds (0.39 cm3) and (B) a cartilage defect (12.3 cm3).   
A 
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5.2 Methods 
5.2.1 Preparation of scaffolds 
Scaffolds were manufactured and prepared for cell-seeding as described in Sections 
2.2.1 and 2.2.5.a.   
 
5.2.2  Cell culture 
OMCs were isolated from ovine meniscal cartilage and cultured as outlined in 
Sections 2.2.3.b and 2.2.4.b.   
 
5.2.3 Culture of cell-seeded scaffolds 
Scaffolds were seeded with OMCs as described in Section 2.2.5.b under the 
conditions optimised in Chapter 3.  NF scaffolds were seeded with agitation at 200 
rpm and SK4 scaffolds were seeded with agitation at 300 rpm (Table 3.2). Following 
overnight seeding, scaffolds were transferred to either static 6-well plates (Section 
2.2.5.c) or RCCS vessels (Section 2.2.5.d). All cultures were maintained for eight 
weeks.  For both static and RCCS cultures, medium was replenished at a rate of 
50% three times per week.  For each culture condition, seven scaffolds of each type 
were cultured, three of which were used for biochemical analysis, two for histology 
and two for Live/Dead staining.  The experiments were repeated twice such that 
for each scaffold type and culture environment, six samples were used in 
biochemical assays, four were stained with Live/Dead stain and examined using 
confocal microscopy and four were embedded in resin and stained with safranin O. 
   
5.2.4 Analyses of constructs 
Following the eight-week culture period, scaffolds were removed from their 
respective culture environments and washed three times in sterile PBS.   
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5.2.4.a   Analysis of viability 
Prior to biochemical analysis, the total relative viability of scaffolds was determined 
using the Alamar blue assay, as described in Section 2.2.6.d.i.  Briefly, scaffolds 
were incubated for 90 minutes with Alamar blue working solution (Appendix 
2.4.4) after which time 200 PL aliquots were removed and the fluorescence measured 
at excitation and emission wavelengths of 530 nm and 590 nm, respectively.  
Scaffolds which were not cultured with cells were also incubated with Alamar blue 
working solution and the resulting fluorescence used as a control.  The relative 
viability per cell for OMCs within the constructs was determined by normalising the 
total relative viability with respect to the number of cells within the scaffolds.       
 
5.2.4.b  Biochemical analyses and assessment of increase in construct 
weight 
Following analysis for total relative viability, scaffolds were washed three times with 
PBS.  Scaffolds were transferred to pre-weighed Eppendorf tubes and re-weighed in 
order to allow calculation of the construct wet weight.  Scaffolds were lyophilised 
and re-weighed so that a dry weight for each construct could be obtained.  The 
percentage increase in construct weight was determined using the equation given in 
Appendix 3.6.  Samples were digested using papain, as outlined in Section 2.2.6.b.  
Following overnight incubation, samples were allowed to cool and aliquots taken for 
DNA, GAG and collagen assays.   
 
5.2.4.b.i Assessment of cell number 
The total cell number for each construct was determined using the Hoechst 33258 
assay.  The assay was performed as in Section 2.2.6.c.  The number of cells within 
each construct was determined and normalised with respect to the mass of the 
constructs (Appendix 3.7).   
 
5.2.4.b.ii Assessment of GAG content 
The DMMB assay was used to quantify the GAG content of each construct according 
to the procedure outlined in Section 2.2.6.e.  The GAG content for each sample was 
calculated using the equation given in Appendix 3.1. 
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5.2.4.b.iii Assessment of total collagen content 
The total collagen content of each sample was assessed using the hydroxyproline 
assay (Section 2.2.6.f) and calculated using the equation given in Appendix 3.2. 
 
5.2.4.c  Histological analysis 
Prior to histological examination, samples were fixed in 4% paraformaldehyde at 
4qC (Appendix 2.5.4).   
 
5.2.4.c.i Resin embedding constructs 
Constructs were processed, embedded in Technovit 8100 resin and sectioned as 
described in Section 2.2.7.c.   
 
5.2.4.c.ii Safranin O staining 
Sections were stained with safranin O as outlined in Section 2.2.7.d.ii.  Following 
staining, sections were mounted and imaged using an inverted microscope. 
 
5.2.4.d  Live/Dead™staining and confocal microscopy 
Prior to staining with Live/Dead stain, scaffolds were washed three times with 
Dulbeccos PBS (DPBS).  Scaffolds were incubated with Live/Dead working 
solution (Appendix 2.7.1) for 30 minutes.  Following the incubation period, scaffolds 
were cut through the sagittal plane (Figure 2.8) and mounted on glass microscope 
slides with DABCO mountant (Appendix 2.7.2) such that images could be obtained 
from both the surface and centre of constructs.  The Live/Dead assay works on the 
principle that live cells have ubiquitous intracellular esterase activity which allows 
enzymatic conversion of calcein AM to calcein.  The second component of the stain, 
ethidium homodimer, is able to penetrate the compromised membranes of non-viable 
cells and upon binding to nucleic acids its fluorescence is enhanced, allowing the 
presence of dead (red) cells to be detected.  Viable and non viable cells can therefore 
be distinguished on the basis of colour with live cells appearing green and dead cells 
appearing red.   
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Scaffolds were imaged using a laser scanning confocal microscope (Leica TCS4D 
system with a Leica DMRBE upright fluorescence microscope and an argon krypton 
laser) by Dr Susan Anderson and Mr Ian Ward (School of Biomedical Sciences, 
University of Nottingham).  The green fluorescence of calcein was excited using the 
488 nm laser line and the red fluorescence of ethidium homodimer was excited with 
the 568 nm laser line.       
 
5.2.5 Analyses of native ovine cartilage 
To allow comparison between the tissue-engineered cartilage and native cartilage, 
samples of ovine articular and meniscal cartilage were analysed with respect to 
biochemical composition and histological appearance. 
 
5.2.5.a  Isolation and preparation of ovine cartilage 
5.2.5.a.i Isolation and preparation of ovine meniscal cartilage 
Ovine meniscal cartilage was isolated as described in Section 2.2.2.b.  Tissue was 
prepared for biochemical analysis as outlined in Section 2.2.6.a.i.  Samples of ovine 
meniscal cartilage were reserved for histological evaluation and prepared as 
described in Section 2.2.7.a. 
 
5.2.5.a.ii Isolation and preparation of ovine articular cartilage 
Ovine articular cartilage was isolated using the method described in Section 2.2.2.c.  
Samples of tissue were taken for biochemical and histological assessment and 
prepared as described in Sections 2.2.6.a.ii and 2.2.7.a.  
 
5.2.5.b  Biochemical analyses of ovine cartilage 
Samples of ovine meniscal and articular cartilage were digested with papain in 
preparation for biochemical analysis as outlined in Section 2.2.6.b.  Samples of both 
articular and meniscal cartilage were taken from 6 different animals.  
  
5.2.5.b.i Assessment of number of cells in cartilage samples 
The Hoechst 33258 assay was used to determine the DNA content of cartilage 
samples and carried out using the method given in Section 2.2.6.c.   
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The DNA content of samples was related to number of cells using a standard curve 
of cell number versus fluorescence for the appropriate cell type.  The number of cells 
per gram dry sample weight was determined using the equation given in Appendix 
3.7.  The statistical significance between the cellularity of the samples was assessed 
using GraphPad InStat version 3.0 (GraphPad Software Inc, San Diego, USA).  
Results were expressed as mean ± SEM.  An unpaired, two-tail t-test was performed 
and since the standard deviations of the two samples were not equal a Welch 
correction was applied.   
     
5.2.5.b.ii Determination of the GAG content of cartilage samples 
The GAG content of samples of each of the cartilage types was determined using the 
DMMB assay (Section 2.2.6.e).  Statistical analysis of the results was carried out as 
described in Section 5.2.5.b.i.  
 
5.2.5.b.iii Quantification of the total collagen content of cartilage samples 
The total collagen content of ovine meniscal and articular cartilage samples was 
quantified using the hydroxyproline assay (Section 2.2.6.f).  Statistical analysis of the 
results was carried out as described in Section 5.2.5.b.i. 
   
5.2.5.c  Histological assessment of ovine cartilage samples 
Ovine meniscal and articular cartilage samples were embedded in paraffin, sectioned 
and stained as described in Sections 2.2.7.a and 2.2.7.b.   
 
5.2.6 Statistical analysis 
The statistical significance of results was assessed using GraphPad InStat version 3.0 
(GraphPad Software Inc, San Diego, USA).  Results were expressed as mean ± SEM.  
An ANOVA and the Tukey-Kramer Multiple Comparisons post-test were performed.  
Results were considered significant when P<0.05 (*), very significant when P<0.01 
(**) and extremely significant when P<0.001 (***). 
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5.3 Results 
5.3.1 Increase in construct weight 
The increase in the weight of the constructs was determined as outlined in Section 
5.2.4.b.  Figure 5.2 shows the percentage increase in construct weight following 8-
week culture for both NF and SK4 scaffolds cultured in either static 6-well plates or 
the RCCS.  The weight of all scaffolds increased over the eight week period 
compared to the weight of the respective constructs after 4-week culture (Table 5.1).  
The percentage increase in construct weights was similar for both scaffold types 
under the different culture conditions; both scaffold types showing approximately a 
40% increase in weight following static culture and a 68% increase following 
RCCS culture.  For SK4 scaffolds, the increase in weight for constructs cultured 
within the RCCS was significantly greater than that of those cultured statically 
(P<0.001, Figure 5.2). 
 
5.3.2 Cell content 
The number of cells per gram of dry construct weight was determined as described in 
Section 5.2.4.b.i.  A graph representing the number of cells in NF and SK4 scaffolds 
following 8-week static and RCCS culture is given in Figure 5.3.  NF scaffolds 
contained a similar number of cells relative to the construct weights following both 
static and RCCS culture.  SK4 scaffolds were also composed of a similar number 
of cells regardless of their culture environment.  The cellularity of NF scaffolds 
cultured in the RCCS for 8 weeks was found to be significantly greater than that of 
SK4 scaffolds following 8-week RCCS culture (P<0.01, Figure 5.3).  The overall 
cellularity of the constructs was lower than the respective constructs following 4-
week culture, although the decreases were not significant (Table 5.1).  The cell 
content of ovine articular and meniscal cartilage is shown in Figure 5.4.  It was found 
that articular cartilage contained more cells than meniscal cartilage (P<0.05, Figure 
5.4). While the cellularity of NF constructs was similar to that of native articular 
cartilage, the cellularity of SK4 constructs was more similar to that of native 
meniscal cartilage (Table 5.2).  
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Figure 5.2 Comparison of the % increase in the weight of NF and SK4 
scaffolds following 8-week      static or      RCCS culture.  Results expressed 
as mean (n=6) r SEM (*** indicates P<0.001). 
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Figure 5.3 Comparison of the number of cells (per gram construct weight) 
in NF and SK4 scaffolds following 8-week tatic or CCS culture. 
Results expressed as mean (n=6) r SEM (** indicates P<0.01). 
  
**
      R      s
 176
  
Scaffold type / 
Culture 
environment 
 
 
 
% increase in weight 
n=6 r SEM 
 
 
Cell number 
(per g dry construct) 
n=6 r SEM 
 
 
GAG content 
(% dry construct) 
n=6 r SEM 
 
 
Collagen content 
(% dry construct) 
n=6 r SEM 
 
 4 week 8 week 4 week 8 week 4 week 8 week 4 week 8 week 
 
NF static 
 
17.4 % 
r 6.2 % 
 
41.1 %
r 11.0 % 
 
8.9 x 108 
r 2.4 x 107
 
3.4 x 108 
r 5.2 x 107
 
5.4 % 
r 0.7 % 
 
12.3 % *
r 1.3 % 
 
0.6 % 
r 0.1 % 
 
5.6 % *
r 1.0 % 
 
NF RCCS 
 
35.5 % 
r 8.4 % 
 
69.5 % * 
r 5.7 % 
 
9.5 x 108 
r 1.6 x 108
 
3.5 x 108 
r 2.0 x 107
 
12.9 % 
r 0.9 % 
 
12.5 % 
r 0.6 % 
 
2.8 % 
r 0.4 % 
 
10.7 % ***
r 0.3 % 
 
SK4 static 
 
35.1 % 
r 5.2 % 
 
41.1 % 
r 2.5 % 
 
5.2 x 108 
r 1.5 x 108
 
2.8 x 108
r 3.6 x 107
 
4.7 % 
r 0.4 % 
 
11.8 % ***
r 0.7 % 
 
0.5 % 
r 0.1 % 
 
4.0 % ***
r 0.3 % 
 
SK4 RCCS 
 
55.7 % 
r 7.7 % 
 
67.3 % 
r 3.4 % 
 
6.7 x 108 
r 5.7 x 107
 
2.4 x 108 
r 1.9 x 107
 
11.3 % 
r 0.1 % 
 
10.1 % 
r 1.5 % 
 
2.2 % 
r 0.7 % 
 
8.1 % ***
r 0.3 % 
Table 5.1   Comparison of the increase in weight and biochemical composition of constructs following 4- and 8-week 
culture. Asterisks indicate significant differences between 4 and 8 week data (* P<0.05, ** P<0.01 and *** P<0.001). 
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Tissue 
component 
 
 
Ovine 
meniscal 
cartilage 
 
 
Ovine 
articular 
cartilage 
 
 
NF static 
construct 
 
NF RCCS 
construct 
 
 
SK4 static 
construct 
 
 
SK4 RCCS 
construct 
 
 
Cell number  
(per g dry 
weight) 
r SEM 
 
2.3 x 108 
r 1.1 x 107
 
3.5 x 108 
r 5.6 x 107
 
3.4 x 108 ** 
r 5.2 x 107
 
3.5 x 108 *** 
r 2.0 x 107
 
2.8 x 108 * 
r 3.6 x 107
 
2.4 x 108 
r 1.9 x 107
 
GAG content 
(% dry weight) 
r SEM 
 
5.9 % 
r 0.5 % 
 
12.6 % 
r 2.3 % 
 
12.3 % *** 
r 1.3 % 
 
12.5 % *** 
r 0.6 % 
 
11.8 % *** 
r 0.7 % 
 
10.1 % ** 
r 1.5 % 
 
Collagen content  
(% dry weight) 
r SEM 
 
17.0 % 
r 0.9 % 
 
9.1 % 
r 2.3 % 
 
5.6 % *** 
r 1.0 % 
 
10.7 % *** 
r 0.3 % 
 
4.0 % ***,  
r 0.3 % 
 
8.1 % *** 
r 0.3 % 
Table 5.2  Comparison of the biochemical composition of native ovine meniscal and articular cartilages with that of the 
8-week tissue engineered constructs.  Asterisks indicate significant differences between construct components and that of 
native tissue (* for differences compared to meniscal cartilage and    for differences compared to articular cartilage; * ( ) 
P<0.05, ** P<0.01 and *** P<0.001).  
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5.3.3 GAG content 
The GAG content of constructs was assessed using the method given in Section 
5.2.4.b.ii and is shown in Figure 5.5.  The GAG content of all constructs was similar, 
regardless of scaffold type or culture environment.  Whilst the GAG content of 
scaffolds cultured in the RCCS for 4 or 8 weeks was not significantly different, a 
significant increase was seen in the GAG contents of NF and SK4 scaffolds cultured 
statically (P<0.05 and P<0.001 respectively, Table 5.1).  Figure 5.6 shows the GAG 
content of samples of ovine articular and meniscal cartilage.  No significant 
difference was detected between the GAG content of each of the constructs and that 
of native ovine articular cartilage, whereas the difference between that of each of the 
constructs and native ovine meniscal cartilage was considered very significant 
(P<0.01 for SK4 RCCS and P<0.001 for all other constructs, Table 5.2).  
 
5.3.4 Total collagen content 
The total collagen content of NF and SK4 scaffolds following 8-week static and 
RCCS culture was determined as outlined in Section 5.2.4.b.iii.  Figure 5.7 shows 
a graphical representation of this data.  For both NF and SK4 constructs, the collagen 
content of scaffolds cultured within the RCCS was significantly greater than that 
of those scaffolds cultured within static 6-well plates (P<0.01 and P<0.001 for NF 
and SK4 scaffolds respectively, Figure 5.7).  In addition, the collagen content of NF 
scaffolds cultured within the RCCS was significantly greater than the collagen 
content of SK4 scaffolds cultured in the same way (P<0.01, Figure 5.7).  For all 
scaffold type and culture system combinations the collagen content significantly 
increased between constructs cultured for 4 weeks and those cultured for 8 weeks 
(P<0.05 for SK4 RCCS and P<0.001 for all other constructs, Table 5.1).  The 
collagen content of native ovine articular and meniscal cartilage was determined and 
is shown in Figure 5.8.  The collagen content of all constructs was significantly 
lower than that of native ovine meniscal cartilage (P<0.001, Table 5.2) and with the 
exception of SK4 scaffolds which were cultured statically, there was no significant 
difference between the total collagen content of each of the constructs and native 
ovine articular cartilage (Table 5.2). 
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Figure 5.4  The cell content of ovine meniscal and articular cartilage 
samples.  Results expressed as mean (n=6) r SEM (* indicates P<0.05). 
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Figure 5.5 Comparison of the GAG content of NF and SK4 scaffolds 
following 8-week      static or      RCCS culture.  Results expressed as mean 
(n=6) r SEM.  
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Figure 5.6 The glycosaminoglycan content of ovine meniscal and articular 
cartilage samples.  Results expressed as mean (n=6) r SEM (* indicates 
P<0.05). 
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Figure 5.7 Comparison of the collagen content of NF and SK4 scaffolds 
following 8-week      static or      RCCS culture.  Results expressed as mean 
(n=6) r SEM (** indicates P<0.01, *** indicates P<0.001). 
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Figure 5.8  The collagen content of ovine meniscal and articular cartilage 
samples.  Results expressed as mean (n=6) r SEM (* indicates P<0.05). 
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5.3.5 Safranin O staining 
Samples of each of the constructs were fixed in 4% paraformaldehyde, embedded in 
Technovit 8100 resin and sectioned as described in Section 5.2.4.c.  Sections taken 
through the surface and central regions of the scaffolds were stained with safranin O 
as outlined in Section 5.2.4.c.ii.  Representative images of sections taken from each 
of the different constructs are shown in Figures 5.9, 5.10 and 5.11.  More cells were 
visible in NF scaffolds following 8 week RCCS culture than static culture (Figure 
5.9).  In general, more cells appeared to be present at the surface of statically 
cultured NF scaffolds than in the centre (Figure 5.9 C & D).  More cells were also 
visible in SK4 scaffolds following 8-week RCCS culture, compared to static 
culture (Figure 5.10).  Cells in SK4 scaffolds cultured within the RCCS appeared 
to be evenly distributed throughout the constructs (Figure 5.10 A & B).  The cells 
within the central region of these constructs were present not only within the bundles 
of fibres but also the aligned channels, suggesting that matrix had filled the spaces 
between the spacer fibres (Figure 5.10 B).  Statically cultured SK4 scaffolds also 
contained evenly distributed cells (Figure 5.10 C & D) and cells present within both 
the spacer fibres and aligned channels (Figure 5.10 D).  Figure 5.11 shows a 
summary of representative sections from all constructs.  NF and SK4 scaffolds 
cultured within the RCCS for 8 weeks were similar in appearance with more 
intense safranin O staining than respective scaffolds cultured within static 6-well 
plates (Figure 5.11).  The histological appearance of native cartilage samples are 
shown in Figure 5.12.  Within both cartilage types, chondrocytes (visible by positive 
haematoxylin staining) were contained within lacunae (highlighted with arrows in 
Figure 5.12).  The fibrous nature of meniscal cartilage is visible (Figure 5.12 A & B).  
Less intense safranin O staining was observed in meniscal samples as a result of the 
lower GAG content of this tissue (Figure 5.12 B & D).  The stratified structure of 
articular cartilage was clearly visible with fewer cells present at the subchondral 
region of the tissue and chondrocytes arranged in columns in the central region 
(Figure 5.12 C).  The difference in more intense staining in sections of native tissue 
compared tissue engineered constructs may be due to the greater permeability of the 
tissue to stain compared to the resin in which the constructs were embedded.  
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Figure 5.9  Representative images of haematoxylin and safranin O stained sections 
through NF scaffolds following 8 week (A and B) RCCS and (C and D) static culture. 
Images show (A and C) sections taken through the surface and (B and D) the centre of 
constructs.  Scale bars represent 100 Pm.   
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Figure 5.10  Representative images of haematoxylin and safranin O stained sections 
through SK4 scaffolds following 8 week (A and B) RCCS and (C and D) static 
culture.  Images show (A and C) sections taken through the surface and (B and D) the 
centre of constructs.  Scale bars represent 100 Pm.  Arrows indicate the aligned bundles 
of fibres.   
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Figure 5.11  Representative images of haematoxylin and safranin O stained sections 
through all constructs following 8 week culture.  Images A, B, C & D taken from NF 
scaffolds and images E, F, G & H taken from SK4 scaffolds.  Sections taken through (A, 
C, E & G) the surface and (B, D, F & H) the centre of constructs.  Scaffolds were 
cultured in either (A, B, E & F) the RCCS or (C, D, G & H) static 6 well plates.  Scale 
bars represent 100 Pm.      
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Figure 5.12 Representative images showing (A and B) meniscal and (C and D) 
articular cartilage samples following (A and C) haematoxylin and eosin and (B and 
D) safranin O staining.  Asterisks (*) on articular cartilage samples indicate the 
articular surface of the tissue.  Arrows (    ) on images highlight the presence of cells 
within lacunae.  Scale bar represents 50 Pm on images A and B and 200 Pm on 
images C and D.     
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5.3.6 Relative cell viability 
The total relative viability of cells within the constructs was determined using the 
Alamar blue assay, as outlined in Section 5.2.4.a.  The total relative viability of cells 
within NF and SK4 scaffolds following 8-week static and RCCS culture is shown 
in Figure 5.13 A.  The total relative viability of the constructs was not significantly 
different between the different scaffold types or culture environments.  The relative 
viability per cell of OMCs within the different constructs was determined by 
normalising the total relative viability with respect to the number of cells within the 
scaffolds.  Figure 5.13 B presents the viability per cell of OMCs within NF and SK4 
scaffolds following 8-week culture in either static 6-well plates or the RCCS.  For 
both scaffold types, the relative viability per cell was greater for OMCs cultured in 
static conditions (P<0.05).   
 
5.3.7 Live/Dead™ staining 
In order to assess the distribution of viable and non viable cells within the different 
constructs following 8-week culture, scaffolds were stained with Live/Dead stain 
using the method described in Section 5.2.4.d.  Representative images of each of the 
different constructs are shown in Figures 5.14, 5.15 and 5.16.  NF scaffolds 
contained a mixed population of viable and non viable cells, as indicated by the 
presence of both red and green cells within constructs (Figure 5.14).  In general, NF 
scaffolds cultured within the RCCS for 8 weeks contained more non viable cells at 
the surface than in the centre (Figure 5.14 A & B).  The distribution of viable and 
non-viable cells at the surface of NF scaffolds was similar for constructs cultured in 
each of the systems (Figure 5.14 A & C).  NF scaffolds cultured within static 6-well 
plates for 8 weeks contained a higher number of non viable cells at the centre than 
those cultured within the RCCS (Figure 5.14 B & D).  SK4 scaffolds also 
contained a mixed population of live and dead cells (Figure 5.15).  Fewer cells were 
detected in the centre of SK4 scaffolds cultured in the RCCS for 8 weeks, 
compared to at the surface of these constructs (Figure 5.15 A & B).  SK4 scaffolds 
cultured within static plates for 8 weeks contained an even distribution of cells 
(Figure 5.15 C & D).   
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Figure 5.13 Comparison of (A) the total relative viability and (B) the relative 
viability per cell of OMCs in NF and SK4 scaffolds following 8-week      static 
or CCS culture.  Results expressed as mean (n=6) r SEM (* indicates 
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Figure 5.14  Representative images of NF scaffolds stained with Live/Dead 
stain following 8 week (A and B) RCCS and (C and D) static culture. 
Images show (A and C) images taken of the surface and (B and D) the centre 
of constructs.  Scale bars represent 25 Pm.   
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Figure 5.15  Representative images of SK4 scaffolds stained with Live/Dead stain 
following 8 week (A and B) RCCS and (C and D) static culture.  Images show (A and 
C) images taken of the surface and (B and D) the centre of constructs.  Scale bars 
represent 25 Pm.   
 193
  
 
  
  
  
  
Figure 5.16  Representative images of scaffolds stained with Live/Dead stain 
following 8 week culture.  Images A, B, C & D taken from NF scaffolds and images E, 
F, G & H taken from SK4 scaffolds.  Sections taken through (A, C, E & G) the surface 
and (B, D, F & H) the centre of constructs.  Scaffolds were cultured in either (A, B, E & 
F) the RCCS or (C, D, G & H) static 6 well plates.  Micron bars represent 25 Pm.      
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More viable cells were present at both the surface and centre of SK4 scaffolds 
following static culture, as compared to SK4 scaffolds cultured within the RCCS 
for 8 weeks (Figure 5.15).  Figure 5.16 shows all the images from Figures 5.14 and 
5.15 to allow comparison between the scaffold types.  NF and SK4 scaffolds that 
were cultured within the RCCS for 8 weeks were similar in appearance with mixed 
populations of viable and non-viable cells throughout the constructs and generally 
more cells present at the surface than in the centre (Figure 5.16 A, B, E & F).  More 
viable cells were present at the centre of SK4 scaffolds than NF scaffolds following 
8-week static culture (Figure 5.16 D & H). 
 
5.4 Discussion  
The main aim of this thesis was to investigate whether scaffolds combining random 
and anisotropic porosity were advantageous for tissue engineering.  The hypothesis 
was that these scaffolds would facilitate in vitro tissue regeneration by improving the 
supply of nutrients to the growing tissue.  The aim of this chapter was to test this 
hypothesis by comparing the cartilage formed in these scaffolds following eight 
week culture in either static plates or RCCS culture with that formed in a random 
fibrous scaffold.   
 
The increase in construct weight was shown to be affected by the culture 
environment but not scaffold architecture, with statically cultured constructs showing 
an increase of approximately 40% and those cultured in the RCCS showing an 
approximate increase of 68%.  The cellularity of the constructs was assessed and 
found to differ slightly between scaffold types, with NF scaffolds containing more 
cells than SK4 scaffolds.  With the exception of SK4 scaffolds which were cultured 
within the RCCS there was no significant difference between the cellularities of 
the constructs and that of native ovine articular cartilage.  The biochemical 
composition of constructs was assessed with respect to total GAG and collagen 
content.   
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The GAG content of all constructs was similar, regardless of scaffold type or culture 
environment and was not found to differ significantly from that of native ovine 
articular cartilage.  All constructs were, however, composed of a significantly greater 
proportion of GAGs than native meniscal tissue.  It was also observed that the GAG 
content of statically cultured NF and SK4 scaffolds was found to increase 
significantly from week 4 to week 8.  Positive safranin O staining, indicative of the 
presence of sulphated GAGs, was observed in all constructs, although it appeared 
more intense in RCCS cultured constructs.  The total collagen content varied 
between NF and SK4 scaffolds cultured for 8 weeks in each of the culture systems.  
In general, scaffolds cultured within the RCCS contained more collagen than those 
cultured in static plates following 8-week culture.  In addition, NF scaffolds 
contained more collagen than SK4 scaffolds following 8-week RCCS culture.  The 
collagen content of all constructs increased significantly between weeks 4 and 8 and 
was found to be similar to that of native ovine articular cartilage following 8-week 
RCCS culture.   
 
The viability of cells within the scaffolds was assessed using the Alamar blue and 
Live/Dead viability/cytotoxicity assays.  The Alamar blue assay results 
indicated that the relative viability of OMCs in both NF and SK4 scaffolds was 
greater following static culture, suggesting that the dynamic culture system caused a 
decrease in cell viability, although this decrease in viability was not sufficient to 
prevent tissue formation by the cells. The Live/Dead assay allows visual 
distinction between viable and non viable cells.  The distribution of live and dead 
cells was found to be similar for both scaffold types following 8-week RCCS 
culture.  The greatest observed difference was in the viability of cells at the centre of 
constructs cultured for 8 weeks in static plates.  Whilst both live and dead cells were 
present at the centre of NF scaffolds, a higher number of cells, of which the majority 
were viable, were present at the centre of SK4 scaffolds.    
 
One of the current challenges of tissue engineering is that of satisfying the mass 
transfer requirements of the growing construct throughout its culture (Freed and 
Vunjak-Novakovic 1998).   
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Woodfield and co-workers have previously emphasised the importance of using 
advanced scaffold designs which take into account the mass transport requirements 
of tissue engineered constructs the size of tissue defects (Woodfield et al 2002 and 
Malda et al 2004).  It was hypothesised that scaffolds with a novel architecture 
combining random and anisotropic porosity would be advantageous for tissue 
engineering since the presence of wider aligned channels within the porous network 
would facilitate the mass transport of nutrients to and removal of waste products 
from the growing tissue.  The results presented in this chapter demonstrated that 
cartilaginous tissue with a similar biochemical composition was generated in SK4 
and NF scaffolds following 8-week culture in the RCCS.   As shown in Table 1.2, 
non woven fibrous scaffolds have been used in many tissue engineering studies.  
Scaffolds with the same architecture as the NF scaffolds used in the studies presented 
in this thesis have supported attachment of different cell types, for example bovine 
articular chondrocytes and embryonic chick bone marrow stromal cells, and 
subsequent extracellular matrix production (Freed et al 1993b and Martin et al 1998).  
Rotating wall bioreactors such as the RCCS have been found to be highly 
efficacious for in vitro cartilage engineering.  In a study by Pei and colleagues, 
constructs cultured within the RCCS were thicker and contained more evenly 
distributed GAGs than constructs cultured in static plates (Pei et al 2002).  The 
findings of this study that 8-week RCCS culture supported chondrogenesis in NF 
scaffolds is therefore in agreement with those reported from other studies.  It was 
found that the tissue formed in SK4 scaffolds following 8-week RCCS was similar 
to that formed in NF scaffolds cultured under the same conditions, indicating that the 
novel scaffold architecture did not have a detrimental effect on in vitro tissue 
formation.  The supply of nutrients to cells within a tissue engineering scaffold in 
vitro is controlled largely by diffusion (Freed and Vunjak-Novakovic 1998).  In 
dynamic culture systems, such as the RCCS, fluid motion within the system 
increases the mass transfer of nutrients to cells.  The mass transfer of nutrients within 
static culture systems is, in contrast, limited (Freed et al 1994b).   
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This phenomenon has been used to explain why tissue engineered constructs 
obtained from static culture systems have generally been found to be inhomogeneous 
and contain lower quantities of ECM components than constructs obtained from 
dynamic culture systems (Freed et al 1994b and Pei et al 2002).  In this study the 
viability of cells at the centre of scaffolds was assessed using Live/Dead staining.  
NF and SK4 scaffolds cultured within the RCCS contained similar distributions of 
viable and non-viable cells.   
 
Following static culture, a large number of non-viable cells were present at the centre 
of NF scaffolds.  This may be due to the limited supply of nutrients to the cells at the 
centre of these scaffolds.  At the centre of SK4 scaffolds cultured within static plates, 
however, the majority of cells were found to be viable.  This suggests that the 
presence of wider channels within the porous structure facilitated the supply of 
nutrients to the growing tissue in a non-ideal culture environment.  The novel 
scaffold architecture combining random and anisotropic porosity therefore appears to 
be beneficial for in vitro tissue regeneration in culture systems usually less 
favourable with respect to nutrient mass transfer. 
 
5.5 Conclusions 
The work presented in this chapter shows that both the NF and SK4 scaffolds 
supported cartilage formation and that this tissue formation was facilitated by the 
commercially available RCCS.  It was also shown that in a less optimum culture 
environment where the supply of nutrients is a limiting factor for tissue regeneration, 
the novel scaffold architecture combining random and anisotropic porosity was 
advantageous. 
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Chapter 6 
General Discussion and Conclusions 
 
One of the challenges of engineering tissues in vitro is that of producing constructs 
of a clinically relevant size.  A common phenomenon in tissue engineering studies is 
the formation of a capsule of tissue at the periphery of the construct, which restricts 
the supply of nutrients to the centre of the growing tissue, causing cell and tissue 
death (Freed et al 1999).  There is therefore a need to improve the transfer of 
nutrients to the entire construct throughout the in vitro culture period (Obradovic et 
al 2000).  Previous attempts to improve the supply of nutrients to growing tissues in 
vitro have been based on modifications to scaffold architecture and culture 
environment (Bhardwaj et al 2001, Woodfield et al 2002 and Malda et al 2005).  
Scaffolds are an integral part of any tissue engineering system, providing cells with a 
structural template which modulates and coordinates tissue formation (Freed and 
Vunjak-Novakovic 1998).  Porosity is a particularly important feature of a tissue 
engineering scaffold, since it influences the number of cells that can initially be 
seeded into the scaffold and the transfer of nutrients to, and waste from, cells during 
culture (Freed et al 1999, Lu et al 2001 and Woodfield et al 2002).  The aims of the 
work presented in this thesis were to evaluate novel scaffolds, which combined 
random and anisotropic porosity, and a novel flow perfusion bioreactor for their 
suitability engineering tissues in vitro.  The first hypothesis was that the presence of 
wider aligned channels within a random porous network would be advantageous for 
in vitro tissue formation since the transfer of nutrients to cells throughout the 
construct would be enhanced.  The second hypothesis was that the continuous flow 
of medium within the flow perfusion bioreactor would improve the transfer of 
nutrients to cells within constructs and hence facilitate in vitro tissue formation.  
Cartilage was selected as an example tissue on which to perform the studies since the 
phenomenon of capsule formation at the periphery of scaffolds has been reported in 
previous cartilage tissue engineering studies (Freed et al 1999). 
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Prior to commencing tissue engineering studies, the scaffolds were characterised and 
the conditions required for seeding cells into the scaffolds evaluated.  It was found 
that the sparse knit scaffolds (which contained both random and anisotropic porosity) 
showed less resistance to fluid flow than the needled felt scaffolds.  For all scaffold 
types it was determined that seeding with agitation led to a greater number of cells 
within the scaffolds compared to static seeding.  This is in agreement with reports in 
the literature that improved cell seeding was observed in scaffolds seeded 
dynamically, compared to scaffolds seeded statically (Li et al 2001).  The selection 
of an optimum agitation speed for each scaffold and cell type was more complex 
than initially anticipated since in addition to allowing more cells to be seeded into the 
scaffolds, agitation led to a reduction in cell viability.  This reduction in cell viability 
did not, however, prevent cell proliferation or tissue formation in the later tissue 
formation studies using OMCs.  The Alamar blue assay detects changes in the 
synthetic rates of cells and therefore reduction in the fluorescence levels in a 
particular culture system would suggest that it is cytotoxic.  This may explain the 
apparent discrepancy between the good performance of sparse knit 4 scaffolds and 
the reduced viability of cells in these scaffolds.   Optimum seeding speeds were 
selected based on cell number and distribution since it has been proposed that it is 
essential that a large number of cells are homogeneously seeded into scaffolds in 
order to ensure functional tissue formation in vitro (Vunjak-Novakovic et al 1998).  
It was found that scaffold architecture influenced the optimum seeding conditions as 
higher agitation speeds were required for seeding BACs and OMCs into the sparse 
knit scaffolds with more densely knitted upper and lower crusts (SK3 and SK4) than 
for scaffolds which had more open structures (NF and SK5).  It was also determined 
that the optimum conditions required for seeding the osteosarcoma cell line into NF 
and SK5 scaffolds were different to those required for the two chondrocyte cell 
types.  This study therefore highlighted the need for seeding optimisation studies 
prior to commencing tissue engineering studies since both scaffold architecture and 
cell type may affect cell seeding. 
 
Initial studies investigated cartilage formation by OMCs in each of the scaffold types 
following four week static, RCCS or flow perfusion culture.   
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Cartilage formation was assessed using biochemical assays for GAG and collagen 
production and safranin O staining for GAGs.  For all scaffold types, lower levels of 
GAGs were detected in constructs cultured within the flow perfusion system 
compared to those cultured either in static tissue culture plates or the RCCS.  This 
finding was in agreement with that of Mizuno and colleagues who detected reduced 
GAG production in scaffolds cultured within a flow perfusion culture system 
compared to that in scaffolds cultured in static plates (Mizuno et al 2001).  Higher 
levels of GAGs and collagens were present in NF, SK3 and SK4 scaffolds cultured 
within the RCCS compared to those scaffolds cultured in static 6-well plates.  This 
work is supported by the findings of Vunjak-Novakovic and colleagues, who have 
reported the advantages of microgravity bioreactor systems for cartilage tissue 
engineering (Vunjak-Novakovic et al 1999 and Pei et al 2002).  Whilst the GAG 
levels of NF, SK3 and SK4 scaffolds were similar following RCCS culture, it was 
observed that the collagen level of the SK3 scaffolds was reduced compared to that 
of the NF and SK4 scaffolds.  NF and SK4 scaffolds, which were of a similar 
density, were less dense than SK3 scaffolds.  This suggests that scaffold density may 
influence the production of ECM components by cells.  Lower levels of GAGs and 
collagens were detected in SK5 scaffolds cultured within the RCCS compared to 
the other scaffolds.  Although these scaffolds showed the least resistance to fluid 
flow, they were the most difficult to seed with cells, as indicated by the lower 
numbers of OMCs seeded into the scaffolds compared to NF, SK3 and SK4 scaffolds 
at each of the agitation speeds.  The poor cartilage formation observed in SK5 
scaffolds cultured within the RCCS may be the result of the low cell seeding since 
it is has been reported that for in vitro cartilage formation, a high density of cells 
within tissue engineering scaffolds is necessary (Vunjak-Novakovic 2003).    
 
Further cartilage formation studies were carried out on NF and SK4 scaffolds by 
culturing them with OMCs in either static plates or the RCCS for eight weeks.   
For all constructs, an increase in weight, decrease in cellularity and increase in 
collagen content was detected between samples cultured for 4 and 8 weeks.  In 
addition the GAG content of NF and SK4 scaffolds cultured in static 6-well plates 
increased from weeks 4 to 8.   
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The GAG and collagen content of NF and SK4 scaffolds following 8-week RCCS 
culture was similar to that reported by Freed and colleagues who cultured BACs in 
PGA non woven scaffolds in rotating wall bioreactors (Freed et al 1994a, Vunjak-
Novakovic et al 1999 and Pei et al 2002).  In both NF and SK4 scaffolds cultured 
within the RCCS the distribution of live and dead cells at the centre of 8-week 
constructs was similar, with mixed populations of live and dead cells visible.  
Following static culture, however, a difference was detected between the number and 
viability of cells at the centre of each of the scaffold types.  Within NF scaffolds, 
fewer cells were visible at the centre of the scaffolds and of these, a large number 
were non viable.  In contrast, more cells were observed at the centre of SK4 scaffolds 
and the majority of these cells were viable.  It was therefore concluded that the wider 
aligned channels within the sparse knit scaffold were advantageous in a culture 
system where the transfer of nutrients was dependent on diffusion.  As previously 
mentioned, one of the key challenges in tissue engineering is that of producing tissue 
constructs of clinically useful sizes.  Evaluation of SK4 scaffolds of clinically 
relevant sizes should be considered for future work.   
 
In the studies presented in this thesis, it was determined that the biochemical 
composition of the NF and SK4 constructs following 8-week RCCS culture was 
similar to that determined experimentally for native ovine articular cartilage.  Huckle 
and co-workers have previously proposed that meniscal fibrochondrocytes may be 
used for engineering articular cartilage, although there was some controversy as to 
whether the cartilage engineered in their study was truly hyaline (Huckle et al 2003).  
Meniscal fibrochondrocytes are advantageous for cartilage tissue engineering since 
their proliferative capacity is greater than that of articular chondrocytes which 
facilitates in vitro expansion of the cells and allows a sufficient number of cells to be 
obtained for in vitro tissue formation.  A disadvantage of using these cells, however, 
is that they have a natural propensity to produce a fibrous matrix which contains type 
I collagen, in contrast to hyaline cartilage which contains a large amount of type II 
collagen and very little type I collagen.   
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There is some evidence in this thesis to suggest that meniscal fibrochondrocytes may 
be used to generate articular cartilage in vitro since the biochemical composition of 
the engineered tissue was more similar to that of articular cartilage, although further 
studies to assess the collagen and GAG types present in the tissue would be required 
to allow a more conclusive comparison between the engineered cartilage and native 
articular cartilage.   
 
It has recently been reported that a population of chondroprogenitor cells reside 
within the superficial zone of cartilage (Douthwaite et al 2004).  These cells have 
been shown to regenerate cartilaginous tissue in pellet cultures, within cartilage 
defects and when injected intravenously in ovo (Thomson et al 2004).  It has also 
been shown that these cells can undergo more population doublings than 
chondrocytes isolated from full thickness articular cartilage and still retain their 
ability to form articular cartilage (Bishop 2003).  These cells are therefore 
advantageous for articular cartilage engineering since they have the natural ability to 
form hyaline cartilage and they can be expanded in vitro in order to obtain a 
sufficient number of cells from a small biopsy of tissue.  Future studies could 
investigate the formation of cartilage in SK4 scaffolds by these cells. 
 
The histological sections of the cartilage engineered in these studies differed from 
those of the native articular cartilage and meniscal fibrocartilage.  The cells within 
the engineered tissue were not contained within lacunae and the engineered tissue 
lacked the organisation of the native tissues, for example the superficial, transitional, 
middle and calcified zones of native articular cartilage were not visible.  Future 
cartilage studies could investigate the ability for the tissue to mature further.  These 
studies could include investigation of the use of culture systems that provide the 
growing tissue with mechanical stimuli, for example the dynamic culture system 
used by Chowdhury and colleagues (Chowdhury et al 2003). 
 
In conclusion, novel tissue engineering scaffolds containing both random and 
anisotopic porosity (sparse knit scaffolds) were characterised and assessed for their 
suitability for in vitro cartilage formation.   
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It was found that sparse knit scaffolds had improved flow properties compared to 
random fibrous scaffolds (needled felt scaffolds).  Similar cartilage formation was 
observed in sparse knit 4 and needled felt scaffolds, following both 4 and 8 week 
culture.  In addition, the commercially available RCCS was found to be optimal 
for in vitro cartilage formation compared to either static plates or the novel flow 
perfusion bioreactor.  In 8-week static cultures, a greater number of viable cells were 
detected at the centre of sparse knit 4 scaffolds than needled felt scaffolds, indicating 
that the novel scaffolds were advantageous in culture systems where nutrient supply 
was dependent on diffusion alone.   
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 Appendix 1  
Materials 
 
Material Supplier 
1,4 diazobicyclo-2-2-2-octane (DABCO)  
 
Sigma-Aldrich 
D2522 
1, 9 dimethylemethylene blue (DMMB) Sigma-Aldrich 
34, 108-8 
Acetone Fisher Chemicals 
A/0520/17 
Alamar Blue solution Serotec 
BUF012B 
Antibiotic Antimycotic solution Sigma-Aldrich 
A5955 
Ascorbic acid-2-phosphate Sigma-Aldrich 
A8960 
BisBenzimide (Hoechst no. 33258) Sigma-Aldrich 
B2883 
Chondroitin-4-sulphate Sigma-Aldrich 
C8529 
cis-4-hydroxy-L-proline Sigma-Aldrich 
H1637 
Citric acid Sigma-Aldrich 
C7129 
Collagenase 
(Worthingtons type II) 
Lorne Laboratories 
LS004176 
Concentrated hydrochloric acid (HCl) Fisher Chemicals 
H/1200/PB17 
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 Cysteine hydrochloride Sigma-Aldrich 
C1276 
Dimethylsulphoxide (DMSO) Sigma-Aldrich 
D8418 
Di-sodium hydrogen phosphate dodecahydrate Fluka 
71663 
Distyrene plasticiser xylene mountant (DPX) Nustain 
AE020 
Dulbeccos Modified Eagles Medium (DMEM) Sigma-Aldrich 
D6429 
Dulbeccos phosphate buffered saline (DPBS) Sigma-Aldrich 
D8537 
Eosin (yellowish) Nustain 
AD046 
Ethanol Fisher Chemicals 
E/0650DF/15 
Ethylenediaminetetracetic acid (EDTA) Sigma-Aldrich 
ED2SS 
Fast Green  Nustain 
AD060 
Foetal calf serum (FCS) Sigma-Aldrich 
F7524 
Formal saline (10% buffered) Nustain 
AF010 
Formic acid VWR International 
101157H 
Gentamicin solution (10 mg/mL) Invitrogen Ltd 
15710-049 
Glacial acetic acid Sigma-Aldrich 
A6283 
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 Glutaraldehyde solution (50%) TAAB 
G006 
Glycerol Sigma-Aldrich 
G7893 
Hanks balanced salt solution (HBSS) 
(without phenol red) 
Sigma-Aldrich 
H1387 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) 
Sigma-Aldrich 
H3375 
Hexamethyldisilaxane (HMDS) Sigma-Aldrich 
H4875 
Industrial methylated spirits (IMS) Fisher Chemicals 
M/4450/17 
L-glutamine solution (200 mM in dH2O) Sigma-Aldrich 
G7513 
L-proline Sigma-Aldrich 
P8449 
Live/Dead viability/cytotoxicity assay kit Molecular Probes 
L3224 
Mayers haematoxylin Nustain 
AS040 
N-chloro-p-toluenesulfonamide (Chloramine T) Sigma-Aldrich 
C9887 
Non essential amino acid solution (NEAA) Sigma-Aldrich 
M7145 
Osmium tetroxide solution (2% w/v) TAAB 
O006 
Papain Sigma-Aldrich 
P4762 
Paraformaldehyde Sigma-Aldrich 
P6148 
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 p-dimethylaminobenzaldehyde (p-DAB) Sigma-Aldrich 
D8904 
Perchloric acid (60%) VWR International 
101752U 
Phosphate buffered saline (PBS) Oxoid Products 
BR0014 
Pronase E 
 
VWR International 
1074330005 
Propan-2-ol Fisher Chemicals 
P/7490/17 
Safranin O Nustain 
AS106 
Saline sodium citrate solution (SSC; 20% v/v) Sigma-Aldrich 
S6639 
Scotts tap water substitute Nustain 
AE077 
Sodium acetate Sigma-Aldrich 
S5636 
Sodium bicarbonate Sigma-Aldrich 
S6014 
Sodium chloride Sigma-Aldrich 
S9888 
Sodium dihydrogen phosphate dihydrate Fluka 
71502 
Sodium formate Fisher Chemicals 
S/4082/53 
Sodium hydroxide (1 M solution) Fisher Chemicals 
J/7620/17 
Sodium hydroxide (pellets) Fisher Chemicals 
S/4880/53 
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 Sodium phosphate dibasic Sigma-Aldrich 
S0876 
Sodium phosphate monobasic Sigma-Aldrich 
S8282 
Technovit 8100 resin kit TAAB 
T220 
Toluene Fisher chemicals 
T/2200/17 
Trizma base Sigma-Aldrich 
T6066 
Trypan blue Sigma-Aldrich 
T8154 
Trypsin solution 
(25 g/L in 0.9% NaCl) 
Sigma-Aldrich 
T4549 
Xylene Fisher Chemicals 
X/0200/17 
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Appendix 2  
Solutions 
2.1 Isolation of cartilage 
2.1.1 Phosphate buffered saline (PBS)  
  PBS      1 tablet 
  Distilled H2O     100 mL 
 
PBS tablets were dissolved in distilled water and autoclaved for 20 minutes at 120qC. 
 
2.1.2 Gentamicin PBS solution 
  PBS      100 mL 
  Gentamicin solution (10 mg/mL)  0.5 mL 
 
Gentamicin PBS solution was stored at 4qC until required. 
 
2.2 Isolation of chondrocytes  
2.2.1 Cartilage digestion medium 
  FCS      50 mL 
  NEAA      10 mL  
  L-glutamine solution (200 mM)  10 mL 
  Gentamicin solution (10 mg/mL)  5 mL 
  HEPES     10 g 
  DMEM     1 L 
 
All supplements were passed through a 0.2 Pm filter into the DMEM.  Cartilage 
digestion medium was stored at 4qC. 
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2.2.2 Pronase digestion medium 
  Pronase E     0.1 g 
  Cartilage digestion medium   100 mL 
 
Pronase E was passed through a 0.2 Pm filter into the cartilage digestion medium.  
Pronase digestion medium was prepared immediately before use.  Cartilage was 
digested using 10 mL of pronase digestion medium per g of tissue. 
 
2.2.3 Collagenase digestion medium 
  Collagenase (Type II)    0.2 g 
  Cartilage digestion medium   100 mL 
 
Collagenase was passed through a 0.2 Pm filter into the cartilage digestion medium.  
Collagenase digestion medium was prepared immediately before use.  Cartilage was 
digested using 10 mL of collagenase digestion medium per g of tissue. 
 
2.3 Cell culture   
2.3.1 Chondrocyte medium 
  FCS      100 mL 
  NEAA      10 mL 
  L-glutamine     10 mL  
  Antibiotic antimycotic solution  10 mL 
  Ascorbic acid-2-phosphate   0.18 g 
  L-proline     0.046 g  
  DMEM     1 L 
 
All supplements were passed through a 0.2 Pm filter into the DMEM.  Antibiotic 
antimycotic solution was composed of 10 000 units/mL penicillin G, 100 mg/mL 
streptomycin sulphate and 25Pg/mL amphotericin B.  Chondrocyte medium was 
stored at 4qC. 
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2.3.2 Trypsin EDTA in PBS 
  EDTA solution (0.02% w/v in dH2O)  10 mL 
  Trypsin solution (25 g/L in 0.9% NaCl) 100 mL 
  PBS                        to 1 L 
 
EDTA and trypsin solutions were passed through a 0.2 Pm filter into PBS.  Trypsin 
EDTA in PBS was stored at -20qC. 
 
2.3.3 Freezing medium 
  DMSO      2 mL 
  FCS      18 mL 
 
Freezing medium was passed through a 0.2 Pm filter and stored at -20qC. 
 
2.3.4 HOS TE85 medium 
FCS      100 mL 
  NEAA      10 mL 
  L-glutamine     10 mL  
  Anitbiotic antimycotic solution   5 mL 
  Ascorbic acid-2-phosphate   0.15 g 
DMEM     1 L 
 
All supplements were passed through a 0.2 Pm filter into the DMEM.  HOS TE85 
medium was stored at 4qC. 
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2.4 Biochemical analysis 
2.4.1 Papain solution 
2.4.1.a  Papain buffer 
  Sodium phosphate (dibasic)   1.42 g (0.1 M) 
  Cysteine hydrochloride   0.079 g (0.005 M) 
  EDTA      0.186 g (0.005 M) 
  Distilled H2O             200 mL 
 
The pH of papain buffer was adjusted to 6.5 when necessary using 1 M HCl or 
NaOH as appropriate.  Papain buffer was stored at 4qC for up to 3 months. 
 
2.4.1.b  Papain solution 
  Papain      0.1056 g 
  Papain buffer            100 mL 
 
Papain solution was prepared immediately before use. 
 
2.4.2 Hoechst buffer 
  Sodium chloride    5.844 g (0.1 M) 
EDTA      3.802 g (0.01 M) 
  Trizma base     1.211 g (0.01 M) 
  Distilled H2O            1 L 
 
The pH of Hoechst buffer was adjusted to 7.0 when necessary using 1 M HCl or 
NaOH as appropriate.  Hoechst buffer was stored at 4qC for up to 6 months. 
 
 
 
 
 
 241
  
2.4.3 Hoechst 33258 working solution 
2.4.3.a  SSC solution (1% v/v) 
  SSC solution (20% (v/v) in dH2O)  1 mL 
  Distilled H2O                       to 20 mL 
 
1% (v/v) SSC solution was prepared immediately before use. 
 
2.4.3.b  Hoechst 33258 stock solution 
  BisBenzimide (Hoechst 33258)  0.01 g 
  1% (v/v) SSC solution    10 mL 
 
Hoechst 33258 stock solution was stored at -20qC for up to 1 year. 
 
2.4.3.c  Hoechst 33258 working solution 
  Hoechst 33258 stock solution   100 PL 
  Hoechst buffer                     to  200 mL   
 
Hoechst 33258 solution was prepared immediately before use. 
 
2.4.4 Alamar blue™ working solution 
2.4.4.a  HBSS solution 
  HBSS      9.8 g 
  Sodium bicarbonate    0.35 g 
  Distilled H2O                       to 1 L 
 
HBSS solution was passed through a 0.2 Pm filter and stored at 4qC. 
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2.4.4.b  Alamar blue™ working solution 
  Alamar blue    2 mL 
  HBSS                        to 20 mL 
 
Alamar blue working solution was prepared immediately before use. 
 
2.4.5 Chondroitin-4-sulphate working solution (100Pg/mL) 
2.4.5.a  Chondroitin-4-sulphate stock solution (1 mg/mL) 
  Chondroitin-4-sulphate   0.01 g 
  Distilled H2O     10 mL 
 
Chondrotin-4-sulphate stock solution was prepared immediately before use. 
 
2.4.5.b  Chondroitin-4-sulphate working solution (100Pg/mL) 
  Chondroitin-4-sulphate stock solution 1 mL 
  Heat-treated papain solution          to 10 mL 
 
Chondroitin-4-sulphate working solution was stored at -20qC for up to 1 year. 
 
2.4.6 DMMB solution 
  Sodium formate    2 g (0.03 M) 
  DMMB     0.016 g (0.046 mM) 
  Ethanol (100%)    5 mL 
  Formic acid     2 mL 
  Distilled H2O                       to 1 L 
 
DMMB was stored at room temperature in a foil-wrapped brown bottle for up to 3 
months. 
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2.4.7 Sodium phosphate buffer (0.25 M) 
  Sodium phosphate (dibasic)   35.5 g (0.25 M) 
  Distilled H2O                       to 1 L 
 
The pH of 0.25 M sodium phosphate buffer was adjusted to 6.5 when necessary 
using 1 M HCl or NaOH as appropriate.  The buffer was stored at 4qC for up to 3 
months. 
 
2.4.8 Hydroxyproline working solution (100Pg/mL) 
2.4.8.a  Hydroxyproline stock solution (1 mg/mL) 
  cis-4-hydroxy-L-proline    0.01 g 
  Distilled H2O     10 mL 
 
Hydrxyproline stock solution was prepared immediately before use. 
 
2.4.8.b  Hydroxyproline working solution (100 Pg/mL) 
  Hydroxyproline stock solution  1 mL 
  Hydrolysed papain solution          to 10 mL 
 
Hydroxyproline solution was stored at -20qC for up to 1 year. 
 
2.4.9 Chloramine T solution 
2.4.9.a  Chloramine stock solution 
2.4.9.a.i Chloramine stock solution a 
  Sodium acetate    120 g    
Citric acid     50 g 
Distilled H2O     650 mL 
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2.4.9.a.ii Chloramine stock solution b 
  Sodium hydroxide    34 g 
  Distilled H2O     250 mL 
 
2.4.9.a.iii Chloramine stock solution 
  Chloramine stock solution a   650 mL 
  Chloramine stock solution b   250 mL 
  Glacial acetic acid    12 mL 
  Toluene     500 PL 
  Distilled H2O                       to 1 L 
 
Chloramine stock solution was stored at 4qC for up to 3 months. 
 
2.4.9.b  Chloramine working solution 
  Propan-2-ol     150 mL 
  Chloramine stock solution   500 mL 
  Distilled H2O                       to 750 mL 
 
The pH of chloramine working solution was adjusted to 6.0 when necessary using  
1 M HCl or NaOH as appropriate.  The solution was stored at 4qC for up to 3 
months. 
 
2.4.9.c  Chloramine T solution 
  Chloramine T      0.3525 g (0.07 M) 
  Propan-2-ol      2.5 mL 
  Chloramine working solution   20 mL 
 
Chloramine T solution was prepared immediately before use. 
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2.4.10 p-DAB solution 
  p-DAB     3.75 g (1.16 M) 
  Perchloric acid (60%)    6.5 mL 
Propan-2-ol     15 mL 
    
p-DAB solution was prepared immediately before use. 
 
2.5 Histology 
2.5.1 Alcoholic eosin solution (1% w/v) 
  Eosin      1 g 
  IMS (25% v/v in dH2O)   100 mL 
 
Alcoholic eosin solution was stored in a foil-wrapped bottle at room temperature. 
 
2.5.2 Aqueous fast green solution (0.02% w/v) 
  Fast green     0.02 g 
  Distilled H2O     100 mL 
 
Aqueous fast green solution was stored in a foil-wrapped bottle at room temperature. 
 
2.5.3 Acetic acid solution (1% v/v) 
  Glacial acetic acid    1 mL 
Distilled H2O                       to 100 mL 
 
Acetic acid solution was stored at room temperature. 
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2.5.4 Paraformaldehyde solution (4% v/v) 
2.5.4.a  Phosphate buffer (0.2 M) 
  Sodium dihydrogen phosphate dihydrate  13.8 g (0.1 M) 
Di-sodium hydrogen phosphate dodecahydrate 35.85 g (0.1 M) 
Distilled H2O                                   to 1 L 
 
The pH of 0.2 M phosphate buffer was adjusted to 7.4 when necessary using 1 M 
HCl of NaOH as appropriate.  
 
2.5.4.b  Paraformaldehyde (10% w/v) 
  Sodium hydroxide (1 M)   20 mL 
  Paraformaldehyde    10 g 
Distilled H2O                      to  100 mL 
 
2.5.4.c  Paraformaldehyde (4% v/v) 
  10% (w/v) paraformaldehyde   80 mL 
  0.2 M phosphate buffer          100 mL 
  Distilled H2O            to 200 mL 
 
4% (v/v) paraformaldehyde solution was stored at -20qC for up to 1 year. 
 
2.5.5 Technovit 8100 infiltration solution 
  Technovit 8100 hardener I   0.6 g   
  Technovit 8100 liquid          to 100 mL 
 
Technovit 8100 infiltration solution was stored at 4 qC for up to 1 month. 
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2.5.6 Technovit 8100 embedding solution 
  Technovit 8100 hardener II   0.5 mL 
  Technovit 8100 infiltration solution        to 50 mL 
 
Technovit 8100 embedding solution was prepared immediately before use. 
 
2.6 Scanning electron microscopy 
2.6.1 Glutaraldehyde solution (3% v/v) 
2.6.1.a  Sodium phosphate buffer (0.1 M) 
  Sodium phosphate (monobasic)  2.76 g (0.023 M) 
  Sodium phosphate (dibasic)   2.84 g (0.02 M) 
  Distilled H2O           to 1 L 
  
The pH of 0.1 M sodium phosphate buffer was adjusted to 7.2 when necessary using 
1 M HCl or NaOH as appropriate.  The buffer was stored at room temperature until 
required.  
 
2.6.1.b  Glutaraldehyde solution (3% v/v) 
  0.1 M sodium phosphate buffer    18.8 mL 
  Glutaraldehyde solution (50% (v/v) in dH2O) 1.2 mL 
 
The 3% (v/v) glutaraldehyde solution was stored at 4qC. 
 
2.6.2 Osmium tetroxide solution (1% v/v) 
2.6.2.a  Sodium phosphate buffer (0.05 M) 
  0.1 M sodium phosphate buffer  50 mL 
  Distilled H2O     50 mL 
 
The 0.05 M sodium phosphate buffer was stored at room temperature until required. 
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2.6.2.b  Osmium tetroxide solution (1% v/v) 
  0.05 M sodium phosphate buffer   5 mL 
  Osmium tetroxide solution (2% (w/v) in dH2O) 5 mL 
 
The 1% (v/v) osmium tetroxide solution was prepared immediately before use. 
 
2.7 Confocal microscopy 
2.7.1 Live/Dead™ working solution 
The Live/Dead viability/cytotoxicity assay kit reagents were thawed and allowed 
to reach room temperature. 
 
2.7.1.a  Ethidium homodimer solution 
Ethidium homodimer-1 (2 mM)   20 PL 
  Dulbeccos PBS (DPBS)    10 mL 
 
The solution was thoroughly mixed. 
 
2.7.1.b  Live/Dead™ working solution 
  Ethidium homodimer solution   10 mL 
  Calcein AM solution (4 mM)    5 PL 
 
Live/Dead working solution was prepared immediately before use and kept 
protected from light. 
 
2.7.2 DABCO mountant 
2.7.2.a  DABCO in PBS 
  1,4 diazobicyclo-2-2-2-octane (DABCO)  20 mg 
  PBS       10 mL 
 
The pH of DABCO in PBS was adjusted to 8.6 when necessary using 1 M HCl or 
NaOH as appropriate.  The buffer was stored at 4qC until required. 
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2.7.2.b  DABCO mountant 
  glycerol      9 mL 
  DABCO in PBS     1 mL 
 
DABCO mountant was stored at 4qC for up to 3 months. 
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 Appendix 3  
Equations 
 
 
3.1 Quantification of GAG content 
GAG content (%) = [chondroitin-4-sulphate] (Pg/mL) x dilution factor x papain volume (PL) x 100% 
           106 x dry tissue weight (g) 
 
Where: 
[Chondroitin-4-sulphate]  - concentration of chondroitin-4-sulphate in sample                 
                                                   calculated from the calibration curve  
Dilution factor    - amount the digested sample was diluted by 
Papain volume   - volume of the original papain digest that was used  
106   - correction factor to take into account the different  
                                                   units  
Dry tissue weight   - mass of lyophilised sample that was digested 
 
3.2 Quantification of collagen content 
collagen content (%) = [hydroxyproline] (Pg/ml) x DF x proportion hydrolysed  x 100% 
                   106 x dry tissue weight x 0.143 
 
Where: 
[Hydroxyproline]  - concentration of hydroxyproline in sample                 
                                                   calculated from the calibration curve  
DF     - amount the digested sample was diluted by 
Proportion hydrolysed - proportion of the original papain digest that was        
                                                   hydrolysed 
106   - correction factor to take into account the different  
                                                   units  
Dry tissue weight   - mass of lyophilised sample that was digested 
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 0.143    - correction factor to take into account that 14.3% of     
                                                   collagen is hydroxyproline 
 
 
3.3 Calculation of the volume of a cylinder 
 
volume (m3) = S x r2 (m2) x h (m) 
Where: 
S = 3.14217 
r = radius of the circle (1/2 the diameter) 
h = height (or thickness) of the cylinder 
 
 
3.4 Calculation of density 
 
density (g m-3)  = mass (g) 
                              volume (m3) 
 
 
3.5 Characterisation of scaffold resistance to flow 
 
R = P x g x h 
       F 
 
Where: 
R = scaffold resistance to flow 
P = pressure of air (1000 mbar) 
F = flow rate 
g = force due to gravity (9.81Pa) 
h = height of water above scaffold 
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3.6 Assessment of increase in construct weight 
 
weight increase  (%) = scaffold weight after culture  (g) -  scaffold  weight before culture (g) x 100% 
          scaffold weight before culture 
 
 
 
 
 
3.7 Normalisation of cell number with respect to dry 
sample weight 
 
number of cells per gram dry tissue weight   =      total number of cells in sample 
       dry weight of sample (g) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 253
